,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1108904,11443,Comparative Toxicogenomics Database (CTD),"2,4-Diisocyanato-1-methylbenzene",D014051,"Toluene 2,4-Diisocyanate",https://ctdbase.org/detail.go?type=chem&acc=D014051,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090,Mus musculus (house mouse),"TSLP protein affects the reaction [toluene 2,4-diisocyanate results in increased secretion of IL4 protein]",,,PMID:31577921,https://www.ncbi.nlm.nih.gov/pubmed/31577921,31577921,,
1,1108905,11443,Comparative Toxicogenomics Database (CTD),"2,4-Diisocyanato-1-methylbenzene",D014051,"Toluene 2,4-Diisocyanate",https://ctdbase.org/detail.go?type=chem&acc=D014051,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090,Mus musculus (house mouse),"TSLP protein alternative form inhibits the reaction [toluene 2,4-diisocyanate results in increased secretion of IL4 protein]",,,PMID:28329851,https://www.ncbi.nlm.nih.gov/pubmed/28329851,28329851,,
2,1108906,11443,Comparative Toxicogenomics Database (CTD),"2,4-Diisocyanato-1-methylbenzene",D014051,"Toluene 2,4-Diisocyanate",https://ctdbase.org/detail.go?type=chem&acc=D014051,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10116,Rattus norvegicus (Norway rat),"Olopatadine hydrochloride inhibits the reaction [toluene 2,4-diisocyanate results in increased expression of IL4 mrna]|epinastine inhibits the reaction [toluene 2,4-diisocyanate results in increased expression of IL4 mrna]|chlorpheniramine inhibits the reaction [toluene 2,4-diisocyanate results in increased expression of IL4 mrna]",,,PMID:19075512,https://www.ncbi.nlm.nih.gov/pubmed/19075512,19075512,,
3,1108907,11443,Comparative Toxicogenomics Database (CTD),"2,4-Diisocyanato-1-methylbenzene",D014051,"Toluene 2,4-Diisocyanate",https://ctdbase.org/detail.go?type=chem&acc=D014051,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10116,Rattus norvegicus (Norway rat),"Quercetin inhibits the reaction [toluene 2,4-diisocyanate results in increased expression of IL4 mrna]",,,PMID:23333628,https://www.ncbi.nlm.nih.gov/pubmed/23333628,23333628,,
4,1108908,11443,Comparative Toxicogenomics Database (CTD),"2,4-Diisocyanato-1-methylbenzene",D014051,"Toluene 2,4-Diisocyanate",https://ctdbase.org/detail.go?type=chem&acc=D014051,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10116,Rattus norvegicus (Norway rat),"Sho-seiryu-to inhibits the reaction [toluene 2,4-diisocyanate results in increased expression of IL4 mrna]",,,PMID:19050374,https://www.ncbi.nlm.nih.gov/pubmed/19050374,19050374,,
5,1108909,11443,Comparative Toxicogenomics Database (CTD),"2,4-Diisocyanato-1-methylbenzene",D014051,"Toluene 2,4-Diisocyanate",https://ctdbase.org/detail.go?type=chem&acc=D014051,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10116,Rattus norvegicus (Norway rat),"Toluene 2,4-diisocyanate results in increased expression of IL4 mRNA",,,PMID:19050374|PMID:19075512|PMID:23333628,https://www.ncbi.nlm.nih.gov/pubmed/19050374|https://www.ncbi.nlm.nih.gov/pubmed/19075512|https://www.ncbi.nlm.nih.gov/pubmed/23333628,19050374|19075512|23333628,,
6,1108910,11443,Comparative Toxicogenomics Database (CTD),"2,4-Diisocyanato-1-methylbenzene",D014051,"Toluene 2,4-Diisocyanate",https://ctdbase.org/detail.go?type=chem&acc=D014051,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10116,Rattus norvegicus (Norway rat),"Toluene 2,4-diisocyanate results in increased expression of IL4 protein",,,PMID:11758997|PMID:15950818,https://www.ncbi.nlm.nih.gov/pubmed/11758997|https://www.ncbi.nlm.nih.gov/pubmed/15950818,11758997|15950818,,
7,1108911,11443,Comparative Toxicogenomics Database (CTD),"2,4-Diisocyanato-1-methylbenzene",D014051,"Toluene 2,4-Diisocyanate",https://ctdbase.org/detail.go?type=chem&acc=D014051,16190,IL4RA,https://ctdbase.org/detail.go?type=gene&acc=16190,,,16190.0,Il4ra,10090,Mus musculus (house mouse),"Toluene 2,4-diisocyanate results in increased expression of IL4RA mRNA",,,PMID:19647056,https://www.ncbi.nlm.nih.gov/pubmed/19647056,19647056,,
8,1109702,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,6904,TBCD,https://ctdbase.org/detail.go?type=gene&acc=6904,,,6904.0,TBCD,9606,Homo sapiens (human),[bisphenol F co-treated with fulvestrant] results in decreased methylation of TBCD gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
9,1109703,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,6904,TBCD,https://ctdbase.org/detail.go?type=gene&acc=6904,,,6904.0,TBCD,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of TBCD mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
10,1109704,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,6905,TBCE,https://ctdbase.org/detail.go?type=gene&acc=6905,,,6905.0,TBCE,9606,Homo sapiens (human),Bisphenol F results in increased expression of TBCE protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
11,1109545,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D004147,Dioxins,https://ctdbase.org/detail.go?type=chem&acc=D004147,259232,NALCN,https://ctdbase.org/detail.go?type=gene&acc=259232,,,259232.0,NALCN,10116,Rattus norvegicus (Norway rat),Dioxins affects the methylation of NALCN gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
12,1109546,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D004147,Dioxins,https://ctdbase.org/detail.go?type=chem&acc=D004147,728215,NALF1,https://ctdbase.org/detail.go?type=gene&acc=728215,,,728215.0,NALF1,10116,Rattus norvegicus (Norway rat),Dioxins affects the methylation of NALF1 gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
13,1109547,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D004147,Dioxins,https://ctdbase.org/detail.go?type=chem&acc=D004147,54187,NANS,https://ctdbase.org/detail.go?type=gene&acc=54187,,,54187.0,NANS,10116,Rattus norvegicus (Norway rat),Dioxins affects the methylation of NANS gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
14,1109548,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D004147,Dioxins,https://ctdbase.org/detail.go?type=chem&acc=D004147,4676,NAP1L4,https://ctdbase.org/detail.go?type=gene&acc=4676,,,4676.0,NAP1L4,7955,Danio rerio (zebrafish),Dioxins affects the expression of NAP1L4 mRNA,,,PMID:20463971,https://www.ncbi.nlm.nih.gov/pubmed/20463971,20463971,,
15,1163657,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,10750,GRAP,https://ctdbase.org/detail.go?type=gene&acc=10750,,,10750.0,GRAP,10090,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of GRAP mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
16,1163658,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,10750,GRAP,https://ctdbase.org/detail.go?type=gene&acc=10750,,,10750.0,GRAP,10116,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin affects the expression of GRAP mRNA,,,PMID:34747641,https://www.ncbi.nlm.nih.gov/pubmed/34747641,34747641,,
17,1163659,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,10750,GRAP,https://ctdbase.org/detail.go?type=gene&acc=10750,,,10750.0,GRAP,10116,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in decreased expression of GRAP mRNA,,,PMID:32109520,https://www.ncbi.nlm.nih.gov/pubmed/32109520,32109520,,
18,1163660,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,10750,GRAP,https://ctdbase.org/detail.go?type=gene&acc=10750,,,10750.0,GRAP,10116,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in increased expression of GRAP mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
19,1164612,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,51155,JPT1,https://ctdbase.org/detail.go?type=gene&acc=51155,,,51155.0,JPT1,10090,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of JPT1 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
20,1164467,17253,Comparative Toxicogenomics Database (CTD),"1,2-Benzanthraquinone",C077646,"7,12-benz(a)anthraquinone",https://ctdbase.org/detail.go?type=chem&acc=C077646,100137725,CYP1C2,https://ctdbase.org/detail.go?type=gene&acc=100137725,,,100137725.0,cyp1c2,7955,Danio rerio (zebrafish),"7,12-benz(a)anthraquinone results in increased expression of CYP1C2 mRNA",,,PMID:23684558|PMID:26141390,https://www.ncbi.nlm.nih.gov/pubmed/23684558|https://www.ncbi.nlm.nih.gov/pubmed/26141390,23684558|26141390,,
21,1164302,23978,Comparative Toxicogenomics Database (CTD),Copper,D003300,Copper,https://ctdbase.org/detail.go?type=chem&acc=D003300,9201,DCLK1,https://ctdbase.org/detail.go?type=gene&acc=9201,,,9201.0,DCLK1,10116,Rattus norvegicus (Norway rat),Copper results in increased expression of DCLK1 mRNA,,,PMID:30556269,https://www.ncbi.nlm.nih.gov/pubmed/30556269,30556269,,
22,1109391,24385,Toxin and Toxin Target Database (T3DB),Nickel Chloride,T3D0687,Nickel chloride,http://www.t3db.ca/toxins/T3D0687,BE0005173,Histone H2B type W-T,http://www.t3db.ca/biodb/bio_entities/BE0005173,Q7Z2G1,Histone H2B type W-T,158983.0,H2BW1,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
23,1109392,24385,Toxin and Toxin Target Database (T3DB),Nickel Chloride,T3D0687,Nickel chloride,http://www.t3db.ca/toxins/T3D0687,BE0005095,Histone H3-like centromeric protein A,http://www.t3db.ca/biodb/bio_entities/BE0005095,P49450,Histone H3-like centromeric protein A,1058.0,CENPA,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
24,1109393,24385,Toxin and Toxin Target Database (T3DB),Nickel Chloride,T3D0687,Nickel chloride,http://www.t3db.ca/toxins/T3D0687,BE0005045,Histone H3.1,http://www.t3db.ca/biodb/bio_entities/BE0005045,P68431,Histone H3.1,8353.0,H3C6,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
25,1109394,24385,Toxin and Toxin Target Database (T3DB),Nickel Chloride,T3D0687,Nickel chloride,http://www.t3db.ca/toxins/T3D0687,BE0004977,Histone H3.1t,http://www.t3db.ca/biodb/bio_entities/BE0004977,Q16695,Histone H3.1t,8290.0,H3-4,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
26,1109395,24385,Toxin and Toxin Target Database (T3DB),Nickel Chloride,T3D0687,Nickel chloride,http://www.t3db.ca/toxins/T3D0687,BE0005046,Histone H3.2,http://www.t3db.ca/biodb/bio_entities/BE0005046,Q71DI3,Histone H3.2,333932.0,H3C15,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
27,1109396,24385,Toxin and Toxin Target Database (T3DB),Nickel Chloride,T3D0687,Nickel chloride,http://www.t3db.ca/toxins/T3D0687,BE0004985,Histone H3.3,http://www.t3db.ca/biodb/bio_entities/BE0004985,P84243,Histone H3.3,3021.0,H3-3B,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
28,1109397,24385,Toxin and Toxin Target Database (T3DB),Nickel Chloride,T3D0687,Nickel chloride,http://www.t3db.ca/toxins/T3D0687,BE0005096,Histone H3.3C,http://www.t3db.ca/biodb/bio_entities/BE0005096,Q6NXT2,Histone H3.3C,440093.0,H3-5,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
29,1109398,24385,Toxin and Toxin Target Database (T3DB),Nickel Chloride,T3D0687,Nickel chloride,http://www.t3db.ca/toxins/T3D0687,BE0004995,Histone H4,http://www.t3db.ca/biodb/bio_entities/BE0004995,P62805,Histone H4,8366.0,H4C2,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
30,1109053,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,4059,BCAM,https://ctdbase.org/detail.go?type=gene&acc=4059,,,4059.0,BCAM,10090,Mus musculus (house mouse),Ozone results in decreased expression of BCAM mRNA,,,PMID:33026818,https://www.ncbi.nlm.nih.gov/pubmed/33026818,33026818,,
31,1109054,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,55973,BCAP29,https://ctdbase.org/detail.go?type=gene&acc=55973,,,55973.0,BCAP29,9606,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of BCAP29 mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
32,1109055,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,9564,BCAR1,https://ctdbase.org/detail.go?type=gene&acc=9564,,,9564.0,BCAR1,10116,Rattus norvegicus (Norway rat),Ozone results in increased expression of BCAR1 mRNA,,,PMID:16330353,https://www.ncbi.nlm.nih.gov/pubmed/16330353,16330353,,
33,1109056,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,8412,BCAR3,https://ctdbase.org/detail.go?type=gene&acc=8412,,,8412.0,BCAR3,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of BCAR3 mrna|[volatile organic compounds co-treated with ozone] results in increased oxidation of BCAR3 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of BCAR3 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
34,1109057,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,8412,BCAR3,https://ctdbase.org/detail.go?type=gene&acc=8412,,,8412.0,BCAR3,10090,Mus musculus (house mouse),Ozone results in increased expression of BCAR3 mRNA,,,PMID:17095637,https://www.ncbi.nlm.nih.gov/pubmed/17095637,17095637,,
35,1109058,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,8537,BCAS1,https://ctdbase.org/detail.go?type=gene&acc=8537,,,8537.0,BCAS1,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of BCAS1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
36,1109059,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,10286,BCAS2,https://ctdbase.org/detail.go?type=gene&acc=10286,,,10286.0,BCAS2,10090,Mus musculus (house mouse),Pyrazolanthrone inhibits the reaction [ozone results in increased expression of BCAS2 mrna],,,PMID:17460151,https://www.ncbi.nlm.nih.gov/pubmed/17460151,17460151,,
37,1109060,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,54828,BCAS3,https://ctdbase.org/detail.go?type=gene&acc=54828,,,54828.0,BCAS3,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of BCAS3 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of BCAS3 mrna|[volatile organic compounds co-treated with ozone] results in decreased expression of BCAS3 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
38,1334711,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,23753,SDF2L1,https://ctdbase.org/detail.go?type=gene&acc=23753,,,23753.0,SDF2L1,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in increased expression of SDF2L1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
39,1334843,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,6391,SDHC,https://ctdbase.org/detail.go?type=gene&acc=6391,,,6391.0,SDHC,10116,Rattus norvegicus (Norway rat),Ozone results in decreased expression of SDHC mRNA,,,PMID:32991914,https://www.ncbi.nlm.nih.gov/pubmed/32991914,32991914,,
40,1334844,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,6392,SDHD,https://ctdbase.org/detail.go?type=gene&acc=6392,,,6392.0,SDHD,9606,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of SDHD mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
41,1334845,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,6392,SDHD,https://ctdbase.org/detail.go?type=gene&acc=6392,,,6392.0,SDHD,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of SDHD mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
42,1334846,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,221935,SDK1,https://ctdbase.org/detail.go?type=gene&acc=221935,,,221935.0,SDK1,10090,Mus musculus (house mouse),Ozone results in decreased expression of SDK1 mRNA,,,PMID:33026818,https://www.ncbi.nlm.nih.gov/pubmed/33026818,33026818,,
43,1334847,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,56948,SDR39U1,https://ctdbase.org/detail.go?type=gene&acc=56948,,,56948.0,SDR39U1,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of SDR39U1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
44,1334848,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,10993,SDS,https://ctdbase.org/detail.go?type=gene&acc=10993,,,10993.0,SDS,10116,Rattus norvegicus (Norway rat),Ozone results in increased expression of SDS mRNA,,,PMID:25838073,https://www.ncbi.nlm.nih.gov/pubmed/25838073,25838073,,
45,1334849,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,113675,SDSL,https://ctdbase.org/detail.go?type=gene&acc=113675,,,113675.0,SDSL,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of SDSL mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
46,1334850,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,6397,SEC14L1,https://ctdbase.org/detail.go?type=gene&acc=6397,,,6397.0,SEC14L1,9606,Homo sapiens (human),[volatile organic compounds co-treated with ozone] results in increased oxidation of SEC14L1 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of SEC14L1 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of SEC14L1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
47,1334851,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,6397,SEC14L1,https://ctdbase.org/detail.go?type=gene&acc=6397,,,6397.0,SEC14L1,9606,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of SEC14L1 mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
48,1334963,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,9919,SEC16A,https://ctdbase.org/detail.go?type=gene&acc=9919,,,9919.0,SEC16A,9606,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of SEC16A mrna|[volatile organic compounds co-treated with ozone] results in increased oxidation of SEC16A mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of SEC16A mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
49,1334964,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,89866,SEC16B,https://ctdbase.org/detail.go?type=gene&acc=89866,,,89866.0,SEC16B,10090,Mus musculus (house mouse),Ozone results in decreased expression of SEC16B mRNA,,,PMID:33026818,https://www.ncbi.nlm.nih.gov/pubmed/33026818,33026818,,
50,1334965,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,9117,SEC22C,https://ctdbase.org/detail.go?type=gene&acc=9117,,,9117.0,SEC22C,9606,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of SEC22C mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
51,1334966,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,10484,SEC23A,https://ctdbase.org/detail.go?type=gene&acc=10484,,,10484.0,SEC23A,9606,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of SEC23A mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
52,1334967,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,10802,SEC24A,https://ctdbase.org/detail.go?type=gene&acc=10802,,,10802.0,SEC24A,9606,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of SEC24A mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
53,1334968,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,9632,SEC24C,https://ctdbase.org/detail.go?type=gene&acc=9632,,,9632.0,SEC24C,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of SEC24C mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of SEC24C mrna|[volatile organic compounds co-treated with ozone] results in increased oxidation of SEC24C mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
54,1334969,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,22872,SEC31A,https://ctdbase.org/detail.go?type=gene&acc=22872,,,22872.0,SEC31A,9606,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of SEC31A mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
55,1334970,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,25956,SEC31B,https://ctdbase.org/detail.go?type=gene&acc=25956,,,25956.0,SEC31B,9606,Homo sapiens (human),[volatile organic compounds co-treated with ozone] results in decreased expression of SEC31B mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of SEC31B mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of SEC31B mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
56,1334971,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,7095,SEC62,https://ctdbase.org/detail.go?type=gene&acc=7095,,,7095.0,SEC62,10116,Rattus norvegicus (Norway rat),Ozone results in increased expression of SEC62 protein,,,PMID:33146391,https://www.ncbi.nlm.nih.gov/pubmed/33146391,33146391,,
57,1335096,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,6401,SELE,https://ctdbase.org/detail.go?type=gene&acc=6401,,,6401.0,SELE,10090,Mus musculus (house mouse),[NOTCH3 gene mutant form affects the susceptibility to ozone] which affects the expression of SELE mRNA,,,PMID:25658374,https://www.ncbi.nlm.nih.gov/pubmed/25658374,25658374,,
58,1335097,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,8991,SELENBP1,https://ctdbase.org/detail.go?type=gene&acc=8991,,,8991.0,SELENBP1,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of SELENBP1 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of SELENBP1 mrna|[volatile organic compounds co-treated with ozone] results in increased oxidation of SELENBP1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
59,1338077,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,387914,SHISA2,https://ctdbase.org/detail.go?type=gene&acc=387914,,,387914.0,SHISA2,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in decreased expression of SHISA2 mRNA,,,PMID:27106289,https://www.ncbi.nlm.nih.gov/pubmed/27106289,27106289,,
60,1338078,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,149345,SHISA4,https://ctdbase.org/detail.go?type=gene&acc=149345,,,149345.0,SHISA4,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in increased expression of SHISA4 mrna|[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of SHISA4 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
61,1338079,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,440829,SHISA8,https://ctdbase.org/detail.go?type=gene&acc=440829,,,440829.0,SHISA8,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in increased expression of SHISA8 mrna|[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of SHISA8 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
62,1338080,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,6470,SHMT1,https://ctdbase.org/detail.go?type=gene&acc=6470,,,6470.0,SHMT1,9606,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased expression of SHMT1 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased expression of SHMT1 mrna|[volatile organic compounds co-treated with ozone] results in increased expression of SHMT1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
63,1338081,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,6470,SHMT1,https://ctdbase.org/detail.go?type=gene&acc=6470,,,6470.0,SHMT1,9606,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with ozone] results in increased expression of SHMT1 mRNA,,,PMID:32845096,https://www.ncbi.nlm.nih.gov/pubmed/32845096,32845096,,
64,1338932,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,121260,SLC15A4,https://ctdbase.org/detail.go?type=gene&acc=121260,,,121260.0,SLC15A4,10116,Rattus norvegicus (Norway rat),[ozone co-treated with chlorine] results in decreased expression of SLC15A4 mRNA,,,PMID:18636392,https://www.ncbi.nlm.nih.gov/pubmed/18636392,18636392,,
65,1338933,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,6566,SLC16A1,https://ctdbase.org/detail.go?type=gene&acc=6566,,,6566.0,SLC16A1,10116,Rattus norvegicus (Norway rat),[ozone co-treated with chlorine] results in increased expression of SLC16A1 mRNA,,,PMID:18636392,https://www.ncbi.nlm.nih.gov/pubmed/18636392,18636392,,
66,1338934,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,6566,SLC16A1,https://ctdbase.org/detail.go?type=gene&acc=6566,,,6566.0,SLC16A1,10116,Rattus norvegicus (Norway rat),Ozone results in decreased expression of SLC16A1 protein|ozone results in increased phosphorylation of SLC16A1 protein,,,PMID:33146391,https://www.ncbi.nlm.nih.gov/pubmed/33146391,33146391,,
67,1338935,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,162515,SLC16A11,https://ctdbase.org/detail.go?type=gene&acc=162515,,,162515.0,SLC16A11,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in decreased expression of SLC16A11 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
68,1340001,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,216441,SLC26A10,https://ctdbase.org/detail.go?type=gene&acc=216441,,,216441.0,Slc26a10,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in decreased expression of SLC26A10 mRNA,,,PMID:27106289,https://www.ncbi.nlm.nih.gov/pubmed/27106289,27106289,,
69,1340002,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,284129,SLC26A11,https://ctdbase.org/detail.go?type=gene&acc=284129,,,284129.0,SLC26A11,9606,Homo sapiens (human),[volatile organic compounds co-treated with ozone] results in increased expression of SLC26A11 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased expression of SLC26A11 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased expression of SLC26A11 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
70,1340003,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5172,SLC26A4,https://ctdbase.org/detail.go?type=gene&acc=5172,,,5172.0,SLC26A4,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of SLC26A4 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
71,1340004,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5172,SLC26A4,https://ctdbase.org/detail.go?type=gene&acc=5172,,,5172.0,SLC26A4,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in increased expression of SLC26A4 mRNA,,,PMID:27106289|PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/27106289|https://www.ncbi.nlm.nih.gov/pubmed/34911549,27106289|34911549,,
72,1340005,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5172,SLC26A4,https://ctdbase.org/detail.go?type=gene&acc=5172,,,5172.0,SLC26A4,10090,Mus musculus (house mouse),[NOTCH4 gene mutant form affects the susceptibility to ozone] which affects the expression of SLC26A4 mrna|[notch3 gene mutant form affects the susceptibility to ozone] which results in increased expression of SLC26A4 mRNA,,,PMID:25658374,https://www.ncbi.nlm.nih.gov/pubmed/25658374,25658374,,
73,1340006,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5172,SLC26A4,https://ctdbase.org/detail.go?type=gene&acc=5172,,,5172.0,SLC26A4,10090,Mus musculus (house mouse),Ozone results in increased expression of SLC26A4 mRNA,,,PMID:33026818,https://www.ncbi.nlm.nih.gov/pubmed/33026818,33026818,,
74,1340007,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5172,SLC26A4,https://ctdbase.org/detail.go?type=gene&acc=5172,,,5172.0,SLC26A4,10090,Mus musculus (house mouse),TTPA protein affects the reaction [ozone results in increased expression of SLC26A4 mrna],,,PMID:19555225,https://www.ncbi.nlm.nih.gov/pubmed/19555225,19555225,,
75,1340008,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,29986,SLC39A2,https://ctdbase.org/detail.go?type=gene&acc=29986,,,29986.0,SLC39A2,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in increased expression of SLC39A2 mrna|[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of SLC39A2 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
76,1340009,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,65010,SLC26A6,https://ctdbase.org/detail.go?type=gene&acc=65010,,,65010.0,SLC26A6,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of SLC26A6 mrna|[volatile organic compounds co-treated with ozone] results in increased oxidation of SLC26A6 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of SLC26A6 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
77,1343146,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,6633,SNRPD2,https://ctdbase.org/detail.go?type=gene&acc=6633,,,6633.0,SNRPD2,9606,Homo sapiens (human),[volatile organic compounds co-treated with ozone] results in increased expression of SNRPD2 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased expression of SNRPD2 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased expression of SNRPD2 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
78,1334230,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,10116,Rattus norvegicus (Norway rat),Anisomycin inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein]]|gamma-glutamylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein]|[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein|2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein]],,,PMID:34767868,https://www.ncbi.nlm.nih.gov/pubmed/34767868,34767868,,
79,1334231,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,5079,PAX5,https://ctdbase.org/detail.go?type=gene&acc=5079,,,5079.0,PAX5,10116,Rattus norvegicus (Norway rat),Cadmium chloride results in increased methylation of PAX5 promoter,,,PMID:22457795,https://www.ncbi.nlm.nih.gov/pubmed/22457795,22457795,,
80,1334232,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,5080,PAX6,https://ctdbase.org/detail.go?type=gene&acc=5080,,,5080.0,PAX6,9606,Homo sapiens (human),[cadmium chloride results in increased abundance of cadmium] which results in increased expression of PAX6 protein,,,PMID:34373904,https://www.ncbi.nlm.nih.gov/pubmed/34373904,34373904,,
81,1334233,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,5080,PAX6,https://ctdbase.org/detail.go?type=gene&acc=5080,,,5080.0,PAX6,6573,Mizuhopecten yessoensis (Yesso scallop),Cadmium chloride results in increased expression of PAX6 mRNA,,,PMID:23741332,https://www.ncbi.nlm.nih.gov/pubmed/23741332,23741332,,
82,1334234,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,5080,PAX6,https://ctdbase.org/detail.go?type=gene&acc=5080,,,5080.0,PAX6,10116,Rattus norvegicus (Norway rat),Cadmium chloride results in increased expression of PAX6 mrna|cadmium chloride results in increased expression of PAX6 protein,,,PMID:30506660,https://www.ncbi.nlm.nih.gov/pubmed/30506660,30506660,,
83,1334235,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,7849,PAX8,https://ctdbase.org/detail.go?type=gene&acc=7849,,,7849.0,PAX8,10116,Rattus norvegicus (Norway rat),Cadmium chloride results in increased methylation of PAX8 promoter,,,PMID:22457795,https://www.ncbi.nlm.nih.gov/pubmed/22457795,22457795,,
84,1335978,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,685778,PDHA1L1,https://ctdbase.org/detail.go?type=gene&acc=685778,,,685778.0,Pdha1l1,10116,Rattus norvegicus (Norway rat),Cadmium chloride results in decreased expression of PDHA1L1 mRNA,,,PMID:33453195,https://www.ncbi.nlm.nih.gov/pubmed/33453195,33453195,,
85,1335979,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,5162,PDHB,https://ctdbase.org/detail.go?type=gene&acc=5162,,,5162.0,PDHB,9606,Homo sapiens (human),[cadmium chloride results in increased abundance of cadmium] which results in increased expression of PDHB mRNA,,,PMID:35301059,https://www.ncbi.nlm.nih.gov/pubmed/35301059,35301059,,
86,1335980,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,5162,PDHB,https://ctdbase.org/detail.go?type=gene&acc=5162,,,5162.0,PDHB,10116,Rattus norvegicus (Norway rat),Cadmium chloride results in decreased expression of PDHB mRNA,,,PMID:33453195,https://www.ncbi.nlm.nih.gov/pubmed/33453195,33453195,,
87,1108912,25122,Comparative Toxicogenomics Database (CTD),Lanthanum nitrate,C016534,lanthanide nitrate,https://ctdbase.org/detail.go?type=chem&acc=C016534,176291,EAT-4,https://ctdbase.org/detail.go?type=gene&acc=176291,,,176291.0,eat-4,6239,Caenorhabditis elegans,Lanthanide nitrate results in increased expression of EAT-4 mRNA,,,PMID:34718030,https://www.ncbi.nlm.nih.gov/pubmed/34718030,34718030,,
88,1108913,25122,Comparative Toxicogenomics Database (CTD),Lanthanum nitrate,C016534,lanthanide nitrate,https://ctdbase.org/detail.go?type=chem&acc=C016534,176204,GLR-1,https://ctdbase.org/detail.go?type=gene&acc=176204,,,176204.0,glr-1,6239,Caenorhabditis elegans,Lanthanide nitrate results in increased expression of GLR-1 mRNA,,,PMID:34718030,https://www.ncbi.nlm.nih.gov/pubmed/34718030,34718030,,
89,1336814,25136,Toxin and Toxin Target Database (T3DB),Barium chromate,T3D0701,Barium chromate,http://www.t3db.ca/toxins/T3D0701,BE0001131,ATP-sensitive inward rectifier potassium channel 12,http://www.t3db.ca/biodb/bio_entities/BE0001131,Q14500,ATP-sensitive inward rectifier potassium channel 12,3768.0,KCNJ12,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
90,1336815,25136,Toxin and Toxin Target Database (T3DB),Barium chromate,T3D0701,Barium chromate,http://www.t3db.ca/toxins/T3D0701,BE0002441,ATP-sensitive inward rectifier potassium channel 8,http://www.t3db.ca/biodb/bio_entities/BE0002441,Q15842,ATP-sensitive inward rectifier potassium channel 8,3764.0,KCNJ8,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
91,1336816,25136,Toxin and Toxin Target Database (T3DB),Barium chromate,T3D0701,Barium chromate,http://www.t3db.ca/toxins/T3D0701,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,P48048,ATP-sensitive inward rectifier potassium channel 1,3758.0,KCNJ1,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
92,1336817,25136,Toxin and Toxin Target Database (T3DB),Barium chromate,T3D0701,Barium chromate,http://www.t3db.ca/toxins/T3D0701,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,P78508,ATP-sensitive inward rectifier potassium channel 10,3766.0,KCNJ10,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
93,1109389,25156,Toxin and Toxin Target Database (T3DB),Zinc metaarsenite,T3D1459,Zinc arsenite,http://www.t3db.ca/toxins/T3D1459,BE0001391,Tubulin alpha-4A chain,http://www.t3db.ca/biodb/bio_entities/BE0001391,P68366,Tubulin alpha-4A chain,7277.0,TUBA4A,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
94,1109390,25156,Toxin and Toxin Target Database (T3DB),Zinc metaarsenite,T3D1459,Zinc arsenite,http://www.t3db.ca/toxins/T3D1459,BE0001359,Tubulin alpha-8 chain,http://www.t3db.ca/biodb/bio_entities/BE0001359,Q9NY65,Tubulin alpha-8 chain,51807.0,TUBA8,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
95,1109539,25156,Toxin and Toxin Target Database (T3DB),Zinc metaarsenite,T3D1459,Zinc arsenite,http://www.t3db.ca/toxins/T3D1459,BE0003401,Tubulin beta-2B chain,http://www.t3db.ca/biodb/bio_entities/BE0003401,Q9BVA1,Tubulin beta-2B chain,347733.0,TUBB2B,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
96,1109540,25156,Toxin and Toxin Target Database (T3DB),Zinc metaarsenite,T3D1459,Zinc arsenite,http://www.t3db.ca/toxins/T3D1459,BE0001415,Tubulin beta-3 chain,http://www.t3db.ca/biodb/bio_entities/BE0001415,Q13509,Tubulin beta-3 chain,10381.0,TUBB3,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
97,1109541,25156,Toxin and Toxin Target Database (T3DB),Zinc metaarsenite,T3D1459,Zinc arsenite,http://www.t3db.ca/toxins/T3D1459,BE0001408,Tubulin beta-4A chain,http://www.t3db.ca/biodb/bio_entities/BE0001408,P04350,Tubulin beta-4A chain,10382.0,TUBB4A,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
98,1109542,25156,Toxin and Toxin Target Database (T3DB),Zinc metaarsenite,T3D1459,Zinc arsenite,http://www.t3db.ca/toxins/T3D1459,BE0001367,Tubulin beta-4B chain,http://www.t3db.ca/biodb/bio_entities/BE0001367,P68371,Tubulin beta-4B chain,10383.0,TUBB4B,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
99,1109543,25156,Toxin and Toxin Target Database (T3DB),Zinc metaarsenite,T3D1459,Zinc arsenite,http://www.t3db.ca/toxins/T3D1459,BE0003402,Tubulin beta-6 chain,http://www.t3db.ca/biodb/bio_entities/BE0003402,Q9BUF5,Tubulin beta-6 chain,84617.0,TUBB6,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
100,1109544,25156,Toxin and Toxin Target Database (T3DB),Zinc metaarsenite,T3D1459,Zinc arsenite,http://www.t3db.ca/toxins/T3D1459,BE0005038,Tubulin beta-8 chain,http://www.t3db.ca/biodb/bio_entities/BE0005038,Q3ZCM7,Tubulin beta-8 chain,347688.0,TUBB8,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
101,1337626,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,5244,ABCB4,https://ctdbase.org/detail.go?type=gene&acc=5244,,,5244.0,ABCB4,7955,Danio rerio (zebrafish),Sodium bichromate results in decreased expression of ABCB4 mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
102,1340884,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,255877,BCL6B,https://ctdbase.org/detail.go?type=gene&acc=255877,,,255877.0,BCL6B,10116,Rattus norvegicus (Norway rat),Sodium bichromate results in decreased expression of BCL6B mRNA,,,PMID:25993096,https://www.ncbi.nlm.nih.gov/pubmed/25993096,25993096,,
103,1340885,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,9275,BCL7B,https://ctdbase.org/detail.go?type=gene&acc=9275,,,9275.0,BCL7B,10090,Mus musculus (house mouse),Sodium bichromate results in decreased expression of BCL7B mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
104,1340886,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,53630,BCO1,https://ctdbase.org/detail.go?type=gene&acc=53630,,,53630.0,BCO1,7955,Danio rerio (zebrafish),Sodium bichromate results in decreased expression of BCO1 mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
105,1340887,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,393580,BCO1L,https://ctdbase.org/detail.go?type=gene&acc=393580,,,393580.0,bco1l,7955,Danio rerio (zebrafish),Sodium bichromate results in decreased expression of BCO1L mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
106,1340888,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,84041,BCO2L,https://ctdbase.org/detail.go?type=gene&acc=84041,,,84041.0,bco2l,7955,Danio rerio (zebrafish),Sodium bichromate results in decreased expression of BCO2L mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
107,1340889,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,617,BCS1L,https://ctdbase.org/detail.go?type=gene&acc=617,,,617.0,BCS1L,10116,Rattus norvegicus (Norway rat),Sodium bichromate affects the expression of BCS1L mRNA,,,PMID:22110744,https://www.ncbi.nlm.nih.gov/pubmed/22110744,22110744,,
108,1340890,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,8678,BECN1,https://ctdbase.org/detail.go?type=gene&acc=8678,,,8678.0,BECN1,10090,Mus musculus (house mouse),Sodium bichromate results in increased expression of BECN1 mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
109,1342698,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,83879,CDCA7,https://ctdbase.org/detail.go?type=gene&acc=83879,,,83879.0,CDCA7,10116,Rattus norvegicus (Norway rat),Sodium bichromate affects the expression of CDCA7 mRNA,,,PMID:22110744,https://www.ncbi.nlm.nih.gov/pubmed/22110744,22110744,,
110,1343296,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,23436,CELA3B,https://ctdbase.org/detail.go?type=gene&acc=23436,,,23436.0,CELA3B,10116,Rattus norvegicus (Norway rat),Sodium bichromate results in decreased expression of CELA3B mrna|sodium bichromate results in increased expression of CELA3B mRNA,,,PMID:22561333,https://www.ncbi.nlm.nih.gov/pubmed/22561333,22561333,,
111,1343297,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,1063,CENPF,https://ctdbase.org/detail.go?type=gene&acc=1063,,,1063.0,CENPF,10090,Mus musculus (house mouse),Sodium bichromate results in decreased expression of CENPF mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
112,1344986,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,1504,CTRB1,https://ctdbase.org/detail.go?type=gene&acc=1504,,,1504.0,CTRB1,10116,Rattus norvegicus (Norway rat),Sodium bichromate results in decreased expression of CTRB1 mRNA,,,PMID:22561333,https://www.ncbi.nlm.nih.gov/pubmed/22561333,22561333,,
113,1344987,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,11330,CTRC,https://ctdbase.org/detail.go?type=gene&acc=11330,,,11330.0,CTRC,10116,Rattus norvegicus (Norway rat),Sodium bichromate results in decreased expression of CTRC mRNA,,,PMID:22561333,https://www.ncbi.nlm.nih.gov/pubmed/22561333,22561333,,
114,1344988,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,1506,CTRL,https://ctdbase.org/detail.go?type=gene&acc=1506,,,1506.0,CTRL,10116,Rattus norvegicus (Norway rat),Sodium bichromate results in decreased expression of CTRL mRNA,,,PMID:22561333,https://www.ncbi.nlm.nih.gov/pubmed/22561333,22561333,,
115,1344989,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,1508,CTSB,https://ctdbase.org/detail.go?type=gene&acc=1508,,,1508.0,CTSB,9606,Homo sapiens (human),Sodium bichromate results in decreased expression of CTSB mRNA,,,PMID:17685462,https://www.ncbi.nlm.nih.gov/pubmed/17685462,17685462,,
116,1346511,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,1730,DIAPH2,https://ctdbase.org/detail.go?type=gene&acc=1730,,,1730.0,DIAPH2,9606,Homo sapiens (human),Sodium bichromate results in decreased expression of DIAPH2 mRNA,,,PMID:17685462,https://www.ncbi.nlm.nih.gov/pubmed/17685462,17685462,,
117,1346512,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,27292,DIMT1,https://ctdbase.org/detail.go?type=gene&acc=27292,,,27292.0,DIMT1,10116,Rattus norvegicus (Norway rat),Sodium bichromate results in increased expression of DIMT1 mRNA,,,PMID:25993096,https://www.ncbi.nlm.nih.gov/pubmed/25993096,25993096,,
118,1346513,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,1733,DIO1,https://ctdbase.org/detail.go?type=gene&acc=1733,,,1733.0,DIO1,7955,Danio rerio (zebrafish),Sodium bichromate results in decreased expression of DIO1 mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
119,1346514,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,22894,DIS3,https://ctdbase.org/detail.go?type=gene&acc=22894,,,22894.0,DIS3,10090,Mus musculus (house mouse),Sodium bichromate results in decreased expression of DIS3 mRNA,,,PMID:31558096,https://www.ncbi.nlm.nih.gov/pubmed/31558096,31558096,,
120,1343508,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,2,A2M,https://ctdbase.org/detail.go?type=gene&acc=2,,,2.0,A2M,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of A2M mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
121,1343509,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,53947,A4GALT,https://ctdbase.org/detail.go?type=gene&acc=53947,,,53947.0,A4GALT,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of A4GALT mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
122,1343510,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,65985,AACS,https://ctdbase.org/detail.go?type=gene&acc=65985,,,65985.0,AACS,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of AACS mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
123,1343511,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,13,AADAC,https://ctdbase.org/detail.go?type=gene&acc=13,,,13.0,AADAC,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of AADAC mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
124,1343512,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,51166,AADAT,https://ctdbase.org/detail.go?type=gene&acc=51166,,,51166.0,AADAT,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of AADAT mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
125,1343513,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,79719,AAGAB,https://ctdbase.org/detail.go?type=gene&acc=79719,,,79719.0,AAGAB,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of AAGAB mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
126,1343514,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,15,AANAT,https://ctdbase.org/detail.go?type=gene&acc=15,,,15.0,AANAT,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of AANAT mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
127,1343633,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,5244,ABCB4,https://ctdbase.org/detail.go?type=gene&acc=5244,,,5244.0,ABCB4,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of ABCB4 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
128,1343634,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,10058,ABCB6,https://ctdbase.org/detail.go?type=gene&acc=10058,,,10058.0,ABCB6,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of ABCB6 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
129,1343635,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,23457,ABCB9,https://ctdbase.org/detail.go?type=gene&acc=23457,,,23457.0,ABCB9,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of ABCB9 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
130,1343636,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of ABCC1 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
131,1343637,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,10057,ABCC5,https://ctdbase.org/detail.go?type=gene&acc=10057,,,10057.0,ABCC5,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of ABCC5 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
132,1343638,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,368,ABCC6,https://ctdbase.org/detail.go?type=gene&acc=368,,,368.0,ABCC6,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of ABCC6 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
133,1343639,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,6833,ABCC8,https://ctdbase.org/detail.go?type=gene&acc=6833,,,6833.0,ABCC8,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of ABCC8 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
134,1343640,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,10060,ABCC9,https://ctdbase.org/detail.go?type=gene&acc=10060,,,10060.0,ABCC9,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of ABCC9 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
135,1345326,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,10116,Rattus norvegicus (Norway rat),Titanium dioxide results in increased expression of ACE mRNA,,,PMID:26277626,https://www.ncbi.nlm.nih.gov/pubmed/26277626,26277626,,
136,1345327,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,59272,ACE2,https://ctdbase.org/detail.go?type=gene&acc=59272,,,59272.0,ACE2,10116,Rattus norvegicus (Norway rat),Titanium dioxide results in increased expression of ACE2 mrna|titanium dioxide results in increased expression of ACE2 protein,,,PMID:26277626,https://www.ncbi.nlm.nih.gov/pubmed/26277626,26277626,,
137,1345328,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,340485,ACER2,https://ctdbase.org/detail.go?type=gene&acc=340485,,,340485.0,ACER2,10090,Mus musculus (house mouse),Titanium dioxide results in decreased expression of ACER2 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
138,1346873,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,11522,ADH1,https://ctdbase.org/detail.go?type=gene&acc=11522,,,11522.0,Adh1,10090,Mus musculus (house mouse),Titanium dioxide results in increased expression of ADH1 mRNA,,,PMID:23131501,https://www.ncbi.nlm.nih.gov/pubmed/23131501,23131501,,
139,1346874,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,128,ADH5,https://ctdbase.org/detail.go?type=gene&acc=128,,,128.0,ADH5,10090,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of ADH5 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
140,1346875,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,131,ADH7,https://ctdbase.org/detail.go?type=gene&acc=131,,,131.0,ADH7,10090,Mus musculus (house mouse),Titanium dioxide results in decreased expression of ADH7 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
141,1346876,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,137872,ADHFE1,https://ctdbase.org/detail.go?type=gene&acc=137872,,,137872.0,ADHFE1,10116,Rattus norvegicus (Norway rat),Titanium dioxide results in decreased expression of ADHFE1 mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
142,1346877,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,10090,Mus musculus (house mouse),Titanium dioxide results in decreased expression of ADIPOQ mRNA,,,PMID:23131501|PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23131501|https://www.ncbi.nlm.nih.gov/pubmed/23557971,23131501|23557971,,
143,1346878,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,79602,ADIPOR2,https://ctdbase.org/detail.go?type=gene&acc=79602,,,79602.0,ADIPOR2,10090,Mus musculus (house mouse),Titanium dioxide results in decreased expression of ADIPOR2 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
144,1347004,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,133,ADM,https://ctdbase.org/detail.go?type=gene&acc=133,,,133.0,ADM,10116,Rattus norvegicus (Norway rat),Titanium dioxide affects the expression of ADM mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
145,1347005,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,134,ADORA1,https://ctdbase.org/detail.go?type=gene&acc=134,,,134.0,ADORA1,10090,Mus musculus (house mouse),Titanium dioxide results in increased expression of ADORA1 mRNA,,,PMID:21259345|PMID:23557971|PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/21259345|https://www.ncbi.nlm.nih.gov/pubmed/23557971|https://www.ncbi.nlm.nih.gov/pubmed/27760801,21259345|23557971|27760801,,
146,1347006,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,135,ADORA2A,https://ctdbase.org/detail.go?type=gene&acc=135,,,135.0,ADORA2A,9606,Homo sapiens (human),Titanium dioxide results in decreased expression of ADORA2A mRNA,,,PMID:22342292,https://www.ncbi.nlm.nih.gov/pubmed/22342292,22342292,,
147,1347007,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,135,ADORA2A,https://ctdbase.org/detail.go?type=gene&acc=135,,,135.0,ADORA2A,9606,Homo sapiens (human),Titanium dioxide results in increased expression of ADORA2A mRNA,,,PMID:34973136,https://www.ncbi.nlm.nih.gov/pubmed/34973136,34973136,,
148,1347008,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,135,ADORA2A,https://ctdbase.org/detail.go?type=gene&acc=135,,,135.0,ADORA2A,10090,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of ADORA2A mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
149,1347009,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,135,ADORA2A,https://ctdbase.org/detail.go?type=gene&acc=135,,,135.0,ADORA2A,10090,Mus musculus (house mouse),Titanium dioxide results in increased expression of ADORA2A mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
150,1347010,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,646023,ADORA2A-AS1,https://ctdbase.org/detail.go?type=gene&acc=646023,,,646023.0,ADORA2A-AS1,9606,Homo sapiens (human),Titanium dioxide results in increased expression of ADORA2A-AS1 mRNA,,,PMID:34973136,https://www.ncbi.nlm.nih.gov/pubmed/34973136,34973136,,
151,1347011,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,136,ADORA2B,https://ctdbase.org/detail.go?type=gene&acc=136,,,136.0,ADORA2B,10090,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] affects the expression of ADORA2B mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
152,1333594,36462,Drug Gene Interaction database (DGIdb),Etoposide,,ETOPOSIDE,https://www.dgidb.org/drugs/rxcui:4179,,TOP2A,https://www.dgidb.org/genes/hgnc:11989,,,7153.0,TOP2A,9606,Homo sapiens (human),Inhibitor,,,,,,,
153,1334578,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,55255,WDR41,https://ctdbase.org/detail.go?type=gene&acc=55255,,,55255.0,WDR41,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WDR41 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
154,1334579,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,56270,WDR45B,https://ctdbase.org/detail.go?type=gene&acc=56270,,,56270.0,WDR45B,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of WDR45B mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
155,1334580,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,256764,WDR72,https://ctdbase.org/detail.go?type=gene&acc=256764,,,256764.0,WDR72,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WDR72 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
156,1334581,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,381693,WDR95,https://ctdbase.org/detail.go?type=gene&acc=381693,,,381693.0,Wdr95,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of WDR95 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
157,1334582,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,10406,WFDC2,https://ctdbase.org/detail.go?type=gene&acc=10406,,,10406.0,WFDC2,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WFDC2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
158,1334702,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,23039,XPO7,https://ctdbase.org/detail.go?type=gene&acc=23039,,,23039.0,XPO7,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of XPO7 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
159,1335971,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,170936,ZFP369,https://ctdbase.org/detail.go?type=gene&acc=170936,,,170936.0,Zfp369,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP369 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
160,1335972,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,677,ZFP36L1,https://ctdbase.org/detail.go?type=gene&acc=677,,,677.0,ZFP36L1,9606,Homo sapiens (human),"2,4,5,2',4',5'-hexachlorobiphenyl affects the expression of ZFP36L1 mRNA",,,PMID:20638727,https://www.ncbi.nlm.nih.gov/pubmed/20638727,20638727,,
161,1335973,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,333473,ZFP36L3,https://ctdbase.org/detail.go?type=gene&acc=333473,,,333473.0,Zfp36l3,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZFP36L3 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
162,1335974,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,278304,ZFP385C,https://ctdbase.org/detail.go?type=gene&acc=278304,,,278304.0,Zfp385c,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZFP385C mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
163,1335975,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,69256,ZFP397,https://ctdbase.org/detail.go?type=gene&acc=69256,,,69256.0,Zfp397,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP397 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
164,1335976,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,2277,VEGFD,https://ctdbase.org/detail.go?type=gene&acc=2277,,,2277.0,VEGFD,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of VEGFD mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
165,1335977,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,7433,VIPR1,https://ctdbase.org/detail.go?type=gene&acc=7433,,,7433.0,VIPR1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of VIPR1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
166,1336433,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,408067,ZFP874B,https://ctdbase.org/detail.go?type=gene&acc=408067,,,408067.0,Zfp874b,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP874B mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
167,1336434,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,242747,ZFP933,https://ctdbase.org/detail.go?type=gene&acc=242747,,,242747.0,Zfp933,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP933 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
168,1336435,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,319615,ZFP944,https://ctdbase.org/detail.go?type=gene&acc=319615,,,319615.0,Zfp944,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP944 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
169,1336436,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,84107,ZIC4,https://ctdbase.org/detail.go?type=gene&acc=84107,,,84107.0,ZIC4,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZIC4 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
170,1336437,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,268417,ZKSCAN17,https://ctdbase.org/detail.go?type=gene&acc=268417,,,268417.0,Zkscan17,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZKSCAN17 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
171,1336438,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,84225,ZMYND15,https://ctdbase.org/detail.go?type=gene&acc=84225,,,84225.0,ZMYND15,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZMYND15 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
172,1336439,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,79894,ZNF672,https://ctdbase.org/detail.go?type=gene&acc=79894,,,79894.0,ZNF672,9606,Homo sapiens (human),"2,4,5,2',4',5'-hexachlorobiphenyl affects the expression of ZNF672 mRNA",,,PMID:20638727,https://www.ncbi.nlm.nih.gov/pubmed/20638727,20638727,,
173,1336440,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,90874,ZNF697,https://ctdbase.org/detail.go?type=gene&acc=90874,,,90874.0,ZNF697,9606,Homo sapiens (human),"2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of ZNF697 mRNA",,,PMID:23146750,https://www.ncbi.nlm.nih.gov/pubmed/23146750,23146750,,
174,1336808,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,55966,AJAP1,https://ctdbase.org/detail.go?type=gene&acc=55966,,,55966.0,AJAP1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AJAP1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
175,1336809,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,203,AK1,https://ctdbase.org/detail.go?type=gene&acc=203,,,203.0,AK1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AK1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
176,1336810,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,11216,AKAP10,https://ctdbase.org/detail.go?type=gene&acc=11216,,,11216.0,AKAP10,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AKAP10 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
177,1336811,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,10142,AKAP9,https://ctdbase.org/detail.go?type=gene&acc=10142,,,10142.0,AKAP9,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AKAP9 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
178,1336812,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,11997,AKR1B7,https://ctdbase.org/detail.go?type=gene&acc=11997,,,11997.0,Akr1b7,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AKR1B7 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
179,1336813,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,203102,ADAM32,https://ctdbase.org/detail.go?type=gene&acc=203102,,,203102.0,ADAM32,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADAM32 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
180,1338072,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,135152,B3GAT2,https://ctdbase.org/detail.go?type=gene&acc=135152,,,135152.0,B3GAT2,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of B3GAT2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
181,1338073,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,338707,B4GALNT4,https://ctdbase.org/detail.go?type=gene&acc=338707,,,338707.0,B4GALNT4,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of B4GALNT4 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
182,1338074,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,339231,ARL16,https://ctdbase.org/detail.go?type=gene&acc=339231,,,339231.0,ARL16,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ARL16 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
183,1338075,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,79642,ARSJ,https://ctdbase.org/detail.go?type=gene&acc=79642,,,79642.0,ARSJ,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ARSJ mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
184,1338076,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,420,ART4,https://ctdbase.org/detail.go?type=gene&acc=420,,,420.0,ART4,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ART4 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
185,1339269,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,2115,ETV1,https://ctdbase.org/detail.go?type=gene&acc=2115,,,2115.0,ETV1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ETV1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
186,1339270,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,9156,EXO1,https://ctdbase.org/detail.go?type=gene&acc=9156,,,9156.0,EXO1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EXO1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
187,1339271,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,2146,EZH2,https://ctdbase.org/detail.go?type=gene&acc=2146,,,2146.0,EZH2,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EZH2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
188,1339272,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,2149,F2R,https://ctdbase.org/detail.go?type=gene&acc=2149,,,2149.0,F2R,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of F2R mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
189,1339273,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,646480,FABP9,https://ctdbase.org/detail.go?type=gene&acc=646480,,,646480.0,FABP9,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FABP9 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
190,1339274,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,23017,FAIM2,https://ctdbase.org/detail.go?type=gene&acc=23017,,,23017.0,FAIM2,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FAIM2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
191,1339275,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,220965,FAM13C,https://ctdbase.org/detail.go?type=gene&acc=220965,,,220965.0,FAM13C,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FAM13C mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
192,1339276,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,63939,FAM217B,https://ctdbase.org/detail.go?type=gene&acc=63939,,,63939.0,FAM217B,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FAM217B mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
193,1340000,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,142679,DUSP19,https://ctdbase.org/detail.go?type=gene&acc=142679,,,142679.0,DUSP19,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DUSP19 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
194,1342421,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,57053,CHRNA10,https://ctdbase.org/detail.go?type=gene&acc=57053,,,57053.0,CHRNA10,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CHRNA10 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
195,1342422,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,1136,CHRNA3,https://ctdbase.org/detail.go?type=gene&acc=1136,,,1136.0,CHRNA3,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CHRNA3 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
196,1343154,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,8900,CCNA1,https://ctdbase.org/detail.go?type=gene&acc=8900,,,8900.0,CCNA1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCNA1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
197,1343155,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,890,CCNA2,https://ctdbase.org/detail.go?type=gene&acc=890,,,890.0,CCNA2,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCNA2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
198,1344471,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,79370,BCL2L14,https://ctdbase.org/detail.go?type=gene&acc=79370,,,79370.0,BCL2L14,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of BCL2L14 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
199,1344472,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,389206,BEND4,https://ctdbase.org/detail.go?type=gene&acc=389206,,,389206.0,BEND4,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of BEND4 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
200,1334042,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,6635,SNRPE,https://ctdbase.org/detail.go?type=gene&acc=6635,,,6635.0,SNRPE,10090,Mus musculus (house mouse),1-methyl-4-phenylpyridinium results in increased expression of SNRPE protein,,,PMID:26558463,https://www.ncbi.nlm.nih.gov/pubmed/26558463,26558463,,
201,1334043,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,6638,SNRPN,https://ctdbase.org/detail.go?type=gene&acc=6638,,,6638.0,SNRPN,10090,Mus musculus (house mouse),1-methyl-4-phenylpyridinium results in increased expression of SNRPN protein,,,PMID:26558463,https://www.ncbi.nlm.nih.gov/pubmed/26558463,26558463,,
202,1334044,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,6640,SNTA1,https://ctdbase.org/detail.go?type=gene&acc=6640,,,6640.0,SNTA1,9606,Homo sapiens (human),1-methyl-4-phenylpyridinium results in increased expression of SNTA1 mRNA,,,PMID:24810058,https://www.ncbi.nlm.nih.gov/pubmed/24810058,24810058,,
203,1334045,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,124460,SNX20,https://ctdbase.org/detail.go?type=gene&acc=124460,,,124460.0,SNX20,10116,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in increased expression of SNX20 mRNA,,,PMID:28801915,https://www.ncbi.nlm.nih.gov/pubmed/28801915,28801915,,
204,1334425,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,9789,SPCS2,https://ctdbase.org/detail.go?type=gene&acc=9789,,,9789.0,SPCS2,10090,Mus musculus (house mouse),1-methyl-4-phenylpyridinium results in decreased expression of SPCS2 protein,,,PMID:26558463,https://www.ncbi.nlm.nih.gov/pubmed/26558463,26558463,,
205,1334426,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,8877,SPHK1,https://ctdbase.org/detail.go?type=gene&acc=8877,,,8877.0,SPHK1,9606,Homo sapiens (human),Sphingosine 1-phosphate inhibits the reaction [1-methyl-4-phenylpyridinium results in decreased expression of SPHK1 mrna]|1-methyl-4-phenylpyridinium results in decreased expression of and results in decreased activity of SPHK1 protein|sphingosine 1-phosphate inhibits the reaction [1-methyl-4-phenylpyridinium results in decreased expression of SPHK1 protein],,,PMID:24399507,https://www.ncbi.nlm.nih.gov/pubmed/24399507,24399507,,
206,1334427,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,8877,SPHK1,https://ctdbase.org/detail.go?type=gene&acc=8877,,,8877.0,SPHK1,9606,Homo sapiens (human),1-methyl-4-phenylpyridinium results in decreased expression of SPHK1 mRNA,,,PMID:24399507|PMID:33414358,https://www.ncbi.nlm.nih.gov/pubmed/24399507|https://www.ncbi.nlm.nih.gov/pubmed/33414358,24399507|33414358,,
207,1335665,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,8407,TAGLN2,https://ctdbase.org/detail.go?type=gene&acc=8407,,,8407.0,TAGLN2,9606,Homo sapiens (human),1-methyl-4-phenylpyridinium results in increased expression of TAGLN2 mRNA,,,PMID:24810058,https://www.ncbi.nlm.nih.gov/pubmed/24810058,24810058,,
208,1335787,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,6934,TCF7L2,https://ctdbase.org/detail.go?type=gene&acc=6934,,,6934.0,TCF7L2,9606,Homo sapiens (human),1-methyl-4-phenylpyridinium results in decreased expression of TCF7L2 mRNA,,,PMID:24810058,https://www.ncbi.nlm.nih.gov/pubmed/24810058,24810058,,
209,1335788,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,6934,TCF7L2,https://ctdbase.org/detail.go?type=gene&acc=6934,,,6934.0,TCF7L2,10090,Mus musculus (house mouse),1-methyl-4-phenylpyridinium results in increased expression of TCF7L2 mRNA,,,PMID:26558463,https://www.ncbi.nlm.nih.gov/pubmed/26558463,26558463,,
210,1335789,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,6934,TCF7L2,https://ctdbase.org/detail.go?type=gene&acc=6934,,,6934.0,TCF7L2,10116,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in decreased expression of TCF7L2 mRNA,,,PMID:28801915,https://www.ncbi.nlm.nih.gov/pubmed/28801915,28801915,,
211,1335790,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,56892,TCIM,https://ctdbase.org/detail.go?type=gene&acc=56892,,,56892.0,TCIM,9606,Homo sapiens (human),1-methyl-4-phenylpyridinium results in increased expression of TCIM mRNA,,,PMID:24810058,https://www.ncbi.nlm.nih.gov/pubmed/24810058,24810058,,
212,1335791,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,6950,TCP1,https://ctdbase.org/detail.go?type=gene&acc=6950,,,6950.0,TCP1,10116,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in decreased expression of TCP1 mRNA,,,PMID:16026605,https://www.ncbi.nlm.nih.gov/pubmed/16026605,16026605,,
213,1335792,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,140290,TCP10L,https://ctdbase.org/detail.go?type=gene&acc=140290,,,140290.0,TCP10L,9606,Homo sapiens (human),1-methyl-4-phenylpyridinium results in increased expression of TCP10L mRNA,,,PMID:24810058,https://www.ncbi.nlm.nih.gov/pubmed/24810058,24810058,,
214,1335793,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,6954,TCP11,https://ctdbase.org/detail.go?type=gene&acc=6954,,,6954.0,TCP11,10116,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in increased expression of TCP11 mRNA,,,PMID:28801915,https://www.ncbi.nlm.nih.gov/pubmed/28801915,28801915,,
215,1336654,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,9606,Homo sapiens (human),TLR4 protein inhibits the reaction [genkwanin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of NLRP3 protein]]|1-methyl-4-phenylpyridinium results in increased expression of TLR4 protein|genkwanin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of TLR4 protein]|tlr4 protein inhibits the reaction [genkwanin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased secretion of TNF protein]]|tlr4 protein inhibits the reaction [genkwanin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of PTGS2 protein]]|tlr4 protein inhibits the reaction [genkwanin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased secretion of IL6 protein]]|tlr4 protein inhibits the reaction [genkwanin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of and results in increased activity of CASP3 protein]]|tlr4 protein inhibits the reaction [genkwanin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of MYD88 protein]]|tlr4 protein inhibits the reaction [genkwanin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased secretion of IL1B protein]],,,PMID:34481870,https://www.ncbi.nlm.nih.gov/pubmed/34481870,34481870,,
216,1336655,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,10090,Mus musculus (house mouse),TLR4 protein affects the reaction [1-methyl-4-phenylpyridinium results in increased secretion of TNF protein]|tlr4 protein affects the reaction [1-methyl-4-phenylpyridinium results in increased secretion of IL1B protein]|tlr4 protein affects the reaction [1-methyl-4-phenylpyridinium results in increased secretion of NOS2 protein]|1-methyl-4-phenylpyridinium results in increased expression of TLR4 mRNA,,,PMID:26881113,https://www.ncbi.nlm.nih.gov/pubmed/26881113,26881113,,
217,1336656,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,10090,Mus musculus (house mouse),1-methyl-4-phenylpyridinium results in increased expression of TLR4 protein,,,PMID:26881113|PMID:31299241,https://www.ncbi.nlm.nih.gov/pubmed/26881113|https://www.ncbi.nlm.nih.gov/pubmed/31299241,26881113|31299241,,
218,1336657,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,10333,TLR6,https://ctdbase.org/detail.go?type=gene&acc=10333,,,10333.0,TLR6,10116,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in decreased expression of TLR6 mRNA,,,PMID:28801915,https://www.ncbi.nlm.nih.gov/pubmed/28801915,28801915,,
219,1336995,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,29767,TMOD2,https://ctdbase.org/detail.go?type=gene&acc=29767,,,29767.0,TMOD2,10090,Mus musculus (house mouse),1-methyl-4-phenylpyridinium results in increased expression of TMOD2 protein,,,PMID:26558463,https://www.ncbi.nlm.nih.gov/pubmed/26558463,26558463,,
220,1336996,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,83857,TMTC1,https://ctdbase.org/detail.go?type=gene&acc=83857,,,83857.0,TMTC1,9606,Homo sapiens (human),1-methyl-4-phenylpyridinium results in decreased expression of TMTC1 mRNA,,,PMID:24810058,https://www.ncbi.nlm.nih.gov/pubmed/24810058,24810058,,
221,1336997,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,56255,TMX4,https://ctdbase.org/detail.go?type=gene&acc=56255,,,56255.0,TMX4,10116,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in increased expression of TMX4 mRNA,,,PMID:28801915,https://www.ncbi.nlm.nih.gov/pubmed/28801915,28801915,,
222,1336998,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),NEAT1 mRNA promotes the reaction [1-methyl-4-phenylpyridinium results in increased expression of TNF mrna]|1-methyl-4-phenylpyridinium results in increased expression of and results in increased secretion of TNF protein|neat1 mRNA promotes the reaction [1-methyl-4-phenylpyridinium results in increased expression of and results in increased secretion of TNF protein],,,PMID:31228597,https://www.ncbi.nlm.nih.gov/pubmed/31228597,31228597,,
223,1336999,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),1-methyl-4-phenylpyridinium results in increased expression of TNF mRNA,,,PMID:31228597|PMID:34481870,https://www.ncbi.nlm.nih.gov/pubmed/31228597|https://www.ncbi.nlm.nih.gov/pubmed/34481870,31228597|34481870,,
224,1337000,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),1-methyl-4-phenylpyridinium results in increased expression of TNF protein,,,PMID:18799798|PMID:28958159|PMID:34427876|PMID:34508910|PMID:35279586,https://www.ncbi.nlm.nih.gov/pubmed/18799798|https://www.ncbi.nlm.nih.gov/pubmed/28958159|https://www.ncbi.nlm.nih.gov/pubmed/34427876|https://www.ncbi.nlm.nih.gov/pubmed/34508910|https://www.ncbi.nlm.nih.gov/pubmed/35279586,18799798|28958159|34427876|34508910|35279586,,
225,1337001,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),1-methyl-4-phenylpyridinium results in increased secretion of TNF protein,,,PMID:28484287|PMID:29611404|PMID:30195017|PMID:34481870|PMID:34773593|PMID:34783303|PMID:35481549|PMID:36515797,https://www.ncbi.nlm.nih.gov/pubmed/28484287|https://www.ncbi.nlm.nih.gov/pubmed/29611404|https://www.ncbi.nlm.nih.gov/pubmed/30195017|https://www.ncbi.nlm.nih.gov/pubmed/34481870|https://www.ncbi.nlm.nih.gov/pubmed/34773593|https://www.ncbi.nlm.nih.gov/pubmed/34783303|https://www.ncbi.nlm.nih.gov/pubmed/35481549|https://www.ncbi.nlm.nih.gov/pubmed/36515797,28484287|29611404|30195017|34481870|34773593|34783303|35481549|36515797,,
226,1337002,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),CDIP1 protein inhibits the reaction [MIR214 inhibits the reaction [1-methyl-4-phenylpyridinium results in increased secretion of TNF protein]]|bace1-AS affects the reaction [1-methyl-4-phenylpyridinium results in increased secretion of TNF protein]|mir214 affects the reaction [BACE1-AS affects the reaction [1-methyl-4-phenylpyridinium results in increased secretion of TNF protein]]|mir214 inhibits the reaction [1-methyl-4-phenylpyridinium results in increased secretion of TNF protein],,,PMID:35481549,https://www.ncbi.nlm.nih.gov/pubmed/35481549,35481549,,
227,1337336,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Donepezil inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of TNF mrna]|donepezil inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of TNF protein],,,PMID:26114860,https://www.ncbi.nlm.nih.gov/pubmed/26114860,26114860,,
228,1337337,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Quercetin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of TNF mrna]|quercetin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of TNF protein]|sesamin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of TNF mrna]|sesamin inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of TNF protein],,,PMID:22919443,https://www.ncbi.nlm.nih.gov/pubmed/22919443,22919443,,
229,1337338,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),TNF protein affects the susceptibility to 1-methyl-4-phenylpyridinium,,,PMID:15140182,https://www.ncbi.nlm.nih.gov/pubmed/15140182,15140182,,
230,1337339,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in increased expression of TNF protein,,,PMID:31351185|PMID:31376345|PMID:31430510,https://www.ncbi.nlm.nih.gov/pubmed/31351185|https://www.ncbi.nlm.nih.gov/pubmed/31376345|https://www.ncbi.nlm.nih.gov/pubmed/31430510,31351185|31376345|31430510,,
231,1337340,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),"N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [1-methyl-4-phenylpyridinium results in increased secretion of TNF protein]|5-hydroxydecanoic acid inhibits the reaction [N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [1-methyl-4-phenylpyridinium results in increased secretion of TNF protein]]|diazoxide inhibits the reaction [1-methyl-4-phenylpyridinium results in increased secretion of TNF protein]|5-hydroxydecanoic acid inhibits the reaction [diazoxide inhibits the reaction [1-methyl-4-phenylpyridinium results in increased secretion of TNF protein]]|1-methyl-4-phenylpyridinium results in increased secretion of TNF protein",,,PMID:18700057,https://www.ncbi.nlm.nih.gov/pubmed/18700057,18700057,,
232,1338523,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,134111,UBE2QL1,https://ctdbase.org/detail.go?type=gene&acc=134111,,,134111.0,UBE2QL1,9606,Homo sapiens (human),1-methyl-4-phenylpyridinium results in increased expression of UBE2QL1 mRNA,,,PMID:24810058,https://www.ncbi.nlm.nih.gov/pubmed/24810058,24810058,,
233,1333885,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,406962,MIR186,https://ctdbase.org/detail.go?type=gene&acc=406962,,,406962.0,MIR186,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of MIR186 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
234,1333886,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,406963,MIR187,https://ctdbase.org/detail.go?type=gene&acc=406963,,,406963.0,MIR187,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased methylation of MIR187 gene,,,PMID:31079544,https://www.ncbi.nlm.nih.gov/pubmed/31079544,31079544,,
235,1333887,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,574033,MIR18B,https://ctdbase.org/detail.go?type=gene&acc=574033,,,574033.0,MIR18B,9606,Homo sapiens (human),Vinclozolin results in decreased expression of MIR18B mRNA,,,PMID:36498866,https://www.ncbi.nlm.nih.gov/pubmed/36498866,36498866,,
236,1333888,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,387190,MIR195A,https://ctdbase.org/detail.go?type=gene&acc=387190,,,387190.0,Mir195a,10090,Mus musculus (house mouse),Vinclozolin results in increased expression of MIR195A mRNA,,,PMID:34182078|PMID:36642194,https://www.ncbi.nlm.nih.gov/pubmed/34182078|https://www.ncbi.nlm.nih.gov/pubmed/36642194,34182078|36642194,,
237,1333889,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,406979,MIR19A,https://ctdbase.org/detail.go?type=gene&acc=406979,,,406979.0,MIR19A,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of MIR19A mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
238,1333890,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,406982,MIR20A,https://ctdbase.org/detail.go?type=gene&acc=406982,,,406982.0,MIR20A,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of MIR20A mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
239,1333891,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,406996,MIR214,https://ctdbase.org/detail.go?type=gene&acc=406996,,,406996.0,MIR214,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of MIR214 mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
240,1333892,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,406997,MIR215,https://ctdbase.org/detail.go?type=gene&acc=406997,,,406997.0,MIR215,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of MIR215 mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
241,1333893,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,407000,MIR218-1,https://ctdbase.org/detail.go?type=gene&acc=407000,,,407000.0,MIR218-1,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of MIR218-1 mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
242,1335246,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,63931,MRPS14,https://ctdbase.org/detail.go?type=gene&acc=63931,,,63931.0,MRPS14,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of MRPS14 mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
243,1335247,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,51373,MRPS17,https://ctdbase.org/detail.go?type=gene&acc=51373,,,51373.0,MRPS17,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of MRPS17 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
244,1335513,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,4485,MST1,https://ctdbase.org/detail.go?type=gene&acc=4485,,,4485.0,MST1,10090,Mus musculus (house mouse),Vinclozolin results in increased expression of MST1 mRNA,,,PMID:34182078,https://www.ncbi.nlm.nih.gov/pubmed/34182078,34182078,,
245,1335514,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,9112,MTA1,https://ctdbase.org/detail.go?type=gene&acc=9112,,,9112.0,MTA1,10116,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of MTA1 mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
246,1335515,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,9112,MTA1,https://ctdbase.org/detail.go?type=gene&acc=9112,,,9112.0,MTA1,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of MTA1 mRNA,,,PMID:18042343|PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/18042343|https://www.ncbi.nlm.nih.gov/pubmed/23034163,18042343|23034163,,
247,1335516,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,27085,MTBP,https://ctdbase.org/detail.go?type=gene&acc=27085,,,27085.0,MTBP,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased methylation of MTBP gene,,,PMID:31079544,https://www.ncbi.nlm.nih.gov/pubmed/31079544,31079544,,
248,1335517,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,4520,MTF1,https://ctdbase.org/detail.go?type=gene&acc=4520,,,4520.0,MTF1,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of MTF1 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
249,1335518,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,26164,MTG2,https://ctdbase.org/detail.go?type=gene&acc=26164,,,26164.0,MTG2,10116,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of MTG2 mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
250,1335519,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,26164,MTG2,https://ctdbase.org/detail.go?type=gene&acc=26164,,,26164.0,MTG2,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased methylation of MTG2 gene,,,PMID:31079544,https://www.ncbi.nlm.nih.gov/pubmed/31079544,31079544,,
251,1335520,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,25902,MTHFD1L,https://ctdbase.org/detail.go?type=gene&acc=25902,,,25902.0,MTHFD1L,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of MTHFD1L mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
252,1335521,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,10797,MTHFD2,https://ctdbase.org/detail.go?type=gene&acc=10797,,,10797.0,MTHFD2,10116,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of MTHFD2 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
253,1335522,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,441024,MTHFD2L,https://ctdbase.org/detail.go?type=gene&acc=441024,,,441024.0,MTHFD2L,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of MTHFD2L mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
254,1337187,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,4711,NDUFB5,https://ctdbase.org/detail.go?type=gene&acc=4711,,,4711.0,NDUFB5,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of NDUFB5 mRNA,,,PMID:23555832,https://www.ncbi.nlm.nih.gov/pubmed/23555832,23555832,,
255,1337188,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,4714,NDUFB8,https://ctdbase.org/detail.go?type=gene&acc=4714,,,4714.0,NDUFB8,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of NDUFB8 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
256,1337189,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,4715,NDUFB9,https://ctdbase.org/detail.go?type=gene&acc=4715,,,4715.0,NDUFB9,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of NDUFB9 mRNA,,,PMID:23555832,https://www.ncbi.nlm.nih.gov/pubmed/23555832,23555832,,
257,1338234,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,51701,NLK,https://ctdbase.org/detail.go?type=gene&acc=51701,,,51701.0,NLK,10116,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of NLK mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
258,1338381,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,135935,NOBOX,https://ctdbase.org/detail.go?type=gene&acc=135935,,,135935.0,NOBOX,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of NOBOX mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
259,1344980,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,408216,SENP17,https://ctdbase.org/detail.go?type=gene&acc=408216,,,408216.0,Senp17,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased methylation of SENP17 gene,,,PMID:31079544,https://www.ncbi.nlm.nih.gov/pubmed/31079544,31079544,,
260,1344981,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,59343,SENP2,https://ctdbase.org/detail.go?type=gene&acc=59343,,,59343.0,SENP2,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of SENP2 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
261,1344982,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,205564,SENP5,https://ctdbase.org/detail.go?type=gene&acc=205564,,,205564.0,SENP5,10116,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of SENP5 mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
262,1344983,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,57337,SENP7,https://ctdbase.org/detail.go?type=gene&acc=57337,,,57337.0,SENP7,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of SENP7 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
263,1344984,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,151011,SEPTIN10,https://ctdbase.org/detail.go?type=gene&acc=151011,,,151011.0,SEPTIN10,7955,Danio rerio (zebrafish),Vinclozolin results in decreased expression of SEPTIN10 mRNA,,,PMID:21126777,https://www.ncbi.nlm.nih.gov/pubmed/21126777,21126777,,
264,1344985,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,55752,SEPTIN11,https://ctdbase.org/detail.go?type=gene&acc=55752,,,55752.0,SEPTIN11,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased methylation of SEPTIN11 gene,,,PMID:31682807,https://www.ncbi.nlm.nih.gov/pubmed/31682807,31682807,,
265,1345851,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,80851,SH3BP5L,https://ctdbase.org/detail.go?type=gene&acc=80851,,,80851.0,SH3BP5L,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of SH3BP5L mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
266,1345852,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,79729,SH3D21,https://ctdbase.org/detail.go?type=gene&acc=79729,,,79729.0,SH3D21,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of SH3D21 mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
267,1345853,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,6457,SH3GL3,https://ctdbase.org/detail.go?type=gene&acc=6457,,,6457.0,SH3GL3,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of SH3GL3 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
268,1345854,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,9644,SH3PXD2A,https://ctdbase.org/detail.go?type=gene&acc=9644,,,9644.0,SH3PXD2A,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased methylation of SH3PXD2A gene,,,PMID:31079544,https://www.ncbi.nlm.nih.gov/pubmed/31079544,31079544,,
269,1345855,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,9644,SH3PXD2A,https://ctdbase.org/detail.go?type=gene&acc=9644,,,9644.0,SH3PXD2A,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of SH3PXD2A mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
270,1345856,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,153769,SH3RF2,https://ctdbase.org/detail.go?type=gene&acc=153769,,,153769.0,SH3RF2,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased methylation of SH3RF2 gene,,,PMID:31079544,https://www.ncbi.nlm.nih.gov/pubmed/31079544,31079544,,
271,1345857,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,153769,SH3RF2,https://ctdbase.org/detail.go?type=gene&acc=153769,,,153769.0,SH3RF2,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased methylation of SH3RF2 gene,,,PMID:31682807,https://www.ncbi.nlm.nih.gov/pubmed/31682807,31682807,,
272,1345858,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,50944,SHANK1,https://ctdbase.org/detail.go?type=gene&acc=50944,,,50944.0,SHANK1,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of SHANK1 mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
273,1346361,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,6557,SLC12A1,https://ctdbase.org/detail.go?type=gene&acc=6557,,,6557.0,SLC12A1,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased methylation of SLC12A1 gene,,,PMID:31079544,https://www.ncbi.nlm.nih.gov/pubmed/31079544,31079544,,
274,1346362,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,6558,SLC12A2,https://ctdbase.org/detail.go?type=gene&acc=6558,,,6558.0,SLC12A2,7955,Danio rerio (zebrafish),Vinclozolin results in decreased expression of SLC12A2 mRNA,,,PMID:21126777,https://www.ncbi.nlm.nih.gov/pubmed/21126777,21126777,,
275,1346363,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,6559,SLC12A3,https://ctdbase.org/detail.go?type=gene&acc=6559,,,6559.0,SLC12A3,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of SLC12A3 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
276,1346364,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,6560,SLC12A4,https://ctdbase.org/detail.go?type=gene&acc=6560,,,6560.0,SLC12A4,7955,Danio rerio (zebrafish),Vinclozolin results in decreased expression of SLC12A4 mRNA,,,PMID:21126777,https://www.ncbi.nlm.nih.gov/pubmed/21126777,21126777,,
277,1346365,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,10723,SLC12A7,https://ctdbase.org/detail.go?type=gene&acc=10723,,,10723.0,SLC12A7,10116,Rattus norvegicus (Norway rat),Vinclozolin results in increased methylation of SLC12A7 gene,,,PMID:31079544|PMID:31682807,https://www.ncbi.nlm.nih.gov/pubmed/31079544|https://www.ncbi.nlm.nih.gov/pubmed/31682807,31079544|31682807,,
278,1346366,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,9058,SLC13A2,https://ctdbase.org/detail.go?type=gene&acc=9058,,,9058.0,SLC13A2,7955,Danio rerio (zebrafish),Vinclozolin results in decreased expression of SLC13A2 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
279,1346367,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,64849,SLC13A3,https://ctdbase.org/detail.go?type=gene&acc=64849,,,64849.0,SLC13A3,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased methylation of SLC13A3 gene,,,PMID:31079544,https://www.ncbi.nlm.nih.gov/pubmed/31079544,31079544,,
280,1339711,39793,Comparative Toxicogenomics Database (CTD),O-Ethyl S-(2-diisopropylaminoethyl) methylphosphonothioate,C009680,VX,https://ctdbase.org/detail.go?type=chem&acc=C009680,3858,KRT10,https://ctdbase.org/detail.go?type=gene&acc=3858,,,3858.0,KRT10,9606,Homo sapiens (human),VX binds to KRT10 protein,,,PMID:22521715,https://www.ncbi.nlm.nih.gov/pubmed/22521715,22521715,,
281,1339712,39793,Comparative Toxicogenomics Database (CTD),O-Ethyl S-(2-diisopropylaminoethyl) methylphosphonothioate,C009680,VX,https://ctdbase.org/detail.go?type=chem&acc=C009680,5184,PEPD,https://ctdbase.org/detail.go?type=gene&acc=5184,,,5184.0,PEPD,9606,Homo sapiens (human),PEPD protein results in increased hydrolysis of VX,,,PMID:22120822,https://www.ncbi.nlm.nih.gov/pubmed/22120822,22120822,,
282,1339713,39793,Comparative Toxicogenomics Database (CTD),O-Ethyl S-(2-diisopropylaminoethyl) methylphosphonothioate,C009680,VX,https://ctdbase.org/detail.go?type=chem&acc=C009680,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),PON1 protein mutant form results in decreased susceptibility to VX|PON1 protein mutant form results in increased hydrolysis of VX,,,PMID:23159884,https://www.ncbi.nlm.nih.gov/pubmed/23159884,23159884,,
283,1339714,39793,Comparative Toxicogenomics Database (CTD),O-Ethyl S-(2-diisopropylaminoethyl) methylphosphonothioate,C009680,VX,https://ctdbase.org/detail.go?type=chem&acc=C009680,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),PON1 protein results in increased hydrolysis of VX,,,PMID:20176005|PMID:23159884,https://www.ncbi.nlm.nih.gov/pubmed/20176005|https://www.ncbi.nlm.nih.gov/pubmed/23159884,20176005|23159884,,
284,1339715,39793,Comparative Toxicogenomics Database (CTD),O-Ethyl S-(2-diisopropylaminoethyl) methylphosphonothioate,C009680,VX,https://ctdbase.org/detail.go?type=chem&acc=C009680,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116,Rattus norvegicus (Norway rat),VX results in increased expression of PTGS2 protein|[n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] which results in decreased susceptibility to VX|VX results in increased expression of PTGS2 mRNA,,,PMID:22306367,https://www.ncbi.nlm.nih.gov/pubmed/22306367,22306367,,
285,1339716,39793,Comparative Toxicogenomics Database (CTD),O-Ethyl S-(2-diisopropylaminoethyl) methylphosphonothioate,C009680,VX,https://ctdbase.org/detail.go?type=chem&acc=C009680,5104,SERPINA5,https://ctdbase.org/detail.go?type=gene&acc=5104,,,5104.0,SERPINA5,10141,Cavia porcellus (domestic guinea pig),VX results in increased expression of SERPINA5 protein,,,PMID:32720192,https://www.ncbi.nlm.nih.gov/pubmed/32720192,32720192,,
286,1339717,39793,Comparative Toxicogenomics Database (CTD),O-Ethyl S-(2-diisopropylaminoethyl) methylphosphonothioate,C009680,VX,https://ctdbase.org/detail.go?type=chem&acc=C009680,6652,SORD,https://ctdbase.org/detail.go?type=gene&acc=6652,,,6652.0,SORD,10141,Cavia porcellus (domestic guinea pig),VX results in increased expression of SORD protein,,,PMID:32720192,https://www.ncbi.nlm.nih.gov/pubmed/32720192,32720192,,
287,1339718,39793,Comparative Toxicogenomics Database (CTD),O-Ethyl S-(2-diisopropylaminoethyl) methylphosphonothioate,C009680,VX,https://ctdbase.org/detail.go?type=chem&acc=C009680,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10116,Rattus norvegicus (Norway rat),VX results in decreased expression of VEGFA protein,,,PMID:34653647,https://www.ncbi.nlm.nih.gov/pubmed/34653647,34653647,,
288,1340307,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498.0,XDH,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of XDH mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
289,1340308,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,23214,XPO6,https://ctdbase.org/detail.go?type=gene&acc=23214,,,23214.0,XPO6,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of XPO6 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
290,1340309,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,7515,XRCC1,https://ctdbase.org/detail.go?type=gene&acc=7515,,,7515.0,XRCC1,9606,Homo sapiens (human),Deoxynivalenol results in increased expression of XRCC1 mrna|deoxynivalenol results in increased expression of XRCC1 protein,,,PMID:24355168,https://www.ncbi.nlm.nih.gov/pubmed/24355168,24355168,,
291,1340310,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,152002,XXYLT1,https://ctdbase.org/detail.go?type=gene&acc=152002,,,152002.0,XXYLT1,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of XXYLT1 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
292,1340311,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,9942,XYLB,https://ctdbase.org/detail.go?type=gene&acc=9942,,,9942.0,XYLB,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of XYLB mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
293,1340441,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,7455,ZAN,https://ctdbase.org/detail.go?type=gene&acc=7455,,,7455.0,ZAN,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of ZAN mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
294,1340442,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,646799,ZAR1L,https://ctdbase.org/detail.go?type=gene&acc=646799,,,646799.0,ZAR1L,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of ZAR1L mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
295,1340443,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,79740,ZBBX,https://ctdbase.org/detail.go?type=gene&acc=79740,,,79740.0,ZBBX,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of ZBBX mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
296,1340570,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,27107,ZBTB11,https://ctdbase.org/detail.go?type=gene&acc=27107,,,27107.0,ZBTB11,9606,Homo sapiens (human),Deoxynivalenol results in increased expression of ZBTB11 mRNA,,,PMID:31863870,https://www.ncbi.nlm.nih.gov/pubmed/31863870,31863870,,
297,1340571,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,27107,ZBTB11,https://ctdbase.org/detail.go?type=gene&acc=27107,,,27107.0,ZBTB11,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of ZBTB11 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
298,1340572,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,10472,ZBTB18,https://ctdbase.org/detail.go?type=gene&acc=10472,,,10472.0,ZBTB18,9606,Homo sapiens (human),Deoxynivalenol results in increased expression of ZBTB18 mRNA,,,PMID:31863870,https://www.ncbi.nlm.nih.gov/pubmed/31863870,31863870,,
299,1340573,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,10472,ZBTB18,https://ctdbase.org/detail.go?type=gene&acc=10472,,,10472.0,ZBTB18,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of ZBTB18 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
300,1340574,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,49854,ZBTB21,https://ctdbase.org/detail.go?type=gene&acc=49854,,,49854.0,ZBTB21,9606,Homo sapiens (human),Deoxynivalenol results in increased expression of ZBTB21 mRNA,,,PMID:31863870,https://www.ncbi.nlm.nih.gov/pubmed/31863870,31863870,,
301,1340575,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,49854,ZBTB21,https://ctdbase.org/detail.go?type=gene&acc=49854,,,49854.0,ZBTB21,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of ZBTB21 protein,,,PMID:37257635,https://www.ncbi.nlm.nih.gov/pubmed/37257635,37257635,,
302,1340576,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,9278,ZBTB22,https://ctdbase.org/detail.go?type=gene&acc=9278,,,9278.0,ZBTB22,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of ZBTB22 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
303,1340577,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,9841,ZBTB24,https://ctdbase.org/detail.go?type=gene&acc=9841,,,9841.0,ZBTB24,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of ZBTB24 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
304,1340578,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,10009,ZBTB33,https://ctdbase.org/detail.go?type=gene&acc=10009,,,10009.0,ZBTB33,9606,Homo sapiens (human),Deoxynivalenol results in increased expression of ZBTB33 mRNA,,,PMID:31863870,https://www.ncbi.nlm.nih.gov/pubmed/31863870,31863870,,
305,1340715,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10090,Mus musculus (house mouse),Deoxynivalenol results in decreased phosphorylation of MAPK9 protein,,,PMID:23352502,https://www.ncbi.nlm.nih.gov/pubmed/23352502,23352502,,
306,1340716,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,64087,MCCC2,https://ctdbase.org/detail.go?type=gene&acc=64087,,,64087.0,MCCC2,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of MCCC2 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
307,1340717,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,401250,MCCD1,https://ctdbase.org/detail.go?type=gene&acc=401250,,,401250.0,MCCD1,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of MCCD1 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
308,1340718,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10090,Mus musculus (house mouse),Deoxynivalenol results in increased phosphorylation of MAPK9 protein,,,PMID:12377986|PMID:12604842|PMID:14644621|PMID:14690764|PMID:15570035|PMID:15772366|PMID:16424113|PMID:18502741|PMID:23811945,https://www.ncbi.nlm.nih.gov/pubmed/12377986|https://www.ncbi.nlm.nih.gov/pubmed/12604842|https://www.ncbi.nlm.nih.gov/pubmed/14644621|https://www.ncbi.nlm.nih.gov/pubmed/14690764|https://www.ncbi.nlm.nih.gov/pubmed/15570035|https://www.ncbi.nlm.nih.gov/pubmed/15772366|https://www.ncbi.nlm.nih.gov/pubmed/16424113|https://www.ncbi.nlm.nih.gov/pubmed/18502741|https://www.ncbi.nlm.nih.gov/pubmed/23811945,12377986|12604842|14644621|14690764|15570035|15772366|16424113|18502741|23811945,,
309,1340719,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10090,Mus musculus (house mouse),Docosahexaenoic acids inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK9 protein],,,PMID:14690764|PMID:15570035|PMID:16424113,https://www.ncbi.nlm.nih.gov/pubmed/14690764|https://www.ncbi.nlm.nih.gov/pubmed/15570035|https://www.ncbi.nlm.nih.gov/pubmed/16424113,14690764|15570035|16424113,,
310,1341057,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,266727,MDGA1,https://ctdbase.org/detail.go?type=gene&acc=266727,,,266727.0,MDGA1,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of MDGA1 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
311,1341058,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4190,MDH1,https://ctdbase.org/detail.go?type=gene&acc=4190,,,4190.0,MDH1,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of MDH1 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
312,1341059,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4192,MDK,https://ctdbase.org/detail.go?type=gene&acc=4192,,,4192.0,MDK,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of MDK mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
313,1341060,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193.0,MDM2,9606,Homo sapiens (human),Deoxynivalenol results in increased expression of MDM2 mRNA,,,PMID:31863870,https://www.ncbi.nlm.nih.gov/pubmed/31863870,31863870,,
314,1341061,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193.0,MDM2,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of MDM2 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
315,1341647,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,58526,MID1IP1,https://ctdbase.org/detail.go?type=gene&acc=58526,,,58526.0,MID1IP1,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of MID1IP1 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
316,1341648,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,125170,MIEF2,https://ctdbase.org/detail.go?type=gene&acc=125170,,,125170.0,MIEF2,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of MIEF2 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
317,1341649,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,84895,MIGA2,https://ctdbase.org/detail.go?type=gene&acc=84895,,,84895.0,MIGA2,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of MIGA2 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
318,1341650,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,407975,MIR17HG,https://ctdbase.org/detail.go?type=gene&acc=407975,,,407975.0,MIR17HG,10090,Mus musculus (house mouse),Deoxynivalenol results in decreased expression of MIR17HG mRNA,,,PMID:23253260,https://www.ncbi.nlm.nih.gov/pubmed/23253260,23253260,,
319,1342858,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,6307,MSMO1,https://ctdbase.org/detail.go?type=gene&acc=6307,,,6307.0,MSMO1,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of MSMO1 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
320,1342859,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,22921,MSRB2,https://ctdbase.org/detail.go?type=gene&acc=22921,,,22921.0,MSRB2,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of MSRB2 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
321,1342860,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,253827,MSRB3,https://ctdbase.org/detail.go?type=gene&acc=253827,,,253827.0,MSRB3,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of MSRB3 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
322,1342861,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4485,MST1,https://ctdbase.org/detail.go?type=gene&acc=4485,,,4485.0,MST1,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of MST1 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
323,1342981,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4488,MSX2,https://ctdbase.org/detail.go?type=gene&acc=4488,,,4488.0,MSX2,9606,Homo sapiens (human),Deoxynivalenol results in increased expression of MSX2 mRNA,,,PMID:31863870,https://www.ncbi.nlm.nih.gov/pubmed/31863870,31863870,,
324,1342982,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,9219,MTA2,https://ctdbase.org/detail.go?type=gene&acc=9219,,,9219.0,MTA2,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of MTA2 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
325,1342983,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,57504,MTA3,https://ctdbase.org/detail.go?type=gene&acc=57504,,,57504.0,MTA3,10090,Mus musculus (house mouse),Deoxynivalenol affects the phosphorylation of MTA3 protein,,,PMID:23352502,https://www.ncbi.nlm.nih.gov/pubmed/23352502,23352502,,
326,1342984,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4507,MTAP,https://ctdbase.org/detail.go?type=gene&acc=4507,,,4507.0,MTAP,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of MTAP mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
327,1344650,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,10529,NEBL,https://ctdbase.org/detail.go?type=gene&acc=10529,,,10529.0,NEBL,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of NEBL mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
328,1344651,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,23327,NEDD4L,https://ctdbase.org/detail.go?type=gene&acc=23327,,,23327.0,NEDD4L,9606,Homo sapiens (human),Deoxynivalenol results in increased expression of NEDD4L mRNA,,,PMID:31863870,https://www.ncbi.nlm.nih.gov/pubmed/31863870,31863870,,
329,1344652,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4739,NEDD9,https://ctdbase.org/detail.go?type=gene&acc=4739,,,4739.0,NEDD9,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of NEDD9 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
330,1344653,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4744,NEFH,https://ctdbase.org/detail.go?type=gene&acc=4744,,,4744.0,NEFH,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of NEFH mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
331,1345158,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4793,NFKBIB,https://ctdbase.org/detail.go?type=gene&acc=4793,,,4793.0,NFKBIB,9606,Homo sapiens (human),Deoxynivalenol results in increased expression of NFKBIB mRNA,,,PMID:22846391,https://www.ncbi.nlm.nih.gov/pubmed/22846391,22846391,,
332,1345159,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4793,NFKBIB,https://ctdbase.org/detail.go?type=gene&acc=4793,,,4793.0,NFKBIB,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of NFKBIB mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
333,1345160,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4800,NFYA,https://ctdbase.org/detail.go?type=gene&acc=4800,,,4800.0,NFYA,9606,Homo sapiens (human),Deoxynivalenol results in increased expression of NFYA protein,,,PMID:33890134,https://www.ncbi.nlm.nih.gov/pubmed/33890134,33890134,,
334,1346031,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606,Homo sapiens (human),Deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]|lactacystin inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]|deoxynivalenol results in increased expression of NOS2 mrna|lactacystin inhibits the reaction [deoxynivalenol results in increased degradation of NOS2 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]|pyrrolidine dithiocarbamic acid inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]|adenine inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]|sb 203580 inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]|deoxynivalenol results in increased ubiquitination of and results in increased degradation of NOS2 protein,,,PMID:25766886,https://www.ncbi.nlm.nih.gov/pubmed/25766886,25766886,,
335,1346032,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of NOS2 protein]|ro 31-8220 inhibits the reaction [deoxynivalenol results in increased expression of NOS2 protein],,,PMID:32416088,https://www.ncbi.nlm.nih.gov/pubmed/32416088,32416088,,
336,1346033,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),"Deoxynivalenol inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of NOS2 mrna]|deoxynivalenol inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of NOS2 protein]",,,PMID:19857559,https://www.ncbi.nlm.nih.gov/pubmed/19857559,19857559,,
337,1346034,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),Deoxynivalenol results in increased expression of NOS2 protein,,,PMID:24937323|PMID:32416088,https://www.ncbi.nlm.nih.gov/pubmed/24937323|https://www.ncbi.nlm.nih.gov/pubmed/32416088,24937323|32416088,,
338,1346035,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Deoxynivalenol inhibits the reaction [lipopolysaccharides results in increased expression of NOS2 protein],,,PMID:21748807,https://www.ncbi.nlm.nih.gov/pubmed/21748807,21748807,,
339,1346682,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,8828,NRP2,https://ctdbase.org/detail.go?type=gene&acc=8828,,,8828.0,NRP2,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of NRP2 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
340,1346683,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,375387,NRROS,https://ctdbase.org/detail.go?type=gene&acc=375387,,,375387.0,NRROS,10090,Mus musculus (house mouse),Deoxynivalenol affects the phosphorylation of NRROS protein,,,PMID:23811945,https://www.ncbi.nlm.nih.gov/pubmed/23811945,23811945,,
341,1346684,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,140767,NRSN1,https://ctdbase.org/detail.go?type=gene&acc=140767,,,140767.0,NRSN1,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of NRSN1 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
342,1346685,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,4902,NRTN,https://ctdbase.org/detail.go?type=gene&acc=4902,,,4902.0,NRTN,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of NRTN mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
343,1341985,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,140701,ABHD16B,https://ctdbase.org/detail.go?type=gene&acc=140701,,,140701.0,ABHD16B,9606,Homo sapiens (human),Permethrin results in increased expression of ABHD16B mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
344,1341986,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,57406,ABHD6,https://ctdbase.org/detail.go?type=gene&acc=57406,,,57406.0,ABHD6,10090,Mus musculus (house mouse),Permethrin results in increased expression of ABHD6 mRNA,,,PMID:30629241,https://www.ncbi.nlm.nih.gov/pubmed/30629241,30629241,,
345,1342113,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),[DEET co-treated with permethrin] results in decreased activity of ACHE protein|permethrin results in increased activity of ACHE protein,,,PMID:11248143|PMID:14713564,https://www.ncbi.nlm.nih.gov/pubmed/11248143|https://www.ncbi.nlm.nih.gov/pubmed/14713564,11248143|14713564,,
346,1342114,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),[malathion co-treated with permethrin] results in decreased activity of ACHE protein|[malathion co-treated with permethrin] results in increased activity of ACHE protein|[deet co-treated with permethrin] results in increased activity of ACHE protein,,,PMID:14713564,https://www.ncbi.nlm.nih.gov/pubmed/14713564,14713564,,
347,1342115,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),Permethrin results in decreased activity of ACHE protein,,,PMID:7595515,https://www.ncbi.nlm.nih.gov/pubmed/7595515,7595515,,
348,1342116,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),[pyridostigmine bromide co-treated with permethrin co-treated with DEET] results in decreased activity of ACHE protein,,,PMID:11248143|PMID:14751452,https://www.ncbi.nlm.nih.gov/pubmed/11248143|https://www.ncbi.nlm.nih.gov/pubmed/14751452,11248143|14751452,,
349,1342117,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),[pyridostigmine bromide co-treated with permethrin] results in increased activity of ACHE protein|[pyridostigmine bromide co-treated with permethrin co-treated with DEET] results in increased activity of ACHE protein,,,PMID:14751452,https://www.ncbi.nlm.nih.gov/pubmed/14751452,14751452,,
350,1342118,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),[pyridostigmine bromide co-treated with permethrin] results in decreased activity of ACHE protein,,,PMID:11248143,https://www.ncbi.nlm.nih.gov/pubmed/11248143,11248143,,
351,1342975,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,311,ANXA11,https://ctdbase.org/detail.go?type=gene&acc=311,,,311.0,ANXA11,10116,Rattus norvegicus (Norway rat),[permethrin co-treated with DEET] results in increased methylation of ANXA11 gene,,,PMID:33148267,https://www.ncbi.nlm.nih.gov/pubmed/33148267,33148267,,
352,1342976,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,312,ANXA13,https://ctdbase.org/detail.go?type=gene&acc=312,,,312.0,ANXA13,10116,Rattus norvegicus (Norway rat),[permethrin co-treated with DEET] results in decreased methylation of ANXA13 gene,,,PMID:33148267,https://www.ncbi.nlm.nih.gov/pubmed/33148267,33148267,,
353,1342977,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,84909,AOPEP,https://ctdbase.org/detail.go?type=gene&acc=84909,,,84909.0,AOPEP,10116,Rattus norvegicus (Norway rat),[permethrin co-treated with DEET] results in decreased methylation of AOPEP gene,,,PMID:33148267,https://www.ncbi.nlm.nih.gov/pubmed/33148267,33148267,,
354,1342978,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,9606,Homo sapiens (human),Permethrin results in increased expression of AOX1 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
355,1342979,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,10090,Mus musculus (house mouse),Permethrin results in increased expression of AOX1 mRNA,,,PMID:30629241,https://www.ncbi.nlm.nih.gov/pubmed/30629241,30629241,,
356,1342980,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,130340,AP1S3,https://ctdbase.org/detail.go?type=gene&acc=130340,,,130340.0,AP1S3,10116,Rattus norvegicus (Norway rat),[permethrin co-treated with DEET] results in decreased methylation of AP1S3 gene,,,PMID:33148267,https://www.ncbi.nlm.nih.gov/pubmed/33148267,33148267,,
357,1343838,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,570772,BCL2A,https://ctdbase.org/detail.go?type=gene&acc=570772,,,570772.0,bcl2a,7955,Danio rerio (zebrafish),Permethrin results in increased expression of BCL2A mRNA,,,PMID:20153439,https://www.ncbi.nlm.nih.gov/pubmed/20153439,20153439,,
358,1343839,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,604,BCL6,https://ctdbase.org/detail.go?type=gene&acc=604,,,604.0,BCL6,10116,Rattus norvegicus (Norway rat),[pyridostigmine bromide co-treated with DEET co-treated with permethrin] results in increased expression of BCL6 mRNA,,,PMID:28659758,https://www.ncbi.nlm.nih.gov/pubmed/28659758,28659758,,
359,1343840,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,9606,Homo sapiens (human),Permethrin results in increased expression of BDNF mrna|permethrin results in decreased methylation of BDNF promoter,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
360,1343841,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10090,Mus musculus (house mouse),[pyridostigmine bromide co-treated with permethrin] results in decreased expression of BDNF protein|nlrp3 protein affects the reaction [[pyridostigmine bromide co-treated with permethrin] results in decreased expression of BDNF protein],,,PMID:32832901,https://www.ncbi.nlm.nih.gov/pubmed/32832901,32832901,,
361,1343842,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10090,Mus musculus (house mouse),[permethrin co-treated with DDT co-treated with diethylstilbestrol] inhibits the reaction [potassium results in increased expression of BDNF mrna]|permethrin inhibits the reaction [potassium results in increased expression of BDNF mrna],,,PMID:15527870,https://www.ncbi.nlm.nih.gov/pubmed/15527870,15527870,,
362,1343843,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10090,Mus musculus (house mouse),Permethrin inhibits the reaction [veratridine results in increased expression of BDNF mrna],,,PMID:11082455,https://www.ncbi.nlm.nih.gov/pubmed/11082455,11082455,,
363,1344644,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Permethrin binds to CAT protein,,,PMID:32278787,https://www.ncbi.nlm.nih.gov/pubmed/32278787,32278787,,
364,1344645,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Permethrin results in decreased activity of CAT protein|dietary fats promotes the reaction [permethrin results in decreased activity of CAT protein]|permethrin promotes the reaction [dietary fats results in decreased activity of CAT protein],,,PMID:34224971,https://www.ncbi.nlm.nih.gov/pubmed/34224971,34224971,,
365,1344646,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Permethrin results in decreased expression of CAT protein,,,PMID:32911180,https://www.ncbi.nlm.nih.gov/pubmed/32911180,32911180,,
366,1344647,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Permethrin results in increased activity of CAT protein,,,PMID:12965126|PMID:28456543,https://www.ncbi.nlm.nih.gov/pubmed/12965126|https://www.ncbi.nlm.nih.gov/pubmed/28456543,12965126|28456543,,
367,1344648,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Permethrin results in increased expression of CAT protein,,,PMID:31175960,https://www.ncbi.nlm.nih.gov/pubmed/31175960,31175960,,
368,1344649,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),[propoxur co-treated with permethrin] results in increased activity of CAT protein,,,PMID:28456543,https://www.ncbi.nlm.nih.gov/pubmed/28456543,28456543,,
369,1345644,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,1129,CHRM2,https://ctdbase.org/detail.go?type=gene&acc=1129,,,1129.0,CHRM2,10116,Rattus norvegicus (Norway rat),Permethrin promotes the reaction [AFDX 384 binds to CHRM2 protein],,,PMID:11248143,https://www.ncbi.nlm.nih.gov/pubmed/11248143,11248143,,
370,1345645,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,1129,CHRM2,https://ctdbase.org/detail.go?type=gene&acc=1129,,,1129.0,CHRM2,10116,Rattus norvegicus (Norway rat),[pyridostigmine bromide co-treated with permethrin] promotes the reaction [AFDX 384 binds to CHRM2 protein]|[pyridostigmine bromide co-treated with permethrin co-treated with DEET] promotes the reaction [AFDX 384 binds to CHRM2 protein],,,PMID:14751452,https://www.ncbi.nlm.nih.gov/pubmed/14751452,14751452,,
371,1345646,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,1135,CHRNA2,https://ctdbase.org/detail.go?type=gene&acc=1135,,,1135.0,CHRNA2,10090,Mus musculus (house mouse),Permethrin results in increased expression of CHRNA2 mRNA,,,PMID:30629241,https://www.ncbi.nlm.nih.gov/pubmed/30629241,30629241,,
372,1345647,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,8534,CHST1,https://ctdbase.org/detail.go?type=gene&acc=8534,,,8534.0,CHST1,9606,Homo sapiens (human),Permethrin results in increased expression of CHST1 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
373,1345648,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,9486,CHST10,https://ctdbase.org/detail.go?type=gene&acc=9486,,,9486.0,CHST10,10116,Rattus norvegicus (Norway rat),[permethrin co-treated with DEET] results in decreased methylation of CHST10 gene,,,PMID:33148267,https://www.ncbi.nlm.nih.gov/pubmed/33148267,33148267,,
374,1345649,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,50515,CHST11,https://ctdbase.org/detail.go?type=gene&acc=50515,,,50515.0,CHST11,10116,Rattus norvegicus (Norway rat),[permethrin co-treated with DEET] results in decreased methylation of CHST11 gene,,,PMID:33148267,https://www.ncbi.nlm.nih.gov/pubmed/33148267,33148267,,
375,1346676,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,1528,CYB5A,https://ctdbase.org/detail.go?type=gene&acc=1528,,,1528.0,CYB5A,29058,Helicoverpa armigera (cotton bollworm),Permethrin results in increased expression of CYB5A mRNA,,,PMID:10620039,https://www.ncbi.nlm.nih.gov/pubmed/10620039,10620039,,
376,1346677,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,40162,CYC,https://ctdbase.org/detail.go?type=gene&acc=40162,,,40162.0,cyc,7227,Drosophila melanogaster (fruit fly),CYC protein results in decreased susceptibility to permethrin,,,PMID:20348229,https://www.ncbi.nlm.nih.gov/pubmed/20348229,20348229,,
377,1346678,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,1537,CYC1,https://ctdbase.org/detail.go?type=gene&acc=1537,,,1537.0,CYC1,10116,Rattus norvegicus (Norway rat),[pyridostigmine bromide co-treated with DEET co-treated with permethrin] results in increased expression of CYC1 mRNA,,,PMID:28659758,https://www.ncbi.nlm.nih.gov/pubmed/28659758,28659758,,
378,1346679,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,26999,CYFIP2,https://ctdbase.org/detail.go?type=gene&acc=26999,,,26999.0,CYFIP2,10116,Rattus norvegicus (Norway rat),[permethrin co-treated with DEET] results in decreased methylation of CYFIP2 gene,,,PMID:33148267,https://www.ncbi.nlm.nih.gov/pubmed/33148267,33148267,,
379,1346680,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,114757,CYGB,https://ctdbase.org/detail.go?type=gene&acc=114757,,,114757.0,CYGB,10116,Rattus norvegicus (Norway rat),[pyridostigmine bromide co-treated with DEET co-treated with permethrin] results in increased expression of CYGB mRNA,,,PMID:28659758,https://www.ncbi.nlm.nih.gov/pubmed/28659758,28659758,,
380,1346681,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10090,Mus musculus (house mouse),Permethrin analog results in decreased expression of CYP11A1 mRNA,,,PMID:21745691,https://www.ncbi.nlm.nih.gov/pubmed/21745691,21745691,,
381,1347177,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,1577,CYP3A5,https://ctdbase.org/detail.go?type=gene&acc=1577,,,1577.0,CYP3A5,9606,Homo sapiens (human),Permethrin results in increased expression of CYP3A5 mRNA,,,PMID:19326768,https://www.ncbi.nlm.nih.gov/pubmed/19326768,19326768,,
382,1347178,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,13117,CYP4A10,https://ctdbase.org/detail.go?type=gene&acc=13117,,,13117.0,Cyp4a10,10090,Mus musculus (house mouse),Permethrin results in increased expression of CYP4A10 mRNA,,,PMID:32040184,https://www.ncbi.nlm.nih.gov/pubmed/32040184,32040184,,
383,1347179,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,1579,CYP4A11,https://ctdbase.org/detail.go?type=gene&acc=1579,,,1579.0,CYP4A11,9606,Homo sapiens (human),Permethrin results in increased expression of CYP4A11 mRNA,,,PMID:32040184,https://www.ncbi.nlm.nih.gov/pubmed/32040184,32040184,,
384,1334036,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,5579,PRKCB,https://ctdbase.org/detail.go?type=gene&acc=5579,,,5579.0,PRKCB,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of PRKCB mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
385,1334037,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,5581,PRKCE,https://ctdbase.org/detail.go?type=gene&acc=5581,,,5581.0,PRKCE,9606,Homo sapiens (human),Chlorodiphenyl (54% chlorine) affects the localization of PRKCE protein,,,PMID:15475174,https://www.ncbi.nlm.nih.gov/pubmed/15475174,15475174,,
386,1334038,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,23683,PRKD3,https://ctdbase.org/detail.go?type=gene&acc=23683,,,23683.0,PRKD3,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of PRKD3 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
387,1334039,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,5071,PRKN,https://ctdbase.org/detail.go?type=gene&acc=5071,,,5071.0,PRKN,10116,Rattus norvegicus (Norway rat),Chlorodiphenyl (54% chlorine) results in increased expression of PRKN protein,,,PMID:16174552,https://www.ncbi.nlm.nih.gov/pubmed/16174552,16174552,,
388,1334040,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,5613,PRKX,https://ctdbase.org/detail.go?type=gene&acc=5613,,,5613.0,PRKX,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of PRKX mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
389,1334041,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,5617,PRL,https://ctdbase.org/detail.go?type=gene&acc=5617,,,5617.0,PRL,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of PRL protein]|chlorodiphenyl (54% chlorine) results in decreased expression of PRL protein|vitamin E inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of PRL protein],,,PMID:16298753,https://www.ncbi.nlm.nih.gov/pubmed/16298753,16298753,,
390,1335656,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,23521,RPL13A,https://ctdbase.org/detail.go?type=gene&acc=23521,,,23521.0,RPL13A,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of RPL13A mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
391,1335657,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,6141,RPL18,https://ctdbase.org/detail.go?type=gene&acc=6141,,,6141.0,RPL18,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of RPL18 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
392,1335658,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,6141,RPL18,https://ctdbase.org/detail.go?type=gene&acc=6141,,,6141.0,RPL18,8260,Platichthys flesus (European flounder),Chlorodiphenyl (54% chlorine) results in increased expression of RPL18 mRNA,,,PMID:18804290,https://www.ncbi.nlm.nih.gov/pubmed/18804290,18804290,,
393,1335659,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,200916,RPL22L1,https://ctdbase.org/detail.go?type=gene&acc=200916,,,200916.0,RPL22L1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of RPL22L1 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
394,1335660,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,9349,RPL23,https://ctdbase.org/detail.go?type=gene&acc=9349,,,9349.0,RPL23,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of RPL23 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
395,1335661,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,6157,RPL27A,https://ctdbase.org/detail.go?type=gene&acc=6157,,,6157.0,RPL27A,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of RPL27A mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
396,1335662,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,6158,RPL28,https://ctdbase.org/detail.go?type=gene&acc=6158,,,6158.0,RPL28,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of RPL28 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
397,1335663,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,6160,RPL31,https://ctdbase.org/detail.go?type=gene&acc=6160,,,6160.0,RPL31,8260,Platichthys flesus (European flounder),Chlorodiphenyl (54% chlorine) results in decreased expression of RPL31 mRNA,,,PMID:18804290,https://www.ncbi.nlm.nih.gov/pubmed/18804290,18804290,,
398,1335664,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,6165,RPL35A,https://ctdbase.org/detail.go?type=gene&acc=6165,,,6165.0,RPL35A,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of RPL35A mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
399,1336993,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,2678,GGT1,https://ctdbase.org/detail.go?type=gene&acc=2678,,,2678.0,GGT1,10116,Rattus norvegicus (Norway rat),Chlorodiphenyl (54% chlorine) results in decreased activity of GGT1 protein,,,PMID:15955608|PMID:16298753|PMID:17283232,https://www.ncbi.nlm.nih.gov/pubmed/15955608|https://www.ncbi.nlm.nih.gov/pubmed/16298753|https://www.ncbi.nlm.nih.gov/pubmed/17283232,15955608|16298753|17283232,,
400,1336994,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,2681,GGTA1,https://ctdbase.org/detail.go?type=gene&acc=2681,,,2681.0,GGTA1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of GGTA1 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
401,1337783,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,2987,GUK1,https://ctdbase.org/detail.go?type=gene&acc=2987,,,2987.0,GUK1,8260,Platichthys flesus (European flounder),Chlorodiphenyl (54% chlorine) results in decreased expression of GUK1 mRNA,,,PMID:18804290,https://www.ncbi.nlm.nih.gov/pubmed/18804290,18804290,,
402,1337784,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,283120,H19,https://ctdbase.org/detail.go?type=gene&acc=283120,,,283120.0,H19,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of H19 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
403,1338514,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3192,HNRNPU,https://ctdbase.org/detail.go?type=gene&acc=3192,,,3192.0,HNRNPU,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of HNRNPU mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
404,1338515,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3216,HOXB6,https://ctdbase.org/detail.go?type=gene&acc=3216,,,3216.0,HOXB6,9606,Homo sapiens (human),Chlorodiphenyl (54% chlorine) results in increased expression of HOXB6 mRNA,,,PMID:16934159,https://www.ncbi.nlm.nih.gov/pubmed/16934159,16934159,,
405,1338516,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3217,HOXB7,https://ctdbase.org/detail.go?type=gene&acc=3217,,,3217.0,HOXB7,9606,Homo sapiens (human),Chlorodiphenyl (54% chlorine) results in increased expression of HOXB7 mRNA,,,PMID:16934159,https://www.ncbi.nlm.nih.gov/pubmed/16934159,16934159,,
406,1338517,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3219,HOXB9,https://ctdbase.org/detail.go?type=gene&acc=3219,,,3219.0,HOXB9,9606,Homo sapiens (human),Chlorodiphenyl (54% chlorine) results in increased expression of HOXB9 mRNA,,,PMID:16934159,https://www.ncbi.nlm.nih.gov/pubmed/16934159,16934159,,
407,1338518,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3233,HOXD4,https://ctdbase.org/detail.go?type=gene&acc=3233,,,3233.0,HOXD4,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of HOXD4 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
408,1338519,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,84842,HPDL,https://ctdbase.org/detail.go?type=gene&acc=84842,,,84842.0,HPDL,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of HPDL mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
409,1338520,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3248,HPGD,https://ctdbase.org/detail.go?type=gene&acc=3248,,,3248.0,HPGD,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of HPGD mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
410,1338521,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3251,HPRT1,https://ctdbase.org/detail.go?type=gene&acc=3251,,,3251.0,HPRT1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of HPRT1 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
411,1338522,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3265,HRAS,https://ctdbase.org/detail.go?type=gene&acc=3265,,,3265.0,HRAS,10116,Rattus norvegicus (Norway rat),Chlorodiphenyl (54% chlorine) results in increased expression of HRAS mRNA,,,PMID:8471063,https://www.ncbi.nlm.nih.gov/pubmed/8471063,8471063,,
412,1338936,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3313,HSPA9,https://ctdbase.org/detail.go?type=gene&acc=3313,,,3313.0,HSPA9,9606,Homo sapiens (human),Chlorodiphenyl (54% chlorine) results in increased expression of HSPA9 mRNA,,,PMID:17851650,https://www.ncbi.nlm.nih.gov/pubmed/17851650,17851650,,
413,1338937,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3313,HSPA9,https://ctdbase.org/detail.go?type=gene&acc=3313,,,3313.0,HSPA9,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of HSPA9 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
414,1338938,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,23640,HSPBP1,https://ctdbase.org/detail.go?type=gene&acc=23640,,,23640.0,HSPBP1,8260,Platichthys flesus (European flounder),Chlorodiphenyl (54% chlorine) results in increased expression of HSPBP1 mRNA,,,PMID:18804290,https://www.ncbi.nlm.nih.gov/pubmed/18804290,18804290,,
415,1338939,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3329,HSPD1,https://ctdbase.org/detail.go?type=gene&acc=3329,,,3329.0,HSPD1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of HSPD1 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
416,1338940,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,10808,HSPH1,https://ctdbase.org/detail.go?type=gene&acc=10808,,,10808.0,HSPH1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of HSPH1 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
417,1338941,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,10808,HSPH1,https://ctdbase.org/detail.go?type=gene&acc=10808,,,10808.0,HSPH1,10116,Rattus norvegicus (Norway rat),Chlorodiphenyl (54% chlorine) results in increased expression of HSPH1 protein,,,PMID:21791222,https://www.ncbi.nlm.nih.gov/pubmed/21791222,21791222,,
418,1339424,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,81533,ITFG1,https://ctdbase.org/detail.go?type=gene&acc=81533,,,81533.0,ITFG1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of ITFG1 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
419,1339425,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3688,ITGB1,https://ctdbase.org/detail.go?type=gene&acc=3688,,,3688.0,ITGB1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of ITGB1 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
420,1340157,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3973,LHCGR,https://ctdbase.org/detail.go?type=gene&acc=3973,,,3973.0,LHCGR,10116,Rattus norvegicus (Norway rat),Chlorodiphenyl (54% chlorine) results in decreased expression of LHCGR mRNA,,,PMID:29208485,https://www.ncbi.nlm.nih.gov/pubmed/29208485,29208485,,
421,1340158,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3973,LHCGR,https://ctdbase.org/detail.go?type=gene&acc=3973,,,3973.0,LHCGR,10116,Rattus norvegicus (Norway rat),Chlorodiphenyl (54% chlorine) results in decreased expression of LHCGR protein,,,PMID:15808795|PMID:29208485,https://www.ncbi.nlm.nih.gov/pubmed/15808795|https://www.ncbi.nlm.nih.gov/pubmed/29208485,15808795|29208485,,
422,1340159,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,51474,LIMA1,https://ctdbase.org/detail.go?type=gene&acc=51474,,,51474.0,LIMA1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of LIMA1 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
423,1340160,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,54923,LIME1,https://ctdbase.org/detail.go?type=gene&acc=54923,,,54923.0,LIME1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of LIME1 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
424,1340161,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3984,LIMK1,https://ctdbase.org/detail.go?type=gene&acc=3984,,,3984.0,LIMK1,10116,Rattus norvegicus (Norway rat),INS1 protein inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of LIMK1 protein]|chlorodiphenyl (54% chlorine) results in decreased expression of LIMK1 protein,,,PMID:17366564,https://www.ncbi.nlm.nih.gov/pubmed/17366564,17366564,,
425,1340162,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,3987,LIMS1,https://ctdbase.org/detail.go?type=gene&acc=3987,,,3987.0,LIMS1,9606,Homo sapiens (human),Chlorodiphenyl (54% chlorine) results in increased expression of LIMS1 mRNA,,,PMID:16934159,https://www.ncbi.nlm.nih.gov/pubmed/16934159,16934159,,
426,1340891,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,284207,METRNL,https://ctdbase.org/detail.go?type=gene&acc=284207,,,284207.0,METRNL,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of METRNL mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
427,1340892,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,366792,METTL7B,https://ctdbase.org/detail.go?type=gene&acc=366792,,,366792.0,Mettl7b,10116,Rattus norvegicus (Norway rat),Chlorodiphenyl (54% chlorine) results in increased expression of METTL7B mRNA,,,PMID:18178546,https://www.ncbi.nlm.nih.gov/pubmed/18178546,18178546,,
428,1340893,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,51108,METTL9,https://ctdbase.org/detail.go?type=gene&acc=51108,,,51108.0,METTL9,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of METTL9 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
429,1341818,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,66116,NAT8F1,https://ctdbase.org/detail.go?type=gene&acc=66116,,,66116.0,Nat8f1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of NAT8F1 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
430,1341819,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,4681,NBL1,https://ctdbase.org/detail.go?type=gene&acc=4681,,,4681.0,NBL1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of NBL1 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
431,1341820,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,4683,NBN,https://ctdbase.org/detail.go?type=gene&acc=4683,,,4683.0,NBN,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of NBN mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
432,1341821,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,4077,NBR1,https://ctdbase.org/detail.go?type=gene&acc=4077,,,4077.0,NBR1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of NBR1 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
433,1341822,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,23397,NCAPH,https://ctdbase.org/detail.go?type=gene&acc=23397,,,23397.0,NCAPH,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of NCAPH mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
434,1341823,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,29781,NCAPH2,https://ctdbase.org/detail.go?type=gene&acc=29781,,,29781.0,NCAPH2,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of NCAPH2 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
435,1341824,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,22916,NCBP2,https://ctdbase.org/detail.go?type=gene&acc=22916,,,22916.0,NCBP2,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of NCBP2 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
436,1341825,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,8440,NCK2,https://ctdbase.org/detail.go?type=gene&acc=8440,,,8440.0,NCK2,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of NCK2 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
437,1341826,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,4691,NCL,https://ctdbase.org/detail.go?type=gene&acc=4691,,,4691.0,NCL,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of NCL mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
438,1341827,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,8031,NCOA4,https://ctdbase.org/detail.go?type=gene&acc=8031,,,8031.0,NCOA4,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of NCOA4 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
439,1342556,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,4867,NPHP1,https://ctdbase.org/detail.go?type=gene&acc=4867,,,4867.0,NPHP1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of NPHP1 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
440,1342557,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,4869,NPM1,https://ctdbase.org/detail.go?type=gene&acc=4869,,,4869.0,NPM1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of NPM1 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
441,1342558,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,4869,NPM1,https://ctdbase.org/detail.go?type=gene&acc=4869,,,4869.0,NPM1,8260,Platichthys flesus (European flounder),Chlorodiphenyl (54% chlorine) results in increased expression of NPM1 mRNA,,,PMID:18804290,https://www.ncbi.nlm.nih.gov/pubmed/18804290,18804290,,
442,1344463,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,55629,PNRC2,https://ctdbase.org/detail.go?type=gene&acc=55629,,,55629.0,PNRC2,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of PNRC2 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
443,1344464,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,79070,POGLUT2,https://ctdbase.org/detail.go?type=gene&acc=79070,,,79070.0,POGLUT2,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of POGLUT2 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
444,1344465,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,57804,POLD4,https://ctdbase.org/detail.go?type=gene&acc=57804,,,57804.0,POLD4,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of POLD4 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
445,1344466,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,56655,POLE4,https://ctdbase.org/detail.go?type=gene&acc=56655,,,56655.0,POLE4,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of POLE4 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
446,1344467,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,51426,POLK,https://ctdbase.org/detail.go?type=gene&acc=51426,,,51426.0,POLK,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of POLK mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
447,1344468,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,9533,POLR1C,https://ctdbase.org/detail.go?type=gene&acc=9533,,,9533.0,POLR1C,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of POLR1C mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
448,1344469,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,51082,POLR1D,https://ctdbase.org/detail.go?type=gene&acc=51082,,,51082.0,POLR1D,8260,Platichthys flesus (European flounder),Chlorodiphenyl (54% chlorine) results in increased expression of POLR1D mRNA,,,PMID:18804290,https://www.ncbi.nlm.nih.gov/pubmed/18804290,18804290,,
449,1344470,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,5437,POLR2H,https://ctdbase.org/detail.go?type=gene&acc=5437,,,5437.0,POLR2H,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of POLR2H mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
450,1344841,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,7180,CRISP2,https://ctdbase.org/detail.go?type=gene&acc=7180,,,7180.0,CRISP2,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of CRISP2 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
451,1344842,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,1398,CRK,https://ctdbase.org/detail.go?type=gene&acc=1398,,,1398.0,CRK,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of CRK mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
452,1344843,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,7812,CSDE1,https://ctdbase.org/detail.go?type=gene&acc=7812,,,7812.0,CSDE1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of CSDE1 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
453,1345473,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),Chlorodiphenyl (54% chlorine) results in increased activity of CYP1A1 protein,,,PMID:16934159,https://www.ncbi.nlm.nih.gov/pubmed/16934159,16934159,,
454,1345474,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),Chlorodiphenyl (54% chlorine) results in increased expression of and results in increased activity of CYP1A1 protein,,,PMID:18708364,https://www.ncbi.nlm.nih.gov/pubmed/18708364,18708364,,
455,1345475,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),Chlorodiphenyl (54% chlorine) results in increased expression of CYP1A1 mRNA,,,PMID:16049271|PMID:16934159|PMID:17851650|PMID:18708364,https://www.ncbi.nlm.nih.gov/pubmed/16049271|https://www.ncbi.nlm.nih.gov/pubmed/16934159|https://www.ncbi.nlm.nih.gov/pubmed/17851650|https://www.ncbi.nlm.nih.gov/pubmed/18708364,16049271|16934159|17851650|18708364,,
456,1345476,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),Chlorodiphenyl (54% chlorine) results in increased expression of CYP1A1 protein,,,PMID:16934159|PMID:17851650|PMID:18767135,https://www.ncbi.nlm.nih.gov/pubmed/16934159|https://www.ncbi.nlm.nih.gov/pubmed/17851650|https://www.ncbi.nlm.nih.gov/pubmed/18767135,16934159|17851650|18767135,,
457,1345477,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9544,Macaca mulatta (Rhesus monkey),Chlorodiphenyl (54% chlorine) results in increased expression of CYP1A1 mRNA,,,PMID:16049271,https://www.ncbi.nlm.nih.gov/pubmed/16049271,16049271,,
458,1345478,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090,Mus musculus (house mouse),"[chlorodiphenyl (54% chlorine) co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased expression of CYP1A1 mRNA",,,PMID:30991879,https://www.ncbi.nlm.nih.gov/pubmed/30991879,30991879,,
459,1345479,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of CYP1A1 mRNA,,,PMID:25270620|PMID:25795401,https://www.ncbi.nlm.nih.gov/pubmed/25270620|https://www.ncbi.nlm.nih.gov/pubmed/25795401,25270620|25795401,,
460,1345480,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,8022,Oncorhynchus mykiss (rainbow trout),Chlorodiphenyl (54% chlorine) results in increased expression of CYP1A1 mRNA,,,PMID:15210299,https://www.ncbi.nlm.nih.gov/pubmed/15210299,15210299,,
461,1345481,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10116,Rattus norvegicus (Norway rat),Chlorodiphenyl (54% chlorine) results in increased activity of CYP1A1 protein,,,PMID:11713002|PMID:18708364|PMID:8471063,https://www.ncbi.nlm.nih.gov/pubmed/11713002|https://www.ncbi.nlm.nih.gov/pubmed/18708364|https://www.ncbi.nlm.nih.gov/pubmed/8471063,11713002|18708364|8471063,,
462,1345849,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,100328933,CYP2C,https://ctdbase.org/detail.go?type=gene&acc=100328933,,,100328933.0,CYP2C,10116,Rattus norvegicus (Norway rat),Chlorodiphenyl (54% chlorine) results in increased expression of CYP2C mRNA,,,PMID:18178546,https://www.ncbi.nlm.nih.gov/pubmed/18178546,18178546,,
463,1345850,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606,Homo sapiens (human),Chlorodiphenyl (54% chlorine) results in increased expression of CYP2C19 mRNA,,,PMID:17851650,https://www.ncbi.nlm.nih.gov/pubmed/17851650,17851650,,
464,1346358,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,10521,DDX17,https://ctdbase.org/detail.go?type=gene&acc=10521,,,10521.0,DDX17,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of DDX17 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
465,1346359,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,8886,DDX18,https://ctdbase.org/detail.go?type=gene&acc=8886,,,8886.0,DDX18,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of DDX18 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
466,1346360,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,55661,DDX27,https://ctdbase.org/detail.go?type=gene&acc=55661,,,55661.0,DDX27,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of DDX27 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
467,1346869,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,1805,DPT,https://ctdbase.org/detail.go?type=gene&acc=1805,,,1805.0,DPT,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of DPT mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
468,1346870,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,10570,DPYSL4,https://ctdbase.org/detail.go?type=gene&acc=10570,,,10570.0,DPYSL4,10116,Rattus norvegicus (Norway rat),Chlorodiphenyl (54% chlorine) results in increased expression of DPYSL4 protein,,,PMID:21791222,https://www.ncbi.nlm.nih.gov/pubmed/21791222,21791222,,
469,1346871,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,1812,DRD1,https://ctdbase.org/detail.go?type=gene&acc=1812,,,1812.0,DRD1,10116,Rattus norvegicus (Norway rat),Chlorodiphenyl (54% chlorine) results in increased expression of DRD1 mrna|quercetin inhibits the reaction [chlorodiphenyl (54% chlorine) results in increased expression of DRD1 mrna],,,PMID:21472459,https://www.ncbi.nlm.nih.gov/pubmed/21472459,21472459,,
470,1346872,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,1813,DRD2,https://ctdbase.org/detail.go?type=gene&acc=1813,,,1813.0,DRD2,10116,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of DRD2 mrna]|chlorodiphenyl (54% chlorine) results in decreased expression of DRD2 mRNA,,,PMID:21472459,https://www.ncbi.nlm.nih.gov/pubmed/21472459,21472459,,
471,1347002,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,285193,DUSP28,https://ctdbase.org/detail.go?type=gene&acc=285193,,,285193.0,DUSP28,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of DUSP28 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
472,1347003,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,1854,DUT,https://ctdbase.org/detail.go?type=gene&acc=1854,,,1854.0,DUT,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of DUT mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
473,1335794,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),Decamethrin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 2-hydroxyestradiol]|decamethrin results in decreased activity of CYP3A4 protein|decamethrin inhibits the reaction [CYP3A4 protein results in increased metabolism of estradiol],,,PMID:16790556,https://www.ncbi.nlm.nih.gov/pubmed/16790556,16790556,,
474,1335795,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),Decamethrin results in increased activity of CYP3A4 protein,,,PMID:22310298,https://www.ncbi.nlm.nih.gov/pubmed/22310298,22310298,,
475,1335796,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),Decamethrin results in increased expression of CYP3A4 mRNA,,,PMID:19249324|PMID:19326768|PMID:22310298,https://www.ncbi.nlm.nih.gov/pubmed/19249324|https://www.ncbi.nlm.nih.gov/pubmed/19326768|https://www.ncbi.nlm.nih.gov/pubmed/22310298,19249324|19326768|22310298,,
476,1336295,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,26528,DAZAP1,https://ctdbase.org/detail.go?type=gene&acc=26528,,,26528.0,DAZAP1,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of DAZAP1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
477,1336296,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,26528,DAZAP1,https://ctdbase.org/detail.go?type=gene&acc=26528,,,26528.0,DAZAP1,10116,Rattus norvegicus (Norway rat),[allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA,,,PMID:33051911,https://www.ncbi.nlm.nih.gov/pubmed/33051911,33051911,,
478,1336297,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,26528,DAZAP1,https://ctdbase.org/detail.go?type=gene&acc=26528,,,26528.0,DAZAP1,10116,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] affects the expression of DAZAP1 mRNA,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
479,1336298,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,26528,DAZAP1,https://ctdbase.org/detail.go?type=gene&acc=26528,,,26528.0,DAZAP1,10116,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of DAZAP1 mRNA,,,PMID:33396045,https://www.ncbi.nlm.nih.gov/pubmed/33396045,33396045,,
480,1336299,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,9802,DAZAP2,https://ctdbase.org/detail.go?type=gene&acc=9802,,,9802.0,DAZAP2,10090,Mus musculus (house mouse),Decamethrin results in increased expression of DAZAP2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
481,1336300,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,1618,DAZL,https://ctdbase.org/detail.go?type=gene&acc=1618,,,1618.0,DAZL,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of DAZL mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
482,1336301,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,1618,DAZL,https://ctdbase.org/detail.go?type=gene&acc=1618,,,1618.0,DAZL,10090,Mus musculus (house mouse),Decamethrin results in increased expression of DAZL mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
483,1336302,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,10926,DBF4,https://ctdbase.org/detail.go?type=gene&acc=10926,,,10926.0,DBF4,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of DBF4 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
484,1336658,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,9201,DCLK1,https://ctdbase.org/detail.go?type=gene&acc=9201,,,9201.0,DCLK1,10090,Mus musculus (house mouse),Decamethrin results in increased expression of DCLK1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
485,1336659,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,85443,DCLK3,https://ctdbase.org/detail.go?type=gene&acc=85443,,,85443.0,DCLK3,10090,Mus musculus (house mouse),Decamethrin results in increased expression of DCLK3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
486,1336660,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,1634,DCN,https://ctdbase.org/detail.go?type=gene&acc=1634,,,1634.0,DCN,10090,Mus musculus (house mouse),Decamethrin affects the expression of DCN mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
487,1336661,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,55802,DCP1A,https://ctdbase.org/detail.go?type=gene&acc=55802,,,55802.0,DCP1A,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of DCP1A mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
488,1336662,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,196513,DCP1B,https://ctdbase.org/detail.go?type=gene&acc=196513,,,196513.0,DCP1B,10090,Mus musculus (house mouse),Decamethrin results in increased expression of DCP1B mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
489,1336663,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,28960,DCPS,https://ctdbase.org/detail.go?type=gene&acc=28960,,,28960.0,DCPS,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of DCPS mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
490,1163831,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,28992,MACROD1,https://ctdbase.org/detail.go?type=gene&acc=28992,,,28992.0,MACROD1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MACROD1 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
491,1163832,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,8379,MAD1L1,https://ctdbase.org/detail.go?type=gene&acc=8379,,,8379.0,MAD1L1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MAD1L1 mRNA",,,PMID:19150397|PMID:20382639|PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/19150397|https://www.ncbi.nlm.nih.gov/pubmed/20382639|https://www.ncbi.nlm.nih.gov/pubmed/26238291,19150397|20382639|26238291,,
492,1163833,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,4085,MAD2L1,https://ctdbase.org/detail.go?type=gene&acc=4085,,,4085.0,MAD2L1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MAD2L1 mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
493,1163976,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,23108,RAP1GAP2,https://ctdbase.org/detail.go?type=gene&acc=23108,,,23108.0,RAP1GAP2,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RAP1GAP2 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
494,1163977,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,5911,RAP2A,https://ctdbase.org/detail.go?type=gene&acc=5911,,,5911.0,RAP2A,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RAP2A mRNA",,,PMID:20018196,https://www.ncbi.nlm.nih.gov/pubmed/20018196,20018196,,
495,1163978,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,5912,RAP2B,https://ctdbase.org/detail.go?type=gene&acc=5912,,,5912.0,RAP2B,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of RAP2B mRNA",,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
496,1164112,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,11228,RASSF8,https://ctdbase.org/detail.go?type=gene&acc=11228,,,11228.0,RASSF8,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RASSF8 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
497,1164113,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,55225,RAVER2,https://ctdbase.org/detail.go?type=gene&acc=55225,,,55225.0,RAVER2,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of RAVER2 mRNA",,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
498,1164468,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,8550,MAPKAPK5,https://ctdbase.org/detail.go?type=gene&acc=8550,,,8550.0,MAPKAPK5,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MAPKAPK5 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
499,1164469,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,4137,MAPT,https://ctdbase.org/detail.go?type=gene&acc=4137,,,4137.0,MAPT,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MAPT mRNA",,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
500,1164470,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,51257,MARCHF2,https://ctdbase.org/detail.go?type=gene&acc=51257,,,51257.0,MARCHF2,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MARCHF2 mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
501,1164471,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,115123,MARCHF3,https://ctdbase.org/detail.go?type=gene&acc=115123,,,115123.0,MARCHF3,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MARCHF3 mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
502,1164472,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,10299,MARCHF6,https://ctdbase.org/detail.go?type=gene&acc=10299,,,10299.0,MARCHF6,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MARCHF6 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
503,1164473,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,64844,MARCHF7,https://ctdbase.org/detail.go?type=gene&acc=64844,,,64844.0,MARCHF7,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MARCHF7 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
504,1164474,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,220972,MARCHF8,https://ctdbase.org/detail.go?type=gene&acc=220972,,,220972.0,MARCHF8,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MARCHF8 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
505,1334573,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,54874,FNBP1L,https://ctdbase.org/detail.go?type=gene&acc=54874,,,54874.0,FNBP1L,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FNBP1L mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
506,1334574,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,23360,FNBP4,https://ctdbase.org/detail.go?type=gene&acc=23360,,,23360.0,FNBP4,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FNBP4 mRNA",,,PMID:19150397|PMID:20018196,https://www.ncbi.nlm.nih.gov/pubmed/19150397|https://www.ncbi.nlm.nih.gov/pubmed/20018196,19150397|20018196,,
507,1334575,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,22862,FNDC3A,https://ctdbase.org/detail.go?type=gene&acc=22862,,,22862.0,FNDC3A,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FNDC3A mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
508,1334576,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,64778,FNDC3B,https://ctdbase.org/detail.go?type=gene&acc=64778,,,64778.0,FNDC3B,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FNDC3B mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
509,1334577,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,96459,FNIP1,https://ctdbase.org/detail.go?type=gene&acc=96459,,,96459.0,FNIP1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FNIP1 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
510,1337341,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of CCL2 mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
511,1337342,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,6364,CCL20,https://ctdbase.org/detail.go?type=gene&acc=6364,,,6364.0,CCL20,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CCL20 mRNA",,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
512,1337343,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,3491,CCN1,https://ctdbase.org/detail.go?type=gene&acc=3491,,,3491.0,CCN1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CCN1 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
513,1337344,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,3491,CCN1,https://ctdbase.org/detail.go?type=gene&acc=3491,,,3491.0,CCN1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CCN1 mRNA",,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
514,1337345,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CCN2 mRNA",,,PMID:20018196,https://www.ncbi.nlm.nih.gov/pubmed/20018196,20018196,,
515,1337460,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,8535,CBX4,https://ctdbase.org/detail.go?type=gene&acc=8535,,,8535.0,CBX4,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CBX4 mRNA",,,PMID:20018196,https://www.ncbi.nlm.nih.gov/pubmed/20018196,20018196,,
516,1337461,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,23468,CBX5,https://ctdbase.org/detail.go?type=gene&acc=23468,,,23468.0,CBX5,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CBX5 mRNA",,,PMID:20018196|PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20018196|https://www.ncbi.nlm.nih.gov/pubmed/20382639,20018196|20382639,,
517,1337462,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,151903,CCDC12,https://ctdbase.org/detail.go?type=gene&acc=151903,,,151903.0,CCDC12,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of CCDC12 mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
518,1337463,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,151903,CCDC12,https://ctdbase.org/detail.go?type=gene&acc=151903,,,151903.0,CCDC12,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CCDC12 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
519,1337928,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,623,BDKRB1,https://ctdbase.org/detail.go?type=gene&acc=623,,,623.0,BDKRB1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of BDKRB1 mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
520,1337929,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BDNF mRNA",,,PMID:19150397|PMID:20018196,https://www.ncbi.nlm.nih.gov/pubmed/19150397|https://www.ncbi.nlm.nih.gov/pubmed/20018196,19150397|20018196,,
521,1337930,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,55814,BDP1,https://ctdbase.org/detail.go?type=gene&acc=55814,,,55814.0,BDP1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BDP1 mRNA",,,PMID:19150397|PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/19150397|https://www.ncbi.nlm.nih.gov/pubmed/26238291,19150397|26238291,,
522,1338669,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,25998,IBTK,https://ctdbase.org/detail.go?type=gene&acc=25998,,,25998.0,IBTK,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of IBTK mRNA",,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
523,1338670,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ICAM1 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
524,1338671,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ICAM1 mRNA",,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
525,1338672,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,3386,ICAM4,https://ctdbase.org/detail.go?type=gene&acc=3386,,,3386.0,ICAM4,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ICAM4 mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
526,1338673,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,3398,ID2,https://ctdbase.org/detail.go?type=gene&acc=3398,,,3398.0,ID2,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ID2 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
527,1338674,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,3399,ID3,https://ctdbase.org/detail.go?type=gene&acc=3399,,,3399.0,ID3,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ID3 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
528,1338675,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,3418,IDH2,https://ctdbase.org/detail.go?type=gene&acc=3418,,,3418.0,IDH2,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of IDH2 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
529,1338788,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,3437,IFIT3,https://ctdbase.org/detail.go?type=gene&acc=3437,,,3437.0,IFIT3,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of IFIT3 mRNA",,,PMID:20018196,https://www.ncbi.nlm.nih.gov/pubmed/20018196,20018196,,
530,1338789,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,8519,IFITM1,https://ctdbase.org/detail.go?type=gene&acc=8519,,,8519.0,IFITM1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of IFITM1 mRNA",,,PMID:19150397|PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/19150397|https://www.ncbi.nlm.nih.gov/pubmed/20382639,19150397|20382639,,
531,1339719,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,55,ACP3,https://ctdbase.org/detail.go?type=gene&acc=55,,,55.0,ACP3,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of ACP3 mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
532,1339720,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,2181,ACSL3,https://ctdbase.org/detail.go?type=gene&acc=2181,,,2181.0,ACSL3,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ACSL3 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
533,1339835,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,11096,ADAMTS5,https://ctdbase.org/detail.go?type=gene&acc=11096,,,11096.0,ADAMTS5,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ADAMTS5 mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
534,1339836,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,55803,ADAP2,https://ctdbase.org/detail.go?type=gene&acc=55803,,,55803.0,ADAP2,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ADAP2 mRNA",,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
535,1339837,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,104,ADARB1,https://ctdbase.org/detail.go?type=gene&acc=104,,,104.0,ADARB1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ADARB1 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
536,1339838,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,23536,ADAT1,https://ctdbase.org/detail.go?type=gene&acc=23536,,,23536.0,ADAT1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ADAT1 mRNA",,,PMID:20018196,https://www.ncbi.nlm.nih.gov/pubmed/20018196,20018196,,
537,1339839,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,134637,ADAT2,https://ctdbase.org/detail.go?type=gene&acc=134637,,,134637.0,ADAT2,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ADAT2 mRNA",,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
538,1339840,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,115,ADCY9,https://ctdbase.org/detail.go?type=gene&acc=115,,,115.0,ADCY9,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ADCY9 mRNA",,,PMID:19150397|PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/19150397|https://www.ncbi.nlm.nih.gov/pubmed/26238291,19150397|26238291,,
539,1340720,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090,Mus musculus (house mouse),"AG 1879 inhibits the reaction [7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased phosphorylation of AKT1 protein]|cyanidin-3-O-beta-glucopyranoside inhibits the reaction [7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased phosphorylation of AKT1 protein]|7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased phosphorylation of AKT1 protein",,,PMID:21501596,https://www.ncbi.nlm.nih.gov/pubmed/21501596,21501596,,
540,1340721,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9606,Homo sapiens (human),"CYP2B6 gene SNP affects the reaction [7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide binds to ALB protein]",,,PMID:22521834,https://www.ncbi.nlm.nih.gov/pubmed/22521834,22521834,,
541,1340722,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,214,ALCAM,https://ctdbase.org/detail.go?type=gene&acc=214,,,214.0,ALCAM,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ALCAM mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
542,1340723,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,229,ALDOB,https://ctdbase.org/detail.go?type=gene&acc=229,,,229.0,ALDOB,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ALDOB mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
543,1341198,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,121601,ANO4,https://ctdbase.org/detail.go?type=gene&acc=121601,,,121601.0,ANO4,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of ANO4 mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
544,1341199,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,196527,ANO6,https://ctdbase.org/detail.go?type=gene&acc=196527,,,196527.0,ANO6,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ANO6 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
545,1341200,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,8125,ANP32A,https://ctdbase.org/detail.go?type=gene&acc=8125,,,8125.0,ANP32A,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ANP32A mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
546,1341201,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,10541,ANP32B,https://ctdbase.org/detail.go?type=gene&acc=10541,,,10541.0,ANP32B,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ANP32B mRNA",,,PMID:19150397|PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/19150397|https://www.ncbi.nlm.nih.gov/pubmed/20382639,19150397|20382639,,
547,1341202,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,84168,ANTXR1,https://ctdbase.org/detail.go?type=gene&acc=84168,,,84168.0,ANTXR1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ANTXR1 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
548,1341203,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,84168,ANTXR1,https://ctdbase.org/detail.go?type=gene&acc=84168,,,84168.0,ANTXR1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ANTXR1 mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
549,1341204,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,301,ANXA1,https://ctdbase.org/detail.go?type=gene&acc=301,,,301.0,ANXA1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ANXA1 mRNA",,,PMID:19150397|PMID:20018196,https://www.ncbi.nlm.nih.gov/pubmed/19150397|https://www.ncbi.nlm.nih.gov/pubmed/20018196,19150397|20018196,,
550,1341205,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,306,ANXA3,https://ctdbase.org/detail.go?type=gene&acc=306,,,306.0,ANXA3,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ANXA3 mRNA",,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
551,1341206,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,314,AOC2,https://ctdbase.org/detail.go?type=gene&acc=314,,,314.0,AOC2,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of AOC2 mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
552,1341322,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of APAF1 mRNA",,,PMID:28593498,https://www.ncbi.nlm.nih.gov/pubmed/28593498,28593498,,
553,1341323,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,323,APBB2,https://ctdbase.org/detail.go?type=gene&acc=323,,,323.0,APBB2,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of APBB2 mRNA",,,PMID:19150397|PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/19150397|https://www.ncbi.nlm.nih.gov/pubmed/20382639,19150397|20382639,,
554,1341324,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,147495,APCDD1,https://ctdbase.org/detail.go?type=gene&acc=147495,,,147495.0,APCDD1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of APCDD1 mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
555,1342264,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,50807,ASAP1,https://ctdbase.org/detail.go?type=gene&acc=50807,,,50807.0,ASAP1,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ASAP1 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
556,1342265,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,8853,ASAP2,https://ctdbase.org/detail.go?type=gene&acc=8853,,,8853.0,ASAP2,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ASAP2 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
557,1342266,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,51130,ASB3,https://ctdbase.org/detail.go?type=gene&acc=51130,,,51130.0,ASB3,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ASB3 mRNA",,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
558,1342267,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,10973,ASCC3,https://ctdbase.org/detail.go?type=gene&acc=10973,,,10973.0,ASCC3,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ASCC3 mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
559,1342268,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,25842,ASF1A,https://ctdbase.org/detail.go?type=gene&acc=25842,,,25842.0,ASF1A,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ASF1A mRNA",,,PMID:19150397|PMID:20018196,https://www.ncbi.nlm.nih.gov/pubmed/19150397|https://www.ncbi.nlm.nih.gov/pubmed/20018196,19150397|20018196,,
560,1342269,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,55723,ASF1B,https://ctdbase.org/detail.go?type=gene&acc=55723,,,55723.0,ASF1B,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ASF1B mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
561,1342270,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,55870,ASH1L,https://ctdbase.org/detail.go?type=gene&acc=55870,,,55870.0,ASH1L,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ASH1L mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
562,1342271,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,435,ASL,https://ctdbase.org/detail.go?type=gene&acc=435,,,435.0,ASL,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ASL mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
563,1342272,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,440,ASNS,https://ctdbase.org/detail.go?type=gene&acc=440,,,440.0,ASNS,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ASNS mRNA",,,PMID:19150397,https://www.ncbi.nlm.nih.gov/pubmed/19150397,19150397,,
564,1333595,42113,Drug Gene Interaction database (DGIdb),Desflurane,,DESFLURANE,https://www.dgidb.org/drugs/rxcui:27340,,MT-ND1,https://www.dgidb.org/genes/hgnc:7455,,,4535.0,ND1,9606,Homo sapiens (human),,,,,,,,
565,1333596,42546,BindingDB,Methyl 2-(aminosulfonyl)benzoate,12152,2-carboxymethylbenzenesulfonamide 5,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12152,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606,Homo sapiens (human),,Ki (nM),35800,PMID:15771455|DOI:10.1021/jm0494826,https://www.ncbi.nlm.nih.gov/pubmed/15771455|https://doi.org/10.1021/jm0494826,15771455,10.1021/jm0494826,
566,1333597,42546,BindingDB,Methyl 2-(aminosulfonyl)benzoate,12152,2-carboxymethylbenzenesulfonamide 5,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12152,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606,Homo sapiens (human),,Ki (nM),420,PMID:15771455|DOI:10.1021/jm0494826,https://www.ncbi.nlm.nih.gov/pubmed/15771455|https://doi.org/10.1021/jm0494826,15771455,10.1021/jm0494826,
567,1333598,42546,BindingDB,Methyl 2-(aminosulfonyl)benzoate,12152,2-carboxymethylbenzenesulfonamide 5,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12152,1233,Carbonic anhydrase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1233,Q16790,Carbonic anhydrase 9,768.0,CA9,9606,Homo sapiens (human),,Ki (nM),680,PMID:15771455|DOI:10.1021/jm0494826,https://www.ncbi.nlm.nih.gov/pubmed/15771455|https://doi.org/10.1021/jm0494826,15771455,10.1021/jm0494826,
568,1333599,42574,Drug Gene Interaction database (DGIdb),Closantel,,CLOSANTEL,https://www.dgidb.org/drugs/ncit:C79920,,KAT2A,https://www.dgidb.org/genes/hgnc:4201,,,2648.0,KAT2A,9606,Homo sapiens (human),,,,,,,,
569,1333600,42586,Comparative Toxicogenomics Database (CTD),Metalaxyl,C028175,metalaxyl,https://ctdbase.org/detail.go?type=chem&acc=C028175,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606,Homo sapiens (human),Metalaxyl results in decreased expression of CYP2C19 protein,,,PMID:32194361,https://www.ncbi.nlm.nih.gov/pubmed/32194361,32194361,,
570,1333726,43032,Drug Gene Interaction database (DGIdb),Midazolam Hydrochloride,,MIDAZOLAM HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203128,,GABRG1,https://www.dgidb.org/genes/hgnc:4086,,,2565.0,GABRG1,9606,Homo sapiens (human),Positive modulator,,,,,,,
571,1333727,43032,Drug Gene Interaction database (DGIdb),Midazolam Hydrochloride,,MIDAZOLAM HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203128,,BRD3,https://www.dgidb.org/genes/hgnc:1104,,,8019.0,BRD3,9606,Homo sapiens (human),,,,,,,,
572,1333728,43032,Drug Gene Interaction database (DGIdb),Midazolam Hydrochloride,,MIDAZOLAM HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203128,,BRD4,https://www.dgidb.org/genes/hgnc:13575,,,23476.0,BRD4,9606,Homo sapiens (human),,,,,,,,
573,1333729,43032,Drug Gene Interaction database (DGIdb),Midazolam Hydrochloride,,MIDAZOLAM HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203128,,GABRB3,https://www.dgidb.org/genes/hgnc:4083,,,2562.0,GABRB3,9606,Homo sapiens (human),,,,,,,,
574,1333730,43032,Drug Gene Interaction database (DGIdb),Midazolam Hydrochloride,,MIDAZOLAM HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203128,,GABRA2,https://www.dgidb.org/genes/hgnc:4076,,,2555.0,GABRA2,9606,Homo sapiens (human),Positive modulator,,,,,,,
575,1333731,43032,Drug Gene Interaction database (DGIdb),Midazolam Hydrochloride,,MIDAZOLAM HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203128,,GABRA2,https://www.dgidb.org/genes/hgnc:4076,,,2555.0,GABRA2,9606,Homo sapiens (human),,,,,,,,
576,1333732,43032,Drug Gene Interaction database (DGIdb),Midazolam Hydrochloride,,MIDAZOLAM HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203128,,GABRB3,https://www.dgidb.org/genes/hgnc:4083,,,2562.0,GABRB3,9606,Homo sapiens (human),,,,,,,,
577,1333733,43032,Drug Gene Interaction database (DGIdb),Midazolam Hydrochloride,,MIDAZOLAM HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203128,,GABRR2,https://www.dgidb.org/genes/hgnc:4091,,,2570.0,GABRR2,9606,Homo sapiens (human),,,,,,,,
578,1333734,43032,Drug Gene Interaction database (DGIdb),Midazolam Hydrochloride,,MIDAZOLAM HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203128,,GABRA2,https://www.dgidb.org/genes/hgnc:4076,,,2555.0,GABRA2,9606,Homo sapiens (human),,,,,,,,
579,1109051,43234,Comparative Toxicogenomics Database (CTD),Propiconazole,C045950,propiconazole,https://ctdbase.org/detail.go?type=chem&acc=C045950,57016,AKR1B10,https://ctdbase.org/detail.go?type=gene&acc=57016,,,57016.0,AKR1B10,9606,Homo sapiens (human),Propiconazole results in increased expression of AKR1B10 mrna|[propiconazole co-treated with tebuconazole] results in increased expression of AKR1B10 mRNA,,,PMID:30989312,https://www.ncbi.nlm.nih.gov/pubmed/30989312,30989312,,
580,1109052,43234,Comparative Toxicogenomics Database (CTD),Propiconazole,C045950,propiconazole,https://ctdbase.org/detail.go?type=chem&acc=C045950,11997,AKR1B7,https://ctdbase.org/detail.go?type=gene&acc=11997,,,11997.0,Akr1b7,10090,Mus musculus (house mouse),Propiconazole results in increased expression of AKR1B7 mRNA,,,PMID:21278054|PMID:22334560|PMID:23970803,https://www.ncbi.nlm.nih.gov/pubmed/21278054|https://www.ncbi.nlm.nih.gov/pubmed/22334560|https://www.ncbi.nlm.nih.gov/pubmed/23970803,21278054|22334560|23970803,,
581,1344011,43815,Comparative Toxicogenomics Database (CTD),Paroxetine,D017374,Paroxetine,https://ctdbase.org/detail.go?type=chem&acc=D017374,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606,Homo sapiens (human),Paroxetine results in decreased activity of CYP2D6 protein,,,PMID:12173784|PMID:12378847|PMID:15632378|PMID:15860655|PMID:19593786|PMID:21915887|PMID:26599973,https://www.ncbi.nlm.nih.gov/pubmed/12173784|https://www.ncbi.nlm.nih.gov/pubmed/12378847|https://www.ncbi.nlm.nih.gov/pubmed/15632378|https://www.ncbi.nlm.nih.gov/pubmed/15860655|https://www.ncbi.nlm.nih.gov/pubmed/19593786|https://www.ncbi.nlm.nih.gov/pubmed/21915887|https://www.ncbi.nlm.nih.gov/pubmed/26599973,12173784|12378847|15632378|15860655|19593786|21915887|26599973,,
582,1344012,43815,Comparative Toxicogenomics Database (CTD),Paroxetine,D017374,Paroxetine,https://ctdbase.org/detail.go?type=chem&acc=D017374,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606,Homo sapiens (human),[paroxetine results in decreased activity of CYP2D6 protein] which results in decreased abundance of 4-hydroxy-N-desmethyltamoxifen,,,PMID:14652237,https://www.ncbi.nlm.nih.gov/pubmed/14652237,14652237,,
583,1344013,43815,Comparative Toxicogenomics Database (CTD),Paroxetine,D017374,Paroxetine,https://ctdbase.org/detail.go?type=chem&acc=D017374,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606,Homo sapiens (human),[paroxetine results in decreased activity of CYP2D6 protein] which results in increased susceptibility to metoprolol|[paroxetine results in decreased activity of CYP2D6 protein] which results in decreased degradation of metoprolol,,,PMID:10470702,https://www.ncbi.nlm.nih.gov/pubmed/10470702,10470702,,
584,1344014,43815,Comparative Toxicogenomics Database (CTD),Paroxetine,D017374,Paroxetine,https://ctdbase.org/detail.go?type=chem&acc=D017374,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606,Homo sapiens (human),[paroxetine results in decreased activity of CYP2D6 protein] which results in decreased metabolism of dextromethorphan,,,PMID:26599973,https://www.ncbi.nlm.nih.gov/pubmed/26599973,26599973,,
585,1344015,43815,Comparative Toxicogenomics Database (CTD),Paroxetine,D017374,Paroxetine,https://ctdbase.org/detail.go?type=chem&acc=D017374,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606,Homo sapiens (human),CYP2D6 protein affects the metabolism of paroxetine,,,PMID:11673748|PMID:8885123,https://www.ncbi.nlm.nih.gov/pubmed/11673748|https://www.ncbi.nlm.nih.gov/pubmed/8885123,11673748|8885123,,
586,1344142,43815,Comparative Toxicogenomics Database (CTD),Paroxetine,D017374,Paroxetine,https://ctdbase.org/detail.go?type=chem&acc=D017374,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606,Homo sapiens (human),Paroxetine results in decreased activity of CYP2D6 protein,,,PMID:10470702|PMID:11673748|PMID:19531695|PMID:7485639,https://www.ncbi.nlm.nih.gov/pubmed/10470702|https://www.ncbi.nlm.nih.gov/pubmed/11673748|https://www.ncbi.nlm.nih.gov/pubmed/19531695|https://www.ncbi.nlm.nih.gov/pubmed/7485639,10470702|11673748|19531695|7485639,,
587,1344143,43815,Comparative Toxicogenomics Database (CTD),Paroxetine,D017374,Paroxetine,https://ctdbase.org/detail.go?type=chem&acc=D017374,1621,DBH,https://ctdbase.org/detail.go?type=gene&acc=1621,,,1621.0,DBH,10090,Mus musculus (house mouse),DBH protein results in increased susceptibility to paroxetine,,,PMID:15148402,https://www.ncbi.nlm.nih.gov/pubmed/15148402,15148402,,
588,1344144,43815,Comparative Toxicogenomics Database (CTD),Paroxetine,D017374,Paroxetine,https://ctdbase.org/detail.go?type=chem&acc=D017374,23576,DDAH1,https://ctdbase.org/detail.go?type=gene&acc=23576,,,23576.0,DDAH1,10090,Mus musculus (house mouse),Paroxetine inhibits the reaction [manganese deficiency results in decreased expression of DDAH1 protein],,,PMID:21312047,https://www.ncbi.nlm.nih.gov/pubmed/21312047,21312047,,
589,1344145,43815,Comparative Toxicogenomics Database (CTD),Paroxetine,D017374,Paroxetine,https://ctdbase.org/detail.go?type=chem&acc=D017374,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10090,Mus musculus (house mouse),[paroxetine binds to and results in increased activity of HTR2C protein] which results in increased phosphorylation of and results in increased activity of EGFR protein|[[paroxetine binds to and results in increased activity of HTR2C protein] which results in increased phosphorylation of and results in increased activity of EGFR protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein|[[paroxetine binds to and results in increased activity of HTR2C protein] which results in increased phosphorylation of and results in increased activity of EGFR protein] which results in increased phosphorylation of and results in increased activity of MAPK3 protein,,,PMID:19662385,https://www.ncbi.nlm.nih.gov/pubmed/19662385,19662385,,
590,1344146,43815,Comparative Toxicogenomics Database (CTD),Paroxetine,D017374,Paroxetine,https://ctdbase.org/detail.go?type=chem&acc=D017374,2746,GLUD1,https://ctdbase.org/detail.go?type=gene&acc=2746,,,2746.0,GLUD1,10090,Mus musculus (house mouse),Paroxetine inhibits the reaction [manganese deficiency results in decreased expression of GLUD1 protein],,,PMID:21312047,https://www.ncbi.nlm.nih.gov/pubmed/21312047,21312047,,
591,1344147,43815,Comparative Toxicogenomics Database (CTD),Paroxetine,D017374,Paroxetine,https://ctdbase.org/detail.go?type=chem&acc=D017374,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10090,Mus musculus (house mouse),Sildenafil citrate inhibits the reaction [paroxetine results in increased activity of GPT protein]|isoliquiritigenin inhibits the reaction [paroxetine results in increased activity of GPT protein]|paroxetine results in increased activity of GPT protein,,,PMID:36740106,https://www.ncbi.nlm.nih.gov/pubmed/36740106,36740106,,
592,1344148,43815,Comparative Toxicogenomics Database (CTD),Paroxetine,D017374,Paroxetine,https://ctdbase.org/detail.go?type=chem&acc=D017374,6011,GRK1,https://ctdbase.org/detail.go?type=gene&acc=6011,,,6011.0,GRK1,9913,Bos taurus (cattle),Paroxetine results in decreased activity of GRK1 protein,,,PMID:26032411,https://www.ncbi.nlm.nih.gov/pubmed/26032411,26032411,,
593,1334226,44259,BindingDB,Staurosporine,2579,"(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8(13),9,11,14(28),15(19),20(27),21(26),22,24-nonaen-16-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2579,50003023,Serine/threonine-protein kinase PLK4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003023,O00444,Serine/threonine-protein kinase PLK4,10733.0,PLK4,9606,Homo sapiens (human),,Ki (nM),2.6,PMID:17655330|DOI:10.1021/bi7008745,https://www.ncbi.nlm.nih.gov/pubmed/17655330|https://doi.org/10.1021/bi7008745,17655330,10.1021/bi7008745,
594,1334227,44259,BindingDB,Staurosporine,2579,"(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8(13),9,11,14(28),15(19),20(27),21(26),22,24-nonaen-16-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2579,3413,Serine/threonine-protein kinase PLK3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3413,Q9H4B4,Serine/threonine-protein kinase PLK3,1263.0,PLK3,9606,Homo sapiens (human),,Ki (nM),1200,PMID:17655330|DOI:10.1021/bi7008745,https://www.ncbi.nlm.nih.gov/pubmed/17655330|https://doi.org/10.1021/bi7008745,17655330,10.1021/bi7008745,
595,1334228,44259,BindingDB,Staurosporine,2579,"(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8(13),9,11,14(28),15(19),20(27),21(26),22,24-nonaen-16-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2579,2700,Serine/threonine-protein kinase PLK1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2700,P53350,Serine/threonine-protein kinase PLK1,5347.0,PLK1,9606,Homo sapiens (human),,Ki (nM),790,PMID:17655330|DOI:10.1021/bi7008745,https://www.ncbi.nlm.nih.gov/pubmed/17655330|https://doi.org/10.1021/bi7008745,17655330,10.1021/bi7008745,
596,1334229,44259,BindingDB,Staurosporine,2579,"(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8(13),9,11,14(28),15(19),20(27),21(26),22,24-nonaen-16-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2579,2702,Serine/threonine-protein kinase PLK2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2702,Q9NYY3,Serine/threonine-protein kinase PLK2,10769.0,PLK2,9606,Homo sapiens (human),,Ki (nM),150,PMID:17655330|DOI:10.1021/bi7008745,https://www.ncbi.nlm.nih.gov/pubmed/17655330|https://doi.org/10.1021/bi7008745,17655330,10.1021/bi7008745,
597,1339841,44602,IUPHAR/BPS Guide to PHARMACOLOGY,Arbaclofen,1064,(-)-baclofen,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1064,240,GABAB1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=240,Q9Z0U4,Gamma-aminobutyric acid type B receptor subunit 1,81657.0,Gabbr1,10116,Rattus norvegicus (Norway rat),Full agonist,pIC50,4.4 - 4.6,PMID:9069281,https://www.ncbi.nlm.nih.gov/pubmed/9069281,9069281,,
598,1339842,44602,IUPHAR/BPS Guide to PHARMACOLOGY,Arbaclofen,1064,(-)-baclofen,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1064,242,GABAB receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=242,O88871,Gamma-aminobutyric acid type B receptor subunit 2,,,10116,Rattus norvegicus (Norway rat),Full agonist,pIC50,8.5,,,,,
599,1339843,44602,IUPHAR/BPS Guide to PHARMACOLOGY,Arbaclofen,1064,(-)-baclofen,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1064,242,GABAB receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=242,Q9Z0U4,Gamma-aminobutyric acid type B receptor subunit 1,,,10116,Rattus norvegicus (Norway rat),Full agonist,pIC50,8.5,,,,,
600,1339844,47811,IUPHAR/BPS Guide to PHARMACOLOGY,Pergolide,48,pergolide,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=48,25,2A-adrenoceptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=25,P08913,Alpha-2A adrenergic receptor,150.0,ADRA2A,9606,Homo sapiens (human),Partial agonist,pKi,7.3,PMID:12388666,https://www.ncbi.nlm.nih.gov/pubmed/12388666,12388666,,
601,1334852,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,9606,Homo sapiens (human),FGF9 protein inhibits the reaction [colforsin promotes the reaction [IGF1 protein results in increased abundance of estradiol]]|colforsin promotes the reaction [IGF1 protein results in increased abundance of estradiol]|fgf9 protein inhibits the reaction [IGF1 protein promotes the reaction [colforsin results in increased abundance of progesterone]]|igf1 protein promotes the reaction [colforsin results in increased abundance of progesterone],,,PMID:22798350,https://www.ncbi.nlm.nih.gov/pubmed/22798350,22798350,,
602,1335098,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),Colforsin promotes the reaction [lipopolysaccharides results in increased secretion of IL6 protein],,,PMID:20388727,https://www.ncbi.nlm.nih.gov/pubmed/20388727,20388727,,
603,1335099,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),Colforsin promotes the reaction [TNF protein results in increased expression of IL6 mrna],,,PMID:24771768,https://www.ncbi.nlm.nih.gov/pubmed/24771768,24771768,,
604,1335100,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090,Mus musculus (house mouse),Oxophenylarsine inhibits the reaction [colforsin results in increased secretion of IL6 protein]|colforsin results in increased secretion of IL6 protein,,,PMID:17141199,https://www.ncbi.nlm.nih.gov/pubmed/17141199,17141199,,
605,1335101,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Colforsin inhibits the reaction [lipopolysaccharides results in increased secretion of IL6 protein],,,PMID:21803157,https://www.ncbi.nlm.nih.gov/pubmed/21803157,21803157,,
606,1335102,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),Colforsin inhibits the reaction [IL6 protein results in increased phosphorylation of and results in increased activity of STAT3 protein]|resveratrol promotes the reaction [colforsin inhibits the reaction [IL6 protein results in increased phosphorylation of and results in increased activity of STAT3 protein]]|flavone promotes the reaction [colforsin inhibits the reaction [IL6 protein results in increased phosphorylation of and results in increased activity of STAT3 protein]]|rolipram promotes the reaction [colforsin inhibits the reaction [IL6 protein results in increased phosphorylation of and results in increased activity of STAT3 protein]],,,PMID:23782265,https://www.ncbi.nlm.nih.gov/pubmed/23782265,23782265,,
607,1335103,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,3624,INHBA,https://ctdbase.org/detail.go?type=gene&acc=3624,,,3624.0,INHBA,9606,Homo sapiens (human),INHBA protein inhibits the reaction [colforsin results in increased secretion of progesterone]|fst protein inhibits the reaction [INHBA protein inhibits the reaction [colforsin results in increased secretion of progesterone]],,,PMID:18936084,https://www.ncbi.nlm.nih.gov/pubmed/18936084,18936084,,
608,1335104,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9913,Bos taurus (cattle),[colforsin co-treated with INS protein] results in increased expression of VEGFA mrna|[colforsin co-treated with INS protein] results in increased expression of HPSE mRNA,,,PMID:18818292,https://www.ncbi.nlm.nih.gov/pubmed/18818292,18818292,,
609,1335105,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9615,Canis lupus familiaris (dog),[colforsin co-treated with INS protein] results in increased phosphorylation of MAPK1 protein|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[colforsin co-treated with INS protein] results in increased phosphorylation of MAPK3 protein]|[colforsin co-treated with INS protein] results in increased phosphorylation of MAPK3 protein|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[colforsin co-treated with INS protein] results in increased phosphorylation of MAPK1 protein],,,PMID:12639917,https://www.ncbi.nlm.nih.gov/pubmed/12639917,12639917,,
610,1336118,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,9913,Bos taurus (cattle),Colforsin results in increased phosphorylation of NOS3 protein,,,PMID:22488414,https://www.ncbi.nlm.nih.gov/pubmed/22488414,22488414,,
611,1336119,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,4878,NPPA,https://ctdbase.org/detail.go?type=gene&acc=4878,,,4878.0,NPPA,10116,Rattus norvegicus (Norway rat),Colforsin inhibits the reaction [dinoprostone results in increased expression of NPPA protein],,,PMID:18851973,https://www.ncbi.nlm.nih.gov/pubmed/18851973,18851973,,
612,1336120,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,4878,NPPA,https://ctdbase.org/detail.go?type=gene&acc=4878,,,4878.0,NPPA,10116,Rattus norvegicus (Norway rat),Colforsin inhibits the reaction [phenylephrine results in increased expression of NPPA mrna],,,PMID:11470465|PMID:18851973,https://www.ncbi.nlm.nih.gov/pubmed/11470465|https://www.ncbi.nlm.nih.gov/pubmed/18851973,11470465|18851973,,
613,1336121,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,190,NR0B1,https://ctdbase.org/detail.go?type=gene&acc=190,,,190.0,NR0B1,9606,Homo sapiens (human),Valproic acid inhibits the reaction [colforsin results in decreased expression of NR0B1 mrna]|colforsin results in decreased expression of NR0B1 mRNA,,,PMID:20726872,https://www.ncbi.nlm.nih.gov/pubmed/20726872,20726872,,
614,1336122,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9615,Canis lupus familiaris (dog),Colforsin results in increased activity of NR1I2 protein,,,PMID:27732639,https://www.ncbi.nlm.nih.gov/pubmed/27732639,27732639,,
615,1336123,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606,Homo sapiens (human),Colforsin results in increased activity of NR1I2 protein|colforsin results in decreased expression of NR1I2 mRNA,,,PMID:29933105,https://www.ncbi.nlm.nih.gov/pubmed/29933105,29933105,,
616,1336124,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,8030,Salmo salar (Atlantic salmon),Tributyltin inhibits the reaction [colforsin results in increased expression of NR1I2 mrna]|colforsin results in increased expression of NR1I2 mRNA,,,PMID:20211155,https://www.ncbi.nlm.nih.gov/pubmed/20211155,20211155,,
617,1336125,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,9606,Homo sapiens (human),Colforsin results in increased activity of NR3C1 protein,,,PMID:19255438,https://www.ncbi.nlm.nih.gov/pubmed/19255438,19255438,,
618,1337627,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,6607,SMN2,https://ctdbase.org/detail.go?type=gene&acc=6607,,,6607.0,SMN2,9606,Homo sapiens (human),Colforsin results in increased expression of SMN2 protein,,,PMID:19150990,https://www.ncbi.nlm.nih.gov/pubmed/19150990,19150990,,
619,1337628,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,6616,SNAP25,https://ctdbase.org/detail.go?type=gene&acc=6616,,,6616.0,SNAP25,10116,Rattus norvegicus (Norway rat),HNRNPA1 mutant form inhibits the reaction [colforsin affects the splicing of SNAP25 exon]|colforsin promotes the reaction [HNRNPK protein binds to SNAP25 exon]|colforsin affects the splicing of SNAP25 exon|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [colforsin affects the splicing of SNAP25 exon],,,PMID:22684629,https://www.ncbi.nlm.nih.gov/pubmed/22684629,22684629,,
620,1337629,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,9021,SOCS3,https://ctdbase.org/detail.go?type=gene&acc=9021,,,9021.0,SOCS3,9606,Homo sapiens (human),"Dorsomorphin inhibits the reaction [[[colforsin co-treated with rolipram] results in increased abundance of cyclic AMP] which results in increased expression of SOCS3 protein]|colforsin results in increased expression of SOCS3 protein|[[colforsin co-treated with rolipram] results in increased abundance of cyclic AMP] which results in increased expression of SOCS3 protein|2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [[[colforsin co-treated with rolipram] results in increased abundance of cyclic AMP] which results in increased expression of SOCS3 protein]",,,PMID:23782265,https://www.ncbi.nlm.nih.gov/pubmed/23782265,23782265,,
621,1337630,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,9021,SOCS3,https://ctdbase.org/detail.go?type=gene&acc=9021,,,9021.0,SOCS3,10090,Mus musculus (house mouse),Colforsin inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of SOCS3 mrna],,,PMID:17407152,https://www.ncbi.nlm.nih.gov/pubmed/17407152,17407152,,
622,1337631,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[EGF co-treated with colforsin co-treated with rotenone] results in increased expression of SOD1 mrna]|acetylcysteine inhibits the reaction [[EGF co-treated with colforsin co-treated with rotenone] results in increased expression of SOD1 protein]|[egf co-treated with colforsin co-treated with rotenone] results in increased expression of SOD1 mrna|[egf co-treated with colforsin co-treated with rotenone] results in increased expression of SOD1 protein,,,PMID:32092105,https://www.ncbi.nlm.nih.gov/pubmed/32092105,32092105,,
623,1337632,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9913,Bos taurus (cattle),Colforsin results in increased expression of SOD2 mRNA,,,PMID:12040026,https://www.ncbi.nlm.nih.gov/pubmed/12040026,12040026,,
624,1337633,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[EGF co-treated with colforsin co-treated with rotenone] results in increased expression of SOD2 protein]|acetylcysteine inhibits the reaction [[EGF co-treated with colforsin co-treated with rotenone] results in increased expression of SOD2 mrna]|[egf co-treated with colforsin co-treated with rotenone] results in increased expression of SOD2 mrna|[egf co-treated with colforsin co-treated with rotenone] results in increased expression of SOD2 protein,,,PMID:32092105,https://www.ncbi.nlm.nih.gov/pubmed/32092105,32092105,,
625,1337634,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),Colforsin results in increased expression of SOD2 mrna|colforsin results in increased activity of SOD2 protein,,,PMID:12093828,https://www.ncbi.nlm.nih.gov/pubmed/12093828,12093828,,
626,1346167,50367,Comparative Toxicogenomics Database (CTD),Buprofezin,C083997,buprofezin,https://ctdbase.org/detail.go?type=chem&acc=C083997,666,BOK,https://ctdbase.org/detail.go?type=gene&acc=666,,,666.0,BOK,9606,Homo sapiens (human),Buprofezin results in increased expression of BOK mRNA,,,PMID:36287832,https://www.ncbi.nlm.nih.gov/pubmed/36287832,36287832,,
627,1346168,50367,Comparative Toxicogenomics Database (CTD),Buprofezin,C083997,buprofezin,https://ctdbase.org/detail.go?type=chem&acc=C083997,79886,CAAP1,https://ctdbase.org/detail.go?type=gene&acc=79886,,,79886.0,CAAP1,9606,Homo sapiens (human),Buprofezin results in decreased expression of CAAP1 mRNA,,,PMID:36287832,https://www.ncbi.nlm.nih.gov/pubmed/36287832,36287832,,
628,1346169,50367,Comparative Toxicogenomics Database (CTD),Buprofezin,C083997,buprofezin,https://ctdbase.org/detail.go?type=chem&acc=C083997,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Buprofezin results in increased activity of CASP3 protein,,,PMID:36287832,https://www.ncbi.nlm.nih.gov/pubmed/36287832,36287832,,
629,1346170,50367,Comparative Toxicogenomics Database (CTD),Buprofezin,C083997,buprofezin,https://ctdbase.org/detail.go?type=chem&acc=C083997,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606,Homo sapiens (human),Buprofezin results in increased activity of CASP9 protein,,,PMID:36287832,https://www.ncbi.nlm.nih.gov/pubmed/36287832,36287832,,
630,1346171,50367,Comparative Toxicogenomics Database (CTD),Buprofezin,C083997,buprofezin,https://ctdbase.org/detail.go?type=chem&acc=C083997,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Buprofezin results in decreased activity of CAT protein,,,PMID:31199169,https://www.ncbi.nlm.nih.gov/pubmed/31199169,31199169,,
631,1346172,50367,Comparative Toxicogenomics Database (CTD),Buprofezin,C083997,buprofezin,https://ctdbase.org/detail.go?type=chem&acc=C083997,13067,CYCT,https://ctdbase.org/detail.go?type=gene&acc=13067,,,13067.0,Cyct,9606,Homo sapiens (human),Buprofezin results in increased localization of CYCT protein,,,PMID:36287832,https://www.ncbi.nlm.nih.gov/pubmed/36287832,36287832,,
632,1346173,50367,Comparative Toxicogenomics Database (CTD),Buprofezin,C083997,buprofezin,https://ctdbase.org/detail.go?type=chem&acc=C083997,2805,GOT1,https://ctdbase.org/detail.go?type=gene&acc=2805,,,2805.0,GOT1,10090,Mus musculus (house mouse),Buprofezin results in increased expression of GOT1 protein,,,PMID:31199169,https://www.ncbi.nlm.nih.gov/pubmed/31199169,31199169,,
633,1346174,50367,Comparative Toxicogenomics Database (CTD),Buprofezin,C083997,buprofezin,https://ctdbase.org/detail.go?type=chem&acc=C083997,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10090,Mus musculus (house mouse),Buprofezin results in increased expression of GPT protein,,,PMID:31199169,https://www.ncbi.nlm.nih.gov/pubmed/31199169,31199169,,
634,1337775,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,63931,MRPS14,https://ctdbase.org/detail.go?type=gene&acc=63931,,,63931.0,MRPS14,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of MRPS14 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
635,1337776,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,64960,MRPS15,https://ctdbase.org/detail.go?type=gene&acc=64960,,,64960.0,MRPS15,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of MRPS15 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
636,1337777,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,28973,MRPS18B,https://ctdbase.org/detail.go?type=gene&acc=28973,,,28973.0,MRPS18B,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of MRPS18B mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
637,1337778,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,51023,MRPS18C,https://ctdbase.org/detail.go?type=gene&acc=51023,,,51023.0,MRPS18C,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of MRPS18C mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
638,1337779,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,56945,MRPS22,https://ctdbase.org/detail.go?type=gene&acc=56945,,,56945.0,MRPS22,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of MRPS22 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
639,1337780,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,64951,MRPS24,https://ctdbase.org/detail.go?type=gene&acc=64951,,,64951.0,MRPS24,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of MRPS24 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
640,1337781,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,10884,MRPS30,https://ctdbase.org/detail.go?type=gene&acc=10884,,,10884.0,MRPS30,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of MRPS30 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
641,1337782,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,10240,MRPS31,https://ctdbase.org/detail.go?type=gene&acc=10240,,,10240.0,MRPS31,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of MRPS31 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
642,1338382,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of NQO1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
643,1338383,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,7376,NR1H2,https://ctdbase.org/detail.go?type=gene&acc=7376,,,7376.0,NR1H2,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of NR1H2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
644,1338384,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of NR1H3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
645,1338385,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606,Homo sapiens (human),Finasteride binds to and results in increased activity of NR1I2 protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
646,1338386,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606,Homo sapiens (human),Finasteride results in increased activity of NR1I2 protein,,,PMID:21068194,https://www.ncbi.nlm.nih.gov/pubmed/21068194,21068194,,
647,1338387,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,2063,NR2F6,https://ctdbase.org/detail.go?type=gene&acc=2063,,,2063.0,NR2F6,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of NR2F6 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
648,1338388,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,55968,NSFL1C,https://ctdbase.org/detail.go?type=gene&acc=55968,,,55968.0,NSFL1C,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of NSFL1C mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
649,1338389,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,197370,NSMCE1,https://ctdbase.org/detail.go?type=gene&acc=197370,,,197370.0,NSMCE1,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of NSMCE1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
650,1338390,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,286053,NSMCE2,https://ctdbase.org/detail.go?type=gene&acc=286053,,,286053.0,NSMCE2,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of NSMCE2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
651,1339556,57363,Drug Gene Interaction database (DGIdb),Finasteride,,FINASTERIDE,https://www.dgidb.org/drugs/rxcui:25025,,TGM2,https://www.dgidb.org/genes/hgnc:11778,,,7052.0,TGM2,9606,Homo sapiens (human),,,,,,,,
652,1340444,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,10928,RALBP1,https://ctdbase.org/detail.go?type=gene&acc=10928,,,10928.0,RALBP1,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of RALBP1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
653,1340445,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,83640,RAMAC,https://ctdbase.org/detail.go?type=gene&acc=83640,,,83640.0,RAMAC,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of RAMAC mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
654,1340446,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,5901,RAN,https://ctdbase.org/detail.go?type=gene&acc=5901,,,5901.0,RAN,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of RAN mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
655,1340447,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,29098,RANGRF,https://ctdbase.org/detail.go?type=gene&acc=29098,,,29098.0,RANGRF,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of RANGRF mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
656,1340448,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,57826,RAP2C,https://ctdbase.org/detail.go?type=gene&acc=57826,,,57826.0,RAP2C,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of RAP2C mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
657,1340449,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,5921,RASA1,https://ctdbase.org/detail.go?type=gene&acc=5921,,,5921.0,RASA1,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of RASA1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
658,1340450,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,166824,RASSF6,https://ctdbase.org/detail.go?type=gene&acc=166824,,,166824.0,RASSF6,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of RASSF6 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
659,1340579,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,129831,RBM45,https://ctdbase.org/detail.go?type=gene&acc=129831,,,129831.0,RBM45,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of RBM45 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
660,1341052,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,112869,SGF29,https://ctdbase.org/detail.go?type=gene&acc=112869,,,112869.0,SGF29,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of SGF29 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
661,1341053,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,6472,SHMT2,https://ctdbase.org/detail.go?type=gene&acc=6472,,,6472.0,SHMT2,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of SHMT2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
662,1341054,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,80349,SKIC8,https://ctdbase.org/detail.go?type=gene&acc=80349,,,80349.0,SKIC8,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of SKIC8 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
663,1341055,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,9194,SLC16A7,https://ctdbase.org/detail.go?type=gene&acc=9194,,,9194.0,SLC16A7,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of SLC16A7 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
664,1341056,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,116843,SLC18B1,https://ctdbase.org/detail.go?type=gene&acc=116843,,,116843.0,SLC18B1,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of SLC18B1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
665,1341651,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,11101,ATE1,https://ctdbase.org/detail.go?type=gene&acc=11101,,,11101.0,ATE1,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of ATE1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
666,1341652,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,64422,ATG3,https://ctdbase.org/detail.go?type=gene&acc=64422,,,64422.0,ATG3,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of ATG3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
667,1341653,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,23250,ATP11A,https://ctdbase.org/detail.go?type=gene&acc=23250,,,23250.0,ATP11A,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of ATP11A mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
668,1341654,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,93974,ATP5IF1,https://ctdbase.org/detail.go?type=gene&acc=93974,,,93974.0,ATP5IF1,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of ATP5IF1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
669,1341655,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,10159,ATP6AP2,https://ctdbase.org/detail.go?type=gene&acc=10159,,,10159.0,ATP6AP2,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of ATP6AP2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
670,1341656,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,523,ATP6V1A,https://ctdbase.org/detail.go?type=gene&acc=523,,,523.0,ATP6V1A,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of ATP6V1A mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
671,1341977,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,7067,THRA,https://ctdbase.org/detail.go?type=gene&acc=7067,,,7067.0,THRA,8479,Chrysemys picta (Painted turtle),Finasteride binds to and results in increased activity of THRA protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
672,1341978,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,7068,THRB,https://ctdbase.org/detail.go?type=gene&acc=7068,,,7068.0,THRB,7955,Danio rerio (zebrafish),Finasteride binds to and results in increased activity of THRB protein|finasteride binds to and results in decreased activity of THRB protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
673,1341979,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,7069,THRSP,https://ctdbase.org/detail.go?type=gene&acc=7069,,,7069.0,THRSP,10116,Rattus norvegicus (Norway rat),Finasteride results in decreased expression of THRSP mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
674,1341980,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,26519,TIMM10,https://ctdbase.org/detail.go?type=gene&acc=26519,,,26519.0,TIMM10,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of TIMM10 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
675,1341981,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,26515,TIMM10B,https://ctdbase.org/detail.go?type=gene&acc=26515,,,26515.0,TIMM10B,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of TIMM10B mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
676,1341982,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,26517,TIMM13,https://ctdbase.org/detail.go?type=gene&acc=26517,,,26517.0,TIMM13,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of TIMM13 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
677,1341983,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,10440,TIMM17A,https://ctdbase.org/detail.go?type=gene&acc=10440,,,10440.0,TIMM17A,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of TIMM17A mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
678,1341984,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,30058,TIMM8A1,https://ctdbase.org/detail.go?type=gene&acc=30058,,,30058.0,Timm8a1,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of TIMM8A1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
679,1342109,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,55374,TMCO6,https://ctdbase.org/detail.go?type=gene&acc=55374,,,55374.0,TMCO6,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of TMCO6 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
680,1342110,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,84233,TMEM126A,https://ctdbase.org/detail.go?type=gene&acc=84233,,,84233.0,TMEM126A,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of TMEM126A mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
681,1342111,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,85014,TMEM141,https://ctdbase.org/detail.go?type=gene&acc=85014,,,85014.0,TMEM141,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of TMEM141 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
682,1342112,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,51522,TMEM14C,https://ctdbase.org/detail.go?type=gene&acc=51522,,,51522.0,TMEM14C,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of TMEM14C mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
683,1342263,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,219771,CCNY,https://ctdbase.org/detail.go?type=gene&acc=219771,,,219771.0,CCNY,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of CCNY mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
684,1342699,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,9354,UBE4A,https://ctdbase.org/detail.go?type=gene&acc=9354,,,9354.0,UBE4A,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of UBE4A mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
685,1342700,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,56061,UBFD1,https://ctdbase.org/detail.go?type=gene&acc=56061,,,56061.0,UBFD1,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of UBFD1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
686,1342701,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,8266,UBL4A,https://ctdbase.org/detail.go?type=gene&acc=8266,,,8266.0,UBL4A,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of UBL4A mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
687,1342702,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,59286,UBL5,https://ctdbase.org/detail.go?type=gene&acc=59286,,,59286.0,UBL5,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of UBL5 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
688,1342703,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,84993,UBL7,https://ctdbase.org/detail.go?type=gene&acc=84993,,,84993.0,UBL7,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of UBL7 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
689,1342704,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,29978,UBQLN2,https://ctdbase.org/detail.go?type=gene&acc=29978,,,29978.0,UBQLN2,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of UBQLN2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
690,1342705,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,23190,UBXN4,https://ctdbase.org/detail.go?type=gene&acc=23190,,,23190.0,UBXN4,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of UBXN4 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
691,1342706,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,114094,UCHL3-PS1,https://ctdbase.org/detail.go?type=gene&acc=114094,,,114094.0,Uchl3-ps1,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of UCHL3-PS1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
692,1342707,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,51377,UCHL5,https://ctdbase.org/detail.go?type=gene&acc=51377,,,51377.0,UCHL5,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of UCHL5 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
693,1342862,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,493753,COA5,https://ctdbase.org/detail.go?type=gene&acc=493753,,,493753.0,COA5,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of COA5 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
694,1342863,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,91949,COG7,https://ctdbase.org/detail.go?type=gene&acc=91949,,,91949.0,COG7,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of COG7 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
695,1342864,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,8292,COLQ,https://ctdbase.org/detail.go?type=gene&acc=8292,,,8292.0,COLQ,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of COLQ mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
696,1342865,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,51397,COMMD10,https://ctdbase.org/detail.go?type=gene&acc=51397,,,51397.0,COMMD10,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of COMMD10 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
697,1342866,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,23412,COMMD3,https://ctdbase.org/detail.go?type=gene&acc=23412,,,23412.0,COMMD3,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of COMMD3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
698,1342867,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,28991,COMMD5,https://ctdbase.org/detail.go?type=gene&acc=28991,,,28991.0,COMMD5,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of COMMD5 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
699,1343298,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,23091,ZC3H13,https://ctdbase.org/detail.go?type=gene&acc=23091,,,23091.0,ZC3H13,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of ZC3H13 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
700,1343299,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,55854,ZC3H15,https://ctdbase.org/detail.go?type=gene&acc=55854,,,55854.0,ZC3H15,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of ZC3H15 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
701,1343300,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,20402,ZFP106,https://ctdbase.org/detail.go?type=gene&acc=20402,,,20402.0,Zfp106,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of ZFP106 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
702,1343301,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,22661,ZFP148,https://ctdbase.org/detail.go?type=gene&acc=22661,,,22661.0,Zfp148,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of ZFP148 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
703,1343302,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,226442,ZFP281,https://ctdbase.org/detail.go?type=gene&acc=226442,,,226442.0,Zfp281,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of ZFP281 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
704,1343303,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,94187,ZFP423,https://ctdbase.org/detail.go?type=gene&acc=94187,,,94187.0,Zfp423,10116,Rattus norvegicus (Norway rat),Finasteride results in decreased expression of ZFP423 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
705,1343304,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,80829,ZFP91,https://ctdbase.org/detail.go?type=gene&acc=80829,,,80829.0,ZFP91,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of ZFP91 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
706,1343305,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,83637,ZMIZ2,https://ctdbase.org/detail.go?type=gene&acc=83637,,,83637.0,ZMIZ2,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of ZMIZ2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
707,1344139,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10047,Meriones unguiculatus (Mongolian gerbil),Finasteride results in increased expression of ESR1 protein,,,PMID:31454150,https://www.ncbi.nlm.nih.gov/pubmed/31454150,31454150,,
708,1344140,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10116,Rattus norvegicus (Norway rat),Finasteride affects the expression of ESR1 mRNA,,,PMID:30768126,https://www.ncbi.nlm.nih.gov/pubmed/30768126,30768126,,
709,1344141,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10116,Rattus norvegicus (Norway rat),Finasteride inhibits the reaction [testosterone results in increased expression of ESR1 protein],,,PMID:27866977,https://www.ncbi.nlm.nih.gov/pubmed/27866977,27866977,,
710,1345650,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,3416,IDE,https://ctdbase.org/detail.go?type=gene&acc=3416,,,3416.0,IDE,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of IDE mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
711,1345651,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,3429,IFI27,https://ctdbase.org/detail.go?type=gene&acc=3429,,,3429.0,IFI27,10116,Rattus norvegicus (Norway rat),Finasteride results in decreased expression of IFI27 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
712,1345652,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,10410,IFITM3,https://ctdbase.org/detail.go?type=gene&acc=10410,,,10410.0,IFITM3,10116,Rattus norvegicus (Norway rat),Finasteride results in decreased expression of IFITM3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
713,1345653,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,3454,IFNAR1,https://ctdbase.org/detail.go?type=gene&acc=3454,,,3454.0,IFNAR1,10116,Rattus norvegicus (Norway rat),Finasteride results in decreased expression of IFNAR1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
714,1346026,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,3875,KRT18,https://ctdbase.org/detail.go?type=gene&acc=3875,,,3875.0,KRT18,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of KRT18 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
715,1346027,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,79036,KXD1,https://ctdbase.org/detail.go?type=gene&acc=79036,,,79036.0,KXD1,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of KXD1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
716,1346028,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,51110,LACTB2,https://ctdbase.org/detail.go?type=gene&acc=51110,,,51110.0,LACTB2,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of LACTB2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
717,1346029,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,389541,LAMTOR4,https://ctdbase.org/detail.go?type=gene&acc=389541,,,389541.0,LAMTOR4,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of LAMTOR4 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
718,1346030,57363,Comparative Toxicogenomics Database (CTD),Finasteride,D018120,Finasteride,https://ctdbase.org/detail.go?type=chem&acc=D018120,10542,LAMTOR5,https://ctdbase.org/detail.go?type=gene&acc=10542,,,10542.0,LAMTOR5,10116,Rattus norvegicus (Norway rat),Finasteride results in increased expression of LAMTOR5 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
719,1339557,59227,IUPHAR/BPS Guide to PHARMACOLOGY,Rotigotine,941,rotigotine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=941,215,D2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=215,P14416,D(2) dopamine receptor,1813.0,DRD2,9606,Homo sapiens (human),Agonist,pKi,10.22,PMID:12086487,https://www.ncbi.nlm.nih.gov/pubmed/12086487,12086487,,
720,1339558,59227,IUPHAR/BPS Guide to PHARMACOLOGY,Rotigotine,941,rotigotine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=941,214,D1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=214,P21728,D(1A) dopamine receptor,1812.0,DRD1,9606,Homo sapiens (human),Full agonist,pKi,5.6,PMID:1826762,https://www.ncbi.nlm.nih.gov/pubmed/1826762,1826762,,
721,1339559,60021,DrugBank,Temafloxacin,DB01405,Temafloxacin,https://www.drugbank.ca/drugs/DB01405,BE0000366,DNA gyrase subunit A,https://www.drugbank.ca/bio_entities/BE0000366,P43700,DNA gyrase subunit A,,,71421,Haemophilus influenzae Rd KW20,Inhibitor,,,PMID:17139284|PMID:17016423|PMID:10500768|PMID:1667255|PMID:1656852|PMID:1662892,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10500768|https://www.ncbi.nlm.nih.gov/pubmed/1667255|https://www.ncbi.nlm.nih.gov/pubmed/1656852|https://www.ncbi.nlm.nih.gov/pubmed/1662892,17139284|17016423|10500768|1667255|1656852|1662892,,
722,1339560,60021,DrugBank,Temafloxacin,DB01405,Temafloxacin,https://www.drugbank.ca/drugs/DB01405,BE0000429,DNA topoisomerase 4 subunit A,https://www.drugbank.ca/bio_entities/BE0000429,P43702,DNA topoisomerase 4 subunit A,,,71421,Haemophilus influenzae Rd KW20,Inhibitor,,,PMID:17139284|PMID:17016423|PMID:1667255|PMID:1656852|PMID:1662892,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/1667255|https://www.ncbi.nlm.nih.gov/pubmed/1656852|https://www.ncbi.nlm.nih.gov/pubmed/1662892,17139284|17016423|1667255|1656852|1662892,,
723,1343505,60198,Drug Gene Interaction database (DGIdb),Exemestane,,EXEMESTANE,https://www.dgidb.org/drugs/rxcui:258494,,ESR1,https://www.dgidb.org/genes/hgnc:3467,,,2099.0,ESR1,9606,Homo sapiens (human),,,,,,,,
724,1343506,60490,Drug Gene Interaction database (DGIdb),Zileuton,,ZILEUTON,https://www.dgidb.org/drugs/rxcui:40575,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606,Homo sapiens (human),,,,,,,,
725,1343507,60490,DrugBank,Zileuton,DB00744,Zileuton,https://www.drugbank.ca/drugs/DB00744,BE0000248,Arachidonate 5-lipoxygenase,https://www.drugbank.ca/bio_entities/BE0000248,P09917,Polyunsaturated fatty acid 5-lipoxygenase,240.0,ALOX5,9606,Homo sapiens (human),Inhibitor,,,PMID:10322101|PMID:10377029|PMID:10694244|PMID:11529688|PMID:11561080|PMID:11752352|PMID:20436887|PMID:19645854|PMID:17394438|PMID:8058773|PMID:8826571|PMID:8950951|PMID:18031150|PMID:20567598,https://www.ncbi.nlm.nih.gov/pubmed/10322101|https://www.ncbi.nlm.nih.gov/pubmed/10377029|https://www.ncbi.nlm.nih.gov/pubmed/10694244|https://www.ncbi.nlm.nih.gov/pubmed/11529688|https://www.ncbi.nlm.nih.gov/pubmed/11561080|https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/20436887|https://www.ncbi.nlm.nih.gov/pubmed/19645854|https://www.ncbi.nlm.nih.gov/pubmed/17394438|https://www.ncbi.nlm.nih.gov/pubmed/8058773|https://www.ncbi.nlm.nih.gov/pubmed/8826571|https://www.ncbi.nlm.nih.gov/pubmed/8950951|https://www.ncbi.nlm.nih.gov/pubmed/18031150|https://www.ncbi.nlm.nih.gov/pubmed/20567598,10322101|10377029|10694244|11529688|11561080|11752352|20436887|19645854|17394438|8058773|8826571|8950951|18031150|20567598,,
726,1340163,60834,Drug Gene Interaction database (DGIdb),Duloxetine Hydrochloride,,DULOXETINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:476250,,TREML4,https://www.dgidb.org/genes/hgnc:30807,,,285852.0,TREML4,9606,Homo sapiens (human),,,,,,,,
727,1340164,60837,Drug Gene Interaction database (DGIdb),Camptosar,,IRINOTECAN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:153329,,MTHFR,https://www.dgidb.org/genes/hgnc:7436,,,4524.0,MTHFR,9606,Homo sapiens (human),,,,,,,,
728,1340165,60837,Drug Gene Interaction database (DGIdb),Camptosar,,IRINOTECAN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:153329,,MAPK10,https://www.dgidb.org/genes/hgnc:6872,,,5602.0,MAPK10,9606,Homo sapiens (human),,,,,,,,
729,1340166,60837,Drug Gene Interaction database (DGIdb),Camptosar,,IRINOTECAN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:153329,,E2F1,https://www.dgidb.org/genes/hgnc:3113,,,1869.0,E2F1,9606,Homo sapiens (human),,,,,,,,
730,1345319,61253,Comparative Toxicogenomics Database (CTD),Octyl gallate,C016627,octyl gallate,https://ctdbase.org/detail.go?type=chem&acc=C016627,1646,AKR1C2,https://ctdbase.org/detail.go?type=gene&acc=1646,,,1646.0,AKR1C2,9606,Homo sapiens (human),Octyl gallate results in decreased activity of AKR1C2 protein,,,PMID:27163852,https://www.ncbi.nlm.nih.gov/pubmed/27163852,27163852,,
731,1345320,61253,Comparative Toxicogenomics Database (CTD),Octyl gallate,C016627,octyl gallate,https://ctdbase.org/detail.go?type=chem&acc=C016627,8644,AKR1C3,https://ctdbase.org/detail.go?type=gene&acc=8644,,,8644.0,AKR1C3,9606,Homo sapiens (human),Octyl gallate results in decreased activity of AKR1C3 protein,,,PMID:27163852,https://www.ncbi.nlm.nih.gov/pubmed/27163852,27163852,,
732,1345321,61253,Comparative Toxicogenomics Database (CTD),Octyl gallate,C016627,octyl gallate,https://ctdbase.org/detail.go?type=chem&acc=C016627,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Octyl gallate results in increased activity of CAT protein,,,PMID:21856409,https://www.ncbi.nlm.nih.gov/pubmed/21856409,21856409,,
733,1345322,61253,Comparative Toxicogenomics Database (CTD),Octyl gallate,C016627,octyl gallate,https://ctdbase.org/detail.go?type=chem&acc=C016627,389434,IYD,https://ctdbase.org/detail.go?type=gene&acc=389434,,,389434.0,IYD,9606,Homo sapiens (human),Octyl gallate inhibits the reaction [IYD protein results in increased metabolism of monoiodotyrosine],,,PMID:33352258,https://www.ncbi.nlm.nih.gov/pubmed/33352258,33352258,,
734,1345323,61253,Comparative Toxicogenomics Database (CTD),Octyl gallate,C016627,octyl gallate,https://ctdbase.org/detail.go?type=chem&acc=C016627,4744,NEFH,https://ctdbase.org/detail.go?type=gene&acc=4744,,,4744.0,NEFH,10116,Rattus norvegicus (Norway rat),Octyl gallate affects the expression of NEFH mRNA,,,PMID:22954530,https://www.ncbi.nlm.nih.gov/pubmed/22954530,22954530,,
735,1345324,61253,Comparative Toxicogenomics Database (CTD),Octyl gallate,C016627,octyl gallate,https://ctdbase.org/detail.go?type=chem&acc=C016627,54577,UGT1A7,https://ctdbase.org/detail.go?type=gene&acc=54577,,,54577.0,UGT1A7,9986,Oryctolagus cuniculus (rabbit),UGT1A7 protein results in increased glucuronidation of octyl gallate,,,PMID:9264550,https://www.ncbi.nlm.nih.gov/pubmed/9264550,9264550,,
736,1345325,61253,Comparative Toxicogenomics Database (CTD),Octyl gallate,C016627,octyl gallate,https://ctdbase.org/detail.go?type=chem&acc=C016627,1109,AKR1C4,https://ctdbase.org/detail.go?type=gene&acc=1109,,,1109.0,AKR1C4,9606,Homo sapiens (human),Octyl gallate results in decreased activity of AKR1C4 protein,,,PMID:27163852,https://www.ncbi.nlm.nih.gov/pubmed/27163852,27163852,,
737,1341489,61628,Toxin and Toxin Target Database (T3DB),"Hypochlorous acid, barium salt",T3D1111,Barium hypochlorite,http://www.t3db.ca/toxins/T3D1111,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q9UNX9,ATP-sensitive inward rectifier potassium channel 14,3770.0,KCNJ14,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
738,1341490,61628,Toxin and Toxin Target Database (T3DB),"Hypochlorous acid, barium salt",T3D1111,Barium hypochlorite,http://www.t3db.ca/toxins/T3D1111,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q99712,ATP-sensitive inward rectifier potassium channel 15,3772.0,KCNJ15,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
739,1341491,61628,Toxin and Toxin Target Database (T3DB),"Hypochlorous acid, barium salt",T3D1111,Barium hypochlorite,http://www.t3db.ca/toxins/T3D1111,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q15842,ATP-sensitive inward rectifier potassium channel 8,3764.0,KCNJ8,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
740,1341492,61628,Toxin and Toxin Target Database (T3DB),"Hypochlorous acid, barium salt",T3D1111,Barium hypochlorite,http://www.t3db.ca/toxins/T3D1111,BE0000418,Calmodulin,http://www.t3db.ca/biodb/bio_entities/BE0000418,P62158,RecName: Full=Calmodulin; Short=CaM,808.0,CALM3,9606,Homo sapiens (human),"Barium is believed to bind and activate calmodulin, causing certain neurotoxic effects. (A145)",,,PMID:17671360,https://www.ncbi.nlm.nih.gov/pubmed/17671360,17671360,,
741,1341493,61628,Toxin and Toxin Target Database (T3DB),"Hypochlorous acid, barium salt",T3D1111,Barium hypochlorite,http://www.t3db.ca/toxins/T3D1111,BE0001028,G protein-activated inward rectifier potassium channel 1,http://www.t3db.ca/biodb/bio_entities/BE0001028,P48549,G protein-activated inward rectifier potassium channel 1,3760.0,KCNJ3,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
742,1342413,62115,ChEMBL,Netilmicin Sulfate,CHEMBL3989829,NETILMICIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989829/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7V0,30S ribosomal protein S2,8913847.0,rpmG,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6927285|PMID:16891542,https://www.ncbi.nlm.nih.gov/pubmed/6927285|https://www.ncbi.nlm.nih.gov/pubmed/16891542,6927285|16891542,,
743,1342414,62115,ChEMBL,Netilmicin Sulfate,CHEMBL3989829,NETILMICIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989829/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7V3,30S ribosomal protein S3,948216.0,rpmH,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6927285|PMID:16891542,https://www.ncbi.nlm.nih.gov/pubmed/6927285|https://www.ncbi.nlm.nih.gov/pubmed/16891542,6927285|16891542,,
744,1342415,62115,ChEMBL,Netilmicin Sulfate,CHEMBL3989829,NETILMICIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989829/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7V8,30S ribosomal protein S4,84238873.0,,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6927285|PMID:16891542,https://www.ncbi.nlm.nih.gov/pubmed/6927285|https://www.ncbi.nlm.nih.gov/pubmed/16891542,6927285|16891542,,
745,1342416,62115,ChEMBL,Netilmicin Sulfate,CHEMBL3989829,NETILMICIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989829/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7W1,30S ribosomal protein S5,946349.0,rpmI,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6927285|PMID:16891542,https://www.ncbi.nlm.nih.gov/pubmed/6927285|https://www.ncbi.nlm.nih.gov/pubmed/16891542,6927285|16891542,,
746,1342417,62115,ChEMBL,Netilmicin Sulfate,CHEMBL3989829,NETILMICIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989829/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7W7,30S ribosomal protein S8,84236820.0,,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6927285|PMID:16891542,https://www.ncbi.nlm.nih.gov/pubmed/6927285|https://www.ncbi.nlm.nih.gov/pubmed/16891542,6927285|16891542,,
747,1342418,62115,ChEMBL,Netilmicin Sulfate,CHEMBL3989829,NETILMICIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989829/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7X3,30S ribosomal protein S9,947805.0,rpmJ,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6927285|PMID:16891542,https://www.ncbi.nlm.nih.gov/pubmed/6927285|https://www.ncbi.nlm.nih.gov/pubmed/16891542,6927285|16891542,,
748,1342419,62115,ChEMBL,Netilmicin Sulfate,CHEMBL3989829,NETILMICIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989829/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AA10,50S ribosomal protein L13,84234858.0,,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6927285|PMID:16891542,https://www.ncbi.nlm.nih.gov/pubmed/6927285|https://www.ncbi.nlm.nih.gov/pubmed/16891542,6927285|16891542,,
749,1342420,62115,ChEMBL,Netilmicin Sulfate,CHEMBL3989829,NETILMICIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989829/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0ADY3,50S ribosomal protein L14,947816.0,rpsJ,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6927285|PMID:16891542,https://www.ncbi.nlm.nih.gov/pubmed/6927285|https://www.ncbi.nlm.nih.gov/pubmed/16891542,6927285|16891542,,
750,1343147,62392,Toxin and Toxin Target Database (T3DB),Barium oxide,T3D1117,Barium oxide,http://www.t3db.ca/toxins/T3D1117,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q15842,ATP-sensitive inward rectifier potassium channel 8,3764.0,KCNJ8,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
751,1343148,62392,Toxin and Toxin Target Database (T3DB),Barium oxide,T3D1117,Barium oxide,http://www.t3db.ca/toxins/T3D1117,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,P48048,ATP-sensitive inward rectifier potassium channel 1,3758.0,KCNJ1,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
752,1343149,62392,Toxin and Toxin Target Database (T3DB),Barium oxide,T3D1117,Barium oxide,http://www.t3db.ca/toxins/T3D1117,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,P78508,ATP-sensitive inward rectifier potassium channel 10,3766.0,KCNJ10,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
753,1343150,62392,Toxin and Toxin Target Database (T3DB),Barium oxide,T3D1117,Barium oxide,http://www.t3db.ca/toxins/T3D1117,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q14654,ATP-sensitive inward rectifier potassium channel 11,3767.0,KCNJ11,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
754,1343151,62392,Toxin and Toxin Target Database (T3DB),Barium oxide,T3D1117,Barium oxide,http://www.t3db.ca/toxins/T3D1117,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q14500,ATP-sensitive inward rectifier potassium channel 12,3768.0,KCNJ12,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
755,1343152,62392,Toxin and Toxin Target Database (T3DB),Barium oxide,T3D1117,Barium oxide,http://www.t3db.ca/toxins/T3D1117,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q9UNX9,ATP-sensitive inward rectifier potassium channel 14,3770.0,KCNJ14,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
756,1343153,62392,Toxin and Toxin Target Database (T3DB),Barium oxide,T3D1117,Barium oxide,http://www.t3db.ca/toxins/T3D1117,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q99712,ATP-sensitive inward rectifier potassium channel 15,3772.0,KCNJ15,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
757,1343641,62392,Toxin and Toxin Target Database (T3DB),Barium oxide,T3D1117,Barium oxide,http://www.t3db.ca/toxins/T3D1117,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q14654,ATP-sensitive inward rectifier potassium channel 11,3767.0,KCNJ11,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
758,1343642,62392,Toxin and Toxin Target Database (T3DB),Barium oxide,T3D1117,Barium oxide,http://www.t3db.ca/toxins/T3D1117,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q14500,ATP-sensitive inward rectifier potassium channel 12,3768.0,KCNJ12,9606,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
759,1344834,62923,Comparative Toxicogenomics Database (CTD),Venlafaxine Hydrochloride,D000069470,Venlafaxine Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069470,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606,Homo sapiens (human),"[[CYP2D6 protein results in increased metabolism of venlafaxine hydrochloride] which results in increased abundance of desvenlafaxine succinate] which results in increased abundance of N,O-didesmethylvenlafaxine|[cyp2d6 protein results in increased metabolism of venlafaxine hydrochloride] which results in increased abundance of desvenlafaxine succinate",,,PMID:21840145,https://www.ncbi.nlm.nih.gov/pubmed/21840145,21840145,,
760,1344835,62923,Comparative Toxicogenomics Database (CTD),Venlafaxine Hydrochloride,D000069470,Venlafaxine Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069470,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),"CYP3A4 protein results in increased metabolism of venlafaxine hydrochloride|[cyp3a4 protein results in increased metabolism of venlafaxine hydrochloride] which results in increased abundance of N-desmethylvenlafaxine|[[cyp3a4 protein results in increased metabolism of venlafaxine hydrochloride] which results in increased abundance of N-desmethylvenlafaxine] which results in increased abundance of N,O-didesmethylvenlafaxine",,,PMID:21840145,https://www.ncbi.nlm.nih.gov/pubmed/21840145,21840145,,
761,1344836,62923,Comparative Toxicogenomics Database (CTD),Venlafaxine Hydrochloride,D000069470,Venlafaxine Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069470,1601,DAB2,https://ctdbase.org/detail.go?type=gene&acc=1601,,,1601.0,DAB2,10116,Rattus norvegicus (Norway rat),Venlafaxine hydrochloride results in increased expression of DAB2 mRNA,,,PMID:25423262,https://www.ncbi.nlm.nih.gov/pubmed/25423262,25423262,,
762,1344837,62923,Comparative Toxicogenomics Database (CTD),Venlafaxine Hydrochloride,D000069470,Venlafaxine Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069470,23576,DDAH1,https://ctdbase.org/detail.go?type=gene&acc=23576,,,23576.0,DDAH1,10116,Rattus norvegicus (Norway rat),Venlafaxine hydrochloride results in increased expression of DDAH1 mRNA,,,PMID:25423262,https://www.ncbi.nlm.nih.gov/pubmed/25423262,25423262,,
763,1344838,62923,Comparative Toxicogenomics Database (CTD),Venlafaxine Hydrochloride,D000069470,Venlafaxine Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069470,90871,DMAC1,https://ctdbase.org/detail.go?type=gene&acc=90871,,,90871.0,DMAC1,9606,Homo sapiens (human),Venlafaxine hydrochloride results in increased expression of DMAC1 mRNA,,,PMID:16341940,https://www.ncbi.nlm.nih.gov/pubmed/16341940,16341940,,
764,1344839,62923,Comparative Toxicogenomics Database (CTD),Venlafaxine Hydrochloride,D000069470,Venlafaxine Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069470,1788,DNMT3A,https://ctdbase.org/detail.go?type=gene&acc=1788,,,1788.0,DNMT3A,10116,Rattus norvegicus (Norway rat),Venlafaxine hydrochloride results in increased expression of DNMT3A mRNA,,,PMID:25423262,https://www.ncbi.nlm.nih.gov/pubmed/25423262,25423262,,
765,1344840,62923,Comparative Toxicogenomics Database (CTD),Venlafaxine Hydrochloride,D000069470,Venlafaxine Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069470,1803,DPP4,https://ctdbase.org/detail.go?type=gene&acc=1803,,,1803.0,DPP4,10116,Rattus norvegicus (Norway rat),Venlafaxine hydrochloride results in increased expression of DPP4 mRNA,,,PMID:25423262,https://www.ncbi.nlm.nih.gov/pubmed/25423262,25423262,,
766,1345472,62923,Comparative Toxicogenomics Database (CTD),Venlafaxine Hydrochloride,D000069470,Venlafaxine Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069470,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,10116,Rattus norvegicus (Norway rat),Chloroquine inhibits the reaction [venlafaxine hydrochloride inhibits the reaction [rotenone results in decreased lipidation of MAP1LC3B protein]]|venlafaxine hydrochloride inhibits the reaction [rotenone results in decreased lipidation of MAP1LC3B protein],,,PMID:35104487,https://www.ncbi.nlm.nih.gov/pubmed/35104487,35104487,,
767,1333884,65335,Comparative Toxicogenomics Database (CTD),Ticlopidine Hydrochloride,D013988,Ticlopidine,https://ctdbase.org/detail.go?type=chem&acc=D013988,55244,SLC47A1,https://ctdbase.org/detail.go?type=gene&acc=55244,,,55244.0,SLC47A1,9606,Homo sapiens (human),Ticlopidine affects the reaction [SLC47A1 protein results in increased uptake of 1-methyl-4-phenylpyridinium],,,PMID:22419765,https://www.ncbi.nlm.nih.gov/pubmed/22419765,22419765,,
768,1164294,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,5514,PPP1R10,https://ctdbase.org/detail.go?type=gene&acc=5514,,,5514.0,PPP1R10,10090,Mus musculus (house mouse),Triptonide results in increased expression of PPP1R10 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
769,1164295,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,6992,PPP1R11,https://ctdbase.org/detail.go?type=gene&acc=6992,,,6992.0,PPP1R11,10090,Mus musculus (house mouse),Triptonide results in increased expression of PPP1R11 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
770,1164296,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,4659,PPP1R12A,https://ctdbase.org/detail.go?type=gene&acc=4659,,,4659.0,PPP1R12A,10090,Mus musculus (house mouse),Triptonide affects the expression of PPP1R12A mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
771,1164297,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,4660,PPP1R12B,https://ctdbase.org/detail.go?type=gene&acc=4660,,,4660.0,PPP1R12B,10090,Mus musculus (house mouse),Triptonide results in decreased expression of PPP1R12B mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
772,1164298,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,23645,PPP1R15A,https://ctdbase.org/detail.go?type=gene&acc=23645,,,23645.0,PPP1R15A,10090,Mus musculus (house mouse),Triptonide results in increased expression of PPP1R15A mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
773,1164299,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,84919,PPP1R15B,https://ctdbase.org/detail.go?type=gene&acc=84919,,,84919.0,PPP1R15B,10090,Mus musculus (house mouse),Triptonide results in increased expression of PPP1R15B mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
774,1164300,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,26051,PPP1R16B,https://ctdbase.org/detail.go?type=gene&acc=26051,,,26051.0,PPP1R16B,10090,Mus musculus (house mouse),Triptonide results in increased expression of PPP1R16B mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
775,1164301,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,170954,PPP1R18,https://ctdbase.org/detail.go?type=gene&acc=170954,,,170954.0,PPP1R18,10090,Mus musculus (house mouse),Triptonide results in increased expression of PPP1R18 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
776,1335239,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,79090,TRAPPC6A,https://ctdbase.org/detail.go?type=gene&acc=79090,,,79090.0,TRAPPC6A,10090,Mus musculus (house mouse),Triptonide results in increased expression of TRAPPC6A mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
777,1335240,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,122553,TRAPPC6B,https://ctdbase.org/detail.go?type=gene&acc=122553,,,122553.0,TRAPPC6B,10090,Mus musculus (house mouse),Triptonide affects the expression of TRAPPC6B mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
778,1335241,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,83696,TRAPPC9,https://ctdbase.org/detail.go?type=gene&acc=83696,,,83696.0,TRAPPC9,10090,Mus musculus (house mouse),Triptonide affects the expression of TRAPPC9 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
779,1335242,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,286753,TRARG1,https://ctdbase.org/detail.go?type=gene&acc=286753,,,286753.0,TRARG1,10090,Mus musculus (house mouse),Triptonide results in increased expression of TRARG1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
780,1335243,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,541610,TRCG1,https://ctdbase.org/detail.go?type=gene&acc=541610,,,541610.0,Trcg1,10090,Mus musculus (house mouse),Triptonide results in increased expression of TRCG1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
781,1335244,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,28526,TRDC,https://ctdbase.org/detail.go?type=gene&acc=28526,,,28526.0,TRDC,10090,Mus musculus (house mouse),Triptonide results in increased expression of TRDC mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
782,1335245,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,79865,TREML2,https://ctdbase.org/detail.go?type=gene&acc=79865,,,79865.0,TREML2,10090,Mus musculus (house mouse),Triptonide results in increased expression of TREML2 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
783,1335375,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,10107,TRIM10,https://ctdbase.org/detail.go?type=gene&acc=10107,,,10107.0,TRIM10,10090,Mus musculus (house mouse),Triptonide results in increased expression of TRIM10 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
784,1335376,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,9830,TRIM14,https://ctdbase.org/detail.go?type=gene&acc=9830,,,9830.0,TRIM14,10090,Mus musculus (house mouse),Triptonide results in increased expression of TRIM14 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
785,1335377,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,8805,TRIM24,https://ctdbase.org/detail.go?type=gene&acc=8805,,,8805.0,TRIM24,10090,Mus musculus (house mouse),Triptonide results in decreased expression of TRIM24 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
786,1335378,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,7706,TRIM25,https://ctdbase.org/detail.go?type=gene&acc=7706,,,7706.0,TRIM25,10090,Mus musculus (house mouse),Triptonide results in increased expression of TRIM25 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
787,1335379,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,7726,TRIM26,https://ctdbase.org/detail.go?type=gene&acc=7726,,,7726.0,TRIM26,10090,Mus musculus (house mouse),Triptonide results in decreased expression of TRIM26 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
788,1335380,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,5987,TRIM27,https://ctdbase.org/detail.go?type=gene&acc=5987,,,5987.0,TRIM27,10090,Mus musculus (house mouse),Triptonide results in decreased expression of TRIM27 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
789,1336126,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,80705,TSGA10,https://ctdbase.org/detail.go?type=gene&acc=80705,,,80705.0,TSGA10,10090,Mus musculus (house mouse),Triptonide results in increased expression of TSGA10 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
790,1336127,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,254187,TSGA10IP,https://ctdbase.org/detail.go?type=gene&acc=254187,,,254187.0,TSGA10IP,10090,Mus musculus (house mouse),Triptonide results in increased expression of TSGA10IP mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
791,1337180,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,127933,UHMK1,https://ctdbase.org/detail.go?type=gene&acc=127933,,,127933.0,UHMK1,10090,Mus musculus (house mouse),Triptonide results in increased expression of UHMK1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
792,1337181,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,29128,UHRF1,https://ctdbase.org/detail.go?type=gene&acc=29128,,,29128.0,UHRF1,10090,Mus musculus (house mouse),Triptonide results in decreased expression of UHRF1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
793,1337182,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,115426,UHRF2,https://ctdbase.org/detail.go?type=gene&acc=115426,,,115426.0,UHRF2,10090,Mus musculus (house mouse),Triptonide affects the expression of UHRF2 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
794,1337183,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,80329,ULBP1,https://ctdbase.org/detail.go?type=gene&acc=80329,,,80329.0,ULBP1,10090,Mus musculus (house mouse),Triptonide results in increased expression of ULBP1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
795,1337184,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,54986,ULK4,https://ctdbase.org/detail.go?type=gene&acc=54986,,,54986.0,ULK4,10090,Mus musculus (house mouse),Triptonide results in decreased expression of ULK4 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
796,1337185,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,10497,UNC13B,https://ctdbase.org/detail.go?type=gene&acc=10497,,,10497.0,UNC13B,10090,Mus musculus (house mouse),Triptonide results in increased expression of UNC13B mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
797,1337186,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,55898,UNC45A,https://ctdbase.org/detail.go?type=gene&acc=55898,,,55898.0,UNC45A,10090,Mus musculus (house mouse),Triptonide affects the expression of UNC45A mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
798,1338225,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,51699,VPS29,https://ctdbase.org/detail.go?type=gene&acc=51699,,,51699.0,VPS29,10090,Mus musculus (house mouse),Triptonide affects the expression of VPS29 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
799,1338226,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,9525,VPS4B,https://ctdbase.org/detail.go?type=gene&acc=9525,,,9525.0,VPS4B,10090,Mus musculus (house mouse),Triptonide results in decreased expression of VPS4B mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
800,1338227,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,51542,VPS54,https://ctdbase.org/detail.go?type=gene&acc=51542,,,51542.0,VPS54,10090,Mus musculus (house mouse),Triptonide results in decreased expression of VPS54 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
801,1338228,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,6944,VPS72,https://ctdbase.org/detail.go?type=gene&acc=6944,,,6944.0,VPS72,10090,Mus musculus (house mouse),Triptonide results in decreased expression of VPS72 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
802,1338229,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,23355,VPS8,https://ctdbase.org/detail.go?type=gene&acc=23355,,,23355.0,VPS8,10090,Mus musculus (house mouse),Triptonide results in decreased expression of VPS8 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
803,1338230,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,9605,VPS9D1,https://ctdbase.org/detail.go?type=gene&acc=9605,,,9605.0,VPS9D1,10090,Mus musculus (house mouse),Triptonide results in increased expression of VPS9D1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
804,1338231,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,7444,VRK2,https://ctdbase.org/detail.go?type=gene&acc=7444,,,7444.0,VRK2,10090,Mus musculus (house mouse),Triptonide results in decreased expression of VRK2 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
805,1338232,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,51231,VRK3,https://ctdbase.org/detail.go?type=gene&acc=51231,,,51231.0,VRK3,10090,Mus musculus (house mouse),Triptonide results in decreased expression of VRK3 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
806,1338233,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,54621,VSIG10,https://ctdbase.org/detail.go?type=gene&acc=54621,,,54621.0,VSIG10,10090,Mus musculus (house mouse),Triptonide results in decreased expression of VSIG10 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
807,1339086,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,2829,XCR1,https://ctdbase.org/detail.go?type=gene&acc=2829,,,2829.0,XCR1,10090,Mus musculus (house mouse),Triptonide results in increased expression of XCR1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
808,1339087,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,10090,Mus musculus (house mouse),Triptonide results in decreased expression of XIAP mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
809,1339088,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,165904,XIRP1,https://ctdbase.org/detail.go?type=gene&acc=165904,,,165904.0,XIRP1,10090,Mus musculus (house mouse),Triptonide results in increased expression of XIRP1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
810,1339089,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,7503,XIST,https://ctdbase.org/detail.go?type=gene&acc=7503,,,7503.0,XIST,10090,Mus musculus (house mouse),Triptonide results in increased expression of XIST mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
811,1339090,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,286046,XKR6,https://ctdbase.org/detail.go?type=gene&acc=286046,,,286046.0,XKR6,10090,Mus musculus (house mouse),Triptonide results in increased expression of XKR6 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
812,1339091,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,402415,XKRX,https://ctdbase.org/detail.go?type=gene&acc=402415,,,402415.0,XKRX,10090,Mus musculus (house mouse),Triptonide results in increased expression of XKRX mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
813,1339092,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,102443350,XNDC1,https://ctdbase.org/detail.go?type=gene&acc=102443350,,,102443350.0,Xndc1,10090,Mus musculus (house mouse),Triptonide affects the expression of XNDC1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
814,1339093,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,102443351,XNTRPC,https://ctdbase.org/detail.go?type=gene&acc=102443351,,,102443351.0,Xntrpc,10090,Mus musculus (house mouse),Triptonide affects the expression of XNTRPC mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
815,1339094,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,7514,XPO1,https://ctdbase.org/detail.go?type=gene&acc=7514,,,7514.0,XPO1,10090,Mus musculus (house mouse),Triptonide results in increased expression of XPO1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
816,1339561,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,201501,ZBTB7C,https://ctdbase.org/detail.go?type=gene&acc=201501,,,201501.0,ZBTB7C,10090,Mus musculus (house mouse),Triptonide results in decreased expression of ZBTB7C mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
817,1339562,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,728116,ZBTB8B,https://ctdbase.org/detail.go?type=gene&acc=728116,,,728116.0,ZBTB8B,10090,Mus musculus (house mouse),Triptonide results in increased expression of ZBTB8B mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
818,1339563,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,340554,ZC3H12B,https://ctdbase.org/detail.go?type=gene&acc=340554,,,340554.0,ZC3H12B,10090,Mus musculus (house mouse),Triptonide results in decreased expression of ZC3H12B mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
819,1339564,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,340152,ZC3H12D,https://ctdbase.org/detail.go?type=gene&acc=340152,,,340152.0,ZC3H12D,10090,Mus musculus (house mouse),Triptonide results in increased expression of ZC3H12D mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
820,1339565,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,55854,ZC3H15,https://ctdbase.org/detail.go?type=gene&acc=55854,,,55854.0,ZC3H15,10090,Mus musculus (house mouse),Triptonide affects the expression of ZC3H15 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
821,1340302,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,668501,ZFP507,https://ctdbase.org/detail.go?type=gene&acc=668501,,,668501.0,Zfp507,10090,Mus musculus (house mouse),Triptonide results in increased expression of ZFP507 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
822,1340303,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,101023,ZFP513,https://ctdbase.org/detail.go?type=gene&acc=101023,,,101023.0,Zfp513,10090,Mus musculus (house mouse),Triptonide results in decreased expression of ZFP513 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
823,1340304,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,328977,ZFP532,https://ctdbase.org/detail.go?type=gene&acc=328977,,,328977.0,Zfp532,10090,Mus musculus (house mouse),Triptonide affects the expression of ZFP532 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
824,1340305,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,100503584,ZFP534,https://ctdbase.org/detail.go?type=gene&acc=100503584,,,100503584.0,Zfp534,10090,Mus musculus (house mouse),Triptonide results in increased expression of ZFP534 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
825,1340306,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,666528,ZFP541,https://ctdbase.org/detail.go?type=gene&acc=666528,,,666528.0,Zfp541,10090,Mus musculus (house mouse),Triptonide results in increased expression of ZFP541 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
826,1341494,65490,BindingDB,Halopemide,50206160,CHEMBL245621,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50206160,4399,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337.0,PLD1,9606,Homo sapiens (human),,IC50 (nM),310,PMID:19136975|DOI:10.1038/nchembio.140,https://www.ncbi.nlm.nih.gov/pubmed/19136975|https://doi.org/10.1038/nchembio.140,19136975,10.1038/nchembio.140,
827,1341495,65490,BindingDB,Halopemide,50206160,CHEMBL245621,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50206160,4399,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337.0,PLD1,9606,Homo sapiens (human),,IC50 (nM),220,PMID:19136975|DOI:10.1038/nchembio.140,https://www.ncbi.nlm.nih.gov/pubmed/19136975|https://doi.org/10.1038/nchembio.140,19136975,10.1038/nchembio.140,
828,1341496,65552,Comparative Toxicogenomics Database (CTD),Tetrac,C011126,tetraiodothyroacetic acid,https://ctdbase.org/detail.go?type=chem&acc=C011126,51715,RAB23,https://ctdbase.org/detail.go?type=gene&acc=51715,,,51715.0,RAB23,7955,Danio rerio (zebrafish),Tetraiodothyroacetic acid results in increased expression of RAB23 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
829,1341497,65559,Comparative Toxicogenomics Database (CTD),"3,3'-Diiodothyronine",C030629,"3,3'-diiodothyronine",https://ctdbase.org/detail.go?type=chem&acc=C030629,1733,DIO1,https://ctdbase.org/detail.go?type=gene&acc=1733,,,1733.0,DIO1,9606,Homo sapiens (human),"[DIO1 protein results in increased metabolism of triiodothyronine, reverse] which results in increased abundance of 3,3'-diiodothyronine|iodoacetates inhibits the reaction [[DIO1 protein results in increased metabolism of triiodothyronine, reverse] which results in increased abundance of 3,3'-diiodothyronine]",,,PMID:21565810,https://www.ncbi.nlm.nih.gov/pubmed/21565810,21565810,,
830,1341498,65559,Comparative Toxicogenomics Database (CTD),"3,3'-Diiodothyronine",C030629,"3,3'-diiodothyronine",https://ctdbase.org/detail.go?type=chem&acc=C030629,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,9606,Homo sapiens (human),"3,3'-diiodothyronine inhibits the reaction [SULT1A1 protein results in increased sulfation of 4-nitrophenol]",,,PMID:15531517,https://www.ncbi.nlm.nih.gov/pubmed/15531517,15531517,,
831,1343834,71060,Drug Gene Interaction database (DGIdb),Naphthol AS-BI,,CHEMBL:CHEMBL1543865,https://www.dgidb.org/drugs/chembl:CHEMBL1543865,,POLB,https://www.dgidb.org/genes/hgnc:9174,,,5423.0,POLB,9606,Homo sapiens (human),,,,,,,,
832,1343835,71060,Drug Gene Interaction database (DGIdb),Naphthol AS-BI,,CHEMBL:CHEMBL1543865,https://www.dgidb.org/drugs/chembl:CHEMBL1543865,,ADAMTSL4-AS1,https://www.dgidb.org/genes/hgnc:32041,,,574406.0,ADAMTSL4-AS1,9606,Homo sapiens (human),,,,,,,,
833,1343836,71060,Drug Gene Interaction database (DGIdb),Naphthol AS-BI,,CHEMBL:CHEMBL1543865,https://www.dgidb.org/drugs/chembl:CHEMBL1543865,,BAZ2B,https://www.dgidb.org/genes/hgnc:963,,,29994.0,BAZ2B,9606,Homo sapiens (human),,,,,,,,
834,1343837,71070,DrugBank,D-Arginine,DB04027,D-arginine,https://www.drugbank.ca/drugs/DB04027,BE0000714,Creatine kinase M-type,https://www.drugbank.ca/bio_entities/BE0000714,P06732,Creatine kinase M-type,1158.0,CKM,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
835,1339426,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,388753,COA6,https://ctdbase.org/detail.go?type=gene&acc=388753,,,388753.0,COA6,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of COA6 protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
836,1339427,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,80347,COASY,https://ctdbase.org/detail.go?type=gene&acc=80347,,,80347.0,COASY,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of COASY protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
837,1339428,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,9318,COPS2,https://ctdbase.org/detail.go?type=gene&acc=9318,,,9318.0,COPS2,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of COPS2 protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
838,1339429,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,8533,COPS3,https://ctdbase.org/detail.go?type=gene&acc=8533,,,8533.0,COPS3,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of COPS3 protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
839,1339430,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,1345,COX6C,https://ctdbase.org/detail.go?type=gene&acc=1345,,,1345.0,COX6C,9606,Homo sapiens (human),Tetrahydropalmatine results in increased expression of COX6C protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
840,1339431,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,1374,CPT1A,https://ctdbase.org/detail.go?type=gene&acc=1374,,,1374.0,CPT1A,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of CPT1A protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
841,1339432,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,1397,CRIP2,https://ctdbase.org/detail.go?type=gene&acc=1397,,,1397.0,CRIP2,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of CRIP2 protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
842,1339433,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,1429,CRYZ,https://ctdbase.org/detail.go?type=gene&acc=1429,,,1429.0,CRYZ,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of CRYZ protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
843,1342559,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,10090,Mus musculus (house mouse),Tetrahydropalmatine results in decreased expression of CYP1A2 protein|tetrahydropalmatine results in decreased expression of CYP1A2 mRNA,,,PMID:28257954,https://www.ncbi.nlm.nih.gov/pubmed/28257954,28257954,,
844,1342560,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,10238,DCAF7,https://ctdbase.org/detail.go?type=gene&acc=10238,,,10238.0,DCAF7,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of DCAF7 protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
845,1342561,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,10540,DCTN2,https://ctdbase.org/detail.go?type=gene&acc=10540,,,10540.0,DCTN2,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of DCTN2 protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
846,1342562,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,11269,DDX19B,https://ctdbase.org/detail.go?type=gene&acc=11269,,,11269.0,DDX19B,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of DDX19B protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
847,1342563,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,79009,DDX50,https://ctdbase.org/detail.go?type=gene&acc=79009,,,79009.0,DDX50,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of DDX50 protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
848,1342564,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,26063,DECR2,https://ctdbase.org/detail.go?type=gene&acc=26063,,,26063.0,DECR2,9606,Homo sapiens (human),Tetrahydropalmatine results in increased expression of DECR2 protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
849,1342565,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,1659,DHX8,https://ctdbase.org/detail.go?type=gene&acc=1659,,,1659.0,DHX8,9606,Homo sapiens (human),Tetrahydropalmatine results in increased expression of DHX8 protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
850,1335381,72304,Comparative Toxicogenomics Database (CTD),Isoflavone,D007529,Isoflavones,https://ctdbase.org/detail.go?type=chem&acc=D007529,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),Isoflavones analog results in increased expression of CYP1A1 mRNA,,,PMID:22507882|PMID:31621310,https://www.ncbi.nlm.nih.gov/pubmed/22507882|https://www.ncbi.nlm.nih.gov/pubmed/31621310,22507882|31621310,,
851,1335382,72304,Comparative Toxicogenomics Database (CTD),Isoflavone,D007529,Isoflavones,https://ctdbase.org/detail.go?type=chem&acc=D007529,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,10090,Mus musculus (house mouse),AHR protein affects the reaction [isoflavones analog results in increased expression of CYP1B1 mrna]|isoflavones analog results in increased expression of CYP1B1 mRNA,,,PMID:31621310,https://www.ncbi.nlm.nih.gov/pubmed/31621310,31621310,,
852,1335383,72304,Comparative Toxicogenomics Database (CTD),Isoflavone,D007529,Isoflavones,https://ctdbase.org/detail.go?type=chem&acc=D007529,1634,DCN,https://ctdbase.org/detail.go?type=gene&acc=1634,,,1634.0,DCN,10116,Rattus norvegicus (Norway rat),"[9,10-dimethyl-1,2-benzanthracene co-treated with isoflavones] results in increased expression of DCN protein|[enng co-treated with isoflavones] results in decreased expression of DCN protein",,,PMID:22248470,https://www.ncbi.nlm.nih.gov/pubmed/22248470,22248470,,
853,1335384,72304,Comparative Toxicogenomics Database (CTD),Isoflavone,D007529,Isoflavones,https://ctdbase.org/detail.go?type=chem&acc=D007529,1653,DDX1,https://ctdbase.org/detail.go?type=gene&acc=1653,,,1653.0,DDX1,10116,Rattus norvegicus (Norway rat),[ENNG co-treated with isoflavones] results in increased expression of DDX1 protein,,,PMID:22248470,https://www.ncbi.nlm.nih.gov/pubmed/22248470,22248470,,
854,1334428,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,67532,MFAP1A,https://ctdbase.org/detail.go?type=gene&acc=67532,,,67532.0,Mfap1a,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of MFAP1A mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
855,1334429,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,100034361,MFAP1B,https://ctdbase.org/detail.go?type=gene&acc=100034361,,,100034361.0,Mfap1b,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of MFAP1B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
856,1334430,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4237,MFAP2,https://ctdbase.org/detail.go?type=gene&acc=4237,,,4237.0,MFAP2,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of MFAP2 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
857,1334431,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4237,MFAP2,https://ctdbase.org/detail.go?type=gene&acc=4237,,,4237.0,MFAP2,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of MFAP2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
858,1334432,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8076,MFAP5,https://ctdbase.org/detail.go?type=gene&acc=8076,,,8076.0,MFAP5,10116,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in increased expression of MFAP5 mRNA,,,PMID:22237054,https://www.ncbi.nlm.nih.gov/pubmed/22237054,22237054,,
859,1334433,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4240,MFGE8,https://ctdbase.org/detail.go?type=gene&acc=4240,,,4240.0,MFGE8,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of MFGE8 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of MFGE8 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
860,1334434,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,558580,MFGE8B,https://ctdbase.org/detail.go?type=gene&acc=558580,,,558580.0,mfge8b,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of MFGE8B mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
861,1336303,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,574031,MIR363,https://ctdbase.org/detail.go?type=gene&acc=574031,,,574031.0,MIR363,10116,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of MIR363 mRNA,,,PMID:24420840,https://www.ncbi.nlm.nih.gov/pubmed/24420840,24420840,,
862,1336431,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,693235,MIR92B,https://ctdbase.org/detail.go?type=gene&acc=693235,,,693235.0,MIR92B,7955,Danio rerio (zebrafish),Perfluorooctane sulfonic acid results in decreased expression of MIR92B mRNA,,,PMID:20878907,https://www.ncbi.nlm.nih.gov/pubmed/20878907,20878907,,
863,1336432,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,407050,MIR93,https://ctdbase.org/detail.go?type=gene&acc=407050,,,407050.0,MIR93,7955,Danio rerio (zebrafish),Perfluorooctane sulfonic acid results in decreased expression of MIR93 mRNA,,,PMID:20878907,https://www.ncbi.nlm.nih.gov/pubmed/20878907,20878907,,
864,1346506,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51702,PADI3,https://ctdbase.org/detail.go?type=gene&acc=51702,,,51702.0,PADI3,10116,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of PADI3 mRNA,,,PMID:16221955,https://www.ncbi.nlm.nih.gov/pubmed/16221955,16221955,,
865,1346507,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,54623,PAF1,https://ctdbase.org/detail.go?type=gene&acc=54623,,,54623.0,PAF1,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of PAF1 protein,,,PMID:24301089,https://www.ncbi.nlm.nih.gov/pubmed/24301089,24301089,,
866,1346508,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5048,PAFAH1B1,https://ctdbase.org/detail.go?type=gene&acc=5048,,,5048.0,PAFAH1B1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of PAFAH1B1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of PAFAH1B1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
867,1346509,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5050,PAFAH1B3,https://ctdbase.org/detail.go?type=gene&acc=5050,,,5050.0,PAFAH1B3,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of PAFAH1B3 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
868,1346510,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5050,PAFAH1B3,https://ctdbase.org/detail.go?type=gene&acc=5050,,,5050.0,PAFAH1B3,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of PAFAH1B3 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
869,1337464,76379,Comparative Toxicogenomics Database (CTD),Tris(4-chlorophenyl)methanol,C104274,tris(4-chlorophenyl)methanol,https://ctdbase.org/detail.go?type=chem&acc=C104274,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,9913,Bos taurus (cattle),Tris(4-chlorophenyl)methanol results in decreased expression of GJA1 protein,,,PMID:11869875,https://www.ncbi.nlm.nih.gov/pubmed/11869875,11869875,,
870,1337465,76379,Comparative Toxicogenomics Database (CTD),Tris(4-chlorophenyl)methanol,C104274,tris(4-chlorophenyl)methanol,https://ctdbase.org/detail.go?type=chem&acc=C104274,406703,GSTA.1,https://ctdbase.org/detail.go?type=gene&acc=406703,,,406703.0,gsta.1,7955,Danio rerio (zebrafish),Tris(4-chlorophenyl)methanol results in decreased expression of GSTA.1 mRNA,,,PMID:36470842,https://www.ncbi.nlm.nih.gov/pubmed/36470842,36470842,,
871,1337466,76379,Comparative Toxicogenomics Database (CTD),Tris(4-chlorophenyl)methanol,C104274,tris(4-chlorophenyl)methanol,https://ctdbase.org/detail.go?type=chem&acc=C104274,119391,GSTO2,https://ctdbase.org/detail.go?type=gene&acc=119391,,,119391.0,GSTO2,7955,Danio rerio (zebrafish),Tris(4-chlorophenyl)methanol results in decreased expression of GSTO2 mRNA,,,PMID:36470842,https://www.ncbi.nlm.nih.gov/pubmed/36470842,36470842,,
872,1337467,76379,Comparative Toxicogenomics Database (CTD),Tris(4-chlorophenyl)methanol,C104274,tris(4-chlorophenyl)methanol,https://ctdbase.org/detail.go?type=chem&acc=C104274,100535101,HSP70.2,https://ctdbase.org/detail.go?type=gene&acc=100535101,,,100535101.0,hsp70.2,7955,Danio rerio (zebrafish),Tris(4-chlorophenyl)methanol results in decreased expression of HSP70.2 mRNA,,,PMID:36470842,https://www.ncbi.nlm.nih.gov/pubmed/36470842,36470842,,
873,1337468,76379,Comparative Toxicogenomics Database (CTD),Tris(4-chlorophenyl)methanol,C104274,tris(4-chlorophenyl)methanol,https://ctdbase.org/detail.go?type=chem&acc=C104274,30671,HSP70.3,https://ctdbase.org/detail.go?type=gene&acc=30671,,,30671.0,hsp70.3,7955,Danio rerio (zebrafish),Tris(4-chlorophenyl)methanol results in decreased expression of HSP70.3 mRNA,,,PMID:36470842,https://www.ncbi.nlm.nih.gov/pubmed/36470842,36470842,,
874,1337469,76379,Comparative Toxicogenomics Database (CTD),Tris(4-chlorophenyl)methanol,C104274,tris(4-chlorophenyl)methanol,https://ctdbase.org/detail.go?type=chem&acc=C104274,560210,HSP70L,https://ctdbase.org/detail.go?type=gene&acc=560210,,,560210.0,hsp70l,7955,Danio rerio (zebrafish),Tris(4-chlorophenyl)methanol results in decreased expression of HSP70L mRNA,,,PMID:36470842,https://www.ncbi.nlm.nih.gov/pubmed/36470842,36470842,,
875,1337931,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Fluorene-9-bisphenol affects the activity of TP53 protein,,,PMID:35435491,https://www.ncbi.nlm.nih.gov/pubmed/35435491,35435491,,
876,1337932,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,58218,TREM3,https://ctdbase.org/detail.go?type=gene&acc=58218,,,58218.0,Trem3,10090,Mus musculus (house mouse),Fluorene-9-bisphenol results in decreased expression of TREM3 mRNA,,,PMID:33989918,https://www.ncbi.nlm.nih.gov/pubmed/33989918,33989918,,
877,1337933,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,4308,TRPM1,https://ctdbase.org/detail.go?type=gene&acc=4308,,,4308.0,TRPM1,10090,Mus musculus (house mouse),Fluorene-9-bisphenol results in decreased expression of TRPM1 mRNA,,,PMID:33989918,https://www.ncbi.nlm.nih.gov/pubmed/33989918,33989918,,
878,1337934,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,9606,Homo sapiens (human),Fluorene-9-bisphenol results in decreased expression of VIM protein,,,PMID:31327139,https://www.ncbi.nlm.nih.gov/pubmed/31327139,31327139,,
879,1337935,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,171233,VMN1R235,https://ctdbase.org/detail.go?type=gene&acc=171233,,,171233.0,Vmn1r235,10090,Mus musculus (house mouse),Fluorene-9-bisphenol results in increased expression of VMN1R235 mRNA,,,PMID:33989918,https://www.ncbi.nlm.nih.gov/pubmed/33989918,33989918,,
880,1337936,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,171268,VMN1R82,https://ctdbase.org/detail.go?type=gene&acc=171268,,,171268.0,Vmn1r82,10090,Mus musculus (house mouse),Fluorene-9-bisphenol results in increased expression of VMN1R82 mRNA,,,PMID:33989918,https://www.ncbi.nlm.nih.gov/pubmed/33989918,33989918,,
881,1337937,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,384220,VMN2R16,https://ctdbase.org/detail.go?type=gene&acc=384220,,,384220.0,Vmn2r16,10090,Mus musculus (house mouse),Fluorene-9-bisphenol results in increased expression of VMN2R16 mRNA,,,PMID:33989918,https://www.ncbi.nlm.nih.gov/pubmed/33989918,33989918,,
882,1338676,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,10116,Rattus norvegicus (Norway rat),Fluorene-9-bisphenol results in decreased expression of SCARB1 mRNA,,,PMID:35764126,https://www.ncbi.nlm.nih.gov/pubmed/35764126,35764126,,
883,1338677,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,6445,SGCG,https://ctdbase.org/detail.go?type=gene&acc=6445,,,6445.0,SGCG,10090,Mus musculus (house mouse),Fluorene-9-bisphenol results in decreased expression of SGCG mRNA,,,PMID:33989918,https://www.ncbi.nlm.nih.gov/pubmed/33989918,33989918,,
884,1338678,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,30269,SHHA,https://ctdbase.org/detail.go?type=gene&acc=30269,,,30269.0,shha,7955,Danio rerio (zebrafish),Fluorene-9-bisphenol results in decreased expression of SHHA mrna|melatonin inhibits the reaction [fluorene-9-bisphenol results in decreased expression of SHHA mrna],,,PMID:30269372,https://www.ncbi.nlm.nih.gov/pubmed/30269372,30269372,,
885,1338790,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,9606,Homo sapiens (human),Fluorene-9-bisphenol results in decreased expression of STAR mrna|fluorene-9-bisphenol inhibits the reaction [bucladesine results in increased expression of STAR mrna],,,PMID:35987080,https://www.ncbi.nlm.nih.gov/pubmed/35987080,35987080,,
886,1338791,77080,Toxin and Toxin Target Database (T3DB),Dichlorodioctyltin,T3D1255,Di-n-octyltin dichloride,http://www.t3db.ca/toxins/T3D1255,BE0000227,Alcohol dehydrogenase 1A,http://www.t3db.ca/biodb/bio_entities/BE0000227,P07327,Alcohol dehydrogenase 1A,124.0,ADH1A,9606,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
887,1338792,77080,Toxin and Toxin Target Database (T3DB),Dichlorodioctyltin,T3D1255,Di-n-octyltin dichloride,http://www.t3db.ca/toxins/T3D1255,BE0000400,Alcohol dehydrogenase 1B,http://www.t3db.ca/biodb/bio_entities/BE0000400,P00325,All-trans-retinol dehydrogenase [NAD(+)] ADH1B,125.0,ADH1B,9606,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
888,1338793,77080,Toxin and Toxin Target Database (T3DB),Dichlorodioctyltin,T3D1255,Di-n-octyltin dichloride,http://www.t3db.ca/toxins/T3D1255,BE0000465,Alcohol dehydrogenase 1C,http://www.t3db.ca/biodb/bio_entities/BE0000465,P00326,Alcohol dehydrogenase 1C,126.0,ADH1C,9606,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
889,1338794,77080,Toxin and Toxin Target Database (T3DB),Dichlorodioctyltin,T3D1255,Di-n-octyltin dichloride,http://www.t3db.ca/toxins/T3D1255,BE0000360,Alcohol dehydrogenase 4,http://www.t3db.ca/biodb/bio_entities/BE0000360,P08319,All-trans-retinol dehydrogenase [NAD(+)] ADH4,127.0,ADH4,9606,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
890,1338795,77080,Toxin and Toxin Target Database (T3DB),Dichlorodioctyltin,T3D1255,Di-n-octyltin dichloride,http://www.t3db.ca/toxins/T3D1255,BE0003545,Alcohol dehydrogenase 6,http://www.t3db.ca/biodb/bio_entities/BE0003545,P28332,Alcohol dehydrogenase 6,130.0,ADH6,9606,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
891,1338796,77080,Toxin and Toxin Target Database (T3DB),Dichlorodioctyltin,T3D1255,Di-n-octyltin dichloride,http://www.t3db.ca/toxins/T3D1255,BE0000522,Alcohol dehydrogenase class 4 mu/sigma chain,http://www.t3db.ca/biodb/bio_entities/BE0000522,P40394,All-trans-retinol dehydrogenase [NAD,131.0,ADH7,9606,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
892,1339268,77793,Drug Gene Interaction database (DGIdb),4'-Methoxyflavone,,4'-METHOXYFLAVONE,https://www.dgidb.org/drugs/chembl:CHEMBL16312,,RAB9A,https://www.dgidb.org/genes/hgnc:9792,,,9367.0,RAB9A,9606,Homo sapiens (human),,,,,,,,
893,1341325,83261,Toxin and Toxin Target Database (T3DB),"1,2-Bis(dimethylarsino)benzene",T3D1304,"1,2-Bis(dimethylarsino)benzene",http://www.t3db.ca/toxins/T3D1304,BE0003400,Tubulin beta-2A chain,http://www.t3db.ca/biodb/bio_entities/BE0003400,Q13885,Tubulin beta-2A chain,7280.0,TUBB2A,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
894,1341326,83261,Toxin and Toxin Target Database (T3DB),"1,2-Bis(dimethylarsino)benzene",T3D1304,"1,2-Bis(dimethylarsino)benzene",http://www.t3db.ca/toxins/T3D1304,BE0003401,Tubulin beta-2B chain,http://www.t3db.ca/biodb/bio_entities/BE0003401,Q9BVA1,Tubulin beta-2B chain,347733.0,TUBB2B,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
895,1341327,83261,Toxin and Toxin Target Database (T3DB),"1,2-Bis(dimethylarsino)benzene",T3D1304,"1,2-Bis(dimethylarsino)benzene",http://www.t3db.ca/toxins/T3D1304,BE0001415,Tubulin beta-3 chain,http://www.t3db.ca/biodb/bio_entities/BE0001415,Q13509,Tubulin beta-3 chain,10381.0,TUBB3,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
896,1341328,83261,Toxin and Toxin Target Database (T3DB),"1,2-Bis(dimethylarsino)benzene",T3D1304,"1,2-Bis(dimethylarsino)benzene",http://www.t3db.ca/toxins/T3D1304,BE0001408,Tubulin beta-4A chain,http://www.t3db.ca/biodb/bio_entities/BE0001408,P04350,Tubulin beta-4A chain,10382.0,TUBB4A,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
897,1341329,83261,Toxin and Toxin Target Database (T3DB),"1,2-Bis(dimethylarsino)benzene",T3D1304,"1,2-Bis(dimethylarsino)benzene",http://www.t3db.ca/toxins/T3D1304,BE0001367,Tubulin beta-4B chain,http://www.t3db.ca/biodb/bio_entities/BE0001367,P68371,Tubulin beta-4B chain,10383.0,TUBB4B,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
898,1341330,83261,Toxin and Toxin Target Database (T3DB),"1,2-Bis(dimethylarsino)benzene",T3D1304,"1,2-Bis(dimethylarsino)benzene",http://www.t3db.ca/toxins/T3D1304,BE0003402,Tubulin beta-6 chain,http://www.t3db.ca/biodb/bio_entities/BE0003402,Q9BUF5,Tubulin beta-6 chain,84617.0,TUBB6,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
899,1341331,83261,Toxin and Toxin Target Database (T3DB),"1,2-Bis(dimethylarsino)benzene",T3D1304,"1,2-Bis(dimethylarsino)benzene",http://www.t3db.ca/toxins/T3D1304,BE0005038,Tubulin beta-8 chain,http://www.t3db.ca/biodb/bio_entities/BE0005038,Q3ZCM7,Tubulin beta-8 chain,347688.0,TUBB8,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
900,1344016,86102,Comparative Toxicogenomics Database (CTD),Tebuconazole,C087114,tebuconazole,https://ctdbase.org/detail.go?type=chem&acc=C087114,3049,HBQ1,https://ctdbase.org/detail.go?type=gene&acc=3049,,,3049.0,HBQ1,9606,Homo sapiens (human),Tebuconazole results in decreased expression of HBQ1 mRNA,,,PMID:30458266,https://www.ncbi.nlm.nih.gov/pubmed/30458266,30458266,,
901,1344017,86102,Comparative Toxicogenomics Database (CTD),Tebuconazole,C087114,tebuconazole,https://ctdbase.org/detail.go?type=chem&acc=C087114,352990,HCP5B,https://ctdbase.org/detail.go?type=gene&acc=352990,,,352990.0,HCP5B,9606,Homo sapiens (human),Tebuconazole results in decreased expression of HCP5B mRNA,,,PMID:30458266,https://www.ncbi.nlm.nih.gov/pubmed/30458266,30458266,,
902,1344018,86102,Comparative Toxicogenomics Database (CTD),Tebuconazole,C087114,tebuconazole,https://ctdbase.org/detail.go?type=chem&acc=C087114,3067,HDC,https://ctdbase.org/detail.go?type=gene&acc=3067,,,3067.0,HDC,9606,Homo sapiens (human),Tebuconazole results in decreased expression of HDC mRNA,,,PMID:30458266,https://www.ncbi.nlm.nih.gov/pubmed/30458266,30458266,,
903,1344019,86102,Comparative Toxicogenomics Database (CTD),Tebuconazole,C087114,tebuconazole,https://ctdbase.org/detail.go?type=chem&acc=C087114,9843,HEPH,https://ctdbase.org/detail.go?type=gene&acc=9843,,,9843.0,HEPH,9606,Homo sapiens (human),Tebuconazole results in decreased expression of HEPH mRNA,,,PMID:30458266,https://www.ncbi.nlm.nih.gov/pubmed/30458266,30458266,,
904,1344020,86102,Comparative Toxicogenomics Database (CTD),Tebuconazole,C087114,tebuconazole,https://ctdbase.org/detail.go?type=chem&acc=C087114,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606,Homo sapiens (human),Tebuconazole results in increased expression of HMGCR mRNA,,,PMID:30458266|PMID:36291160,https://www.ncbi.nlm.nih.gov/pubmed/30458266|https://www.ncbi.nlm.nih.gov/pubmed/36291160,30458266|36291160,,
905,1344292,86102,Comparative Toxicogenomics Database (CTD),Tebuconazole,C087114,tebuconazole,https://ctdbase.org/detail.go?type=chem&acc=C087114,197021,LCTL,https://ctdbase.org/detail.go?type=gene&acc=197021,,,197021.0,LCTL,9606,Homo sapiens (human),Tebuconazole results in decreased expression of LCTL mRNA,,,PMID:30458266,https://www.ncbi.nlm.nih.gov/pubmed/30458266,30458266,,
906,1344293,86102,Comparative Toxicogenomics Database (CTD),Tebuconazole,C087114,tebuconazole,https://ctdbase.org/detail.go?type=chem&acc=C087114,100288122,LDLRAD4-AS1,https://ctdbase.org/detail.go?type=gene&acc=100288122,,,100288122.0,LDLRAD4-AS1,9606,Homo sapiens (human),Tebuconazole results in decreased expression of LDLRAD4-AS1 mRNA,,,PMID:30458266,https://www.ncbi.nlm.nih.gov/pubmed/30458266,30458266,,
907,1164114,92815,Comparative Toxicogenomics Database (CTD),Methyloxoarsine,C080197,methylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C080197,641,BLM,https://ctdbase.org/detail.go?type=gene&acc=641,,,641.0,BLM,10116,Rattus norvegicus (Norway rat),Methylarsine oxide results in decreased expression of BLM mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
908,1164115,92815,Comparative Toxicogenomics Database (CTD),Methyloxoarsine,C080197,methylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C080197,84162,BLTP1,https://ctdbase.org/detail.go?type=gene&acc=84162,,,84162.0,BLTP1,10090,Mus musculus (house mouse),Methylarsine oxide results in increased expression of BLTP1 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
909,1164116,92815,Comparative Toxicogenomics Database (CTD),Methyloxoarsine,C080197,methylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C080197,9703,BLTP2,https://ctdbase.org/detail.go?type=gene&acc=9703,,,9703.0,BLTP2,10090,Mus musculus (house mouse),Methylarsine oxide results in increased expression of BLTP2 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
910,1164117,92815,Comparative Toxicogenomics Database (CTD),Methyloxoarsine,C080197,methylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C080197,359710,BPIFB3,https://ctdbase.org/detail.go?type=gene&acc=359710,,,359710.0,BPIFB3,10090,Mus musculus (house mouse),Methylarsine oxide results in decreased expression of BPIFB3 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
911,1164118,92815,Comparative Toxicogenomics Database (CTD),Methyloxoarsine,C080197,methylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C080197,673,BRAF,https://ctdbase.org/detail.go?type=gene&acc=673,,,673.0,BRAF,10090,Mus musculus (house mouse),Methylarsine oxide results in increased expression of BRAF mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
912,1164119,92815,Comparative Toxicogenomics Database (CTD),Methyloxoarsine,C080197,methylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C080197,672,BRCA1,https://ctdbase.org/detail.go?type=gene&acc=672,,,672.0,BRCA1,10116,Rattus norvegicus (Norway rat),Methylarsine oxide results in decreased expression of BRCA1 mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
913,1164120,92815,Comparative Toxicogenomics Database (CTD),Methyloxoarsine,C080197,methylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C080197,675,BRCA2,https://ctdbase.org/detail.go?type=gene&acc=675,,,675.0,BRCA2,10116,Rattus norvegicus (Norway rat),Methylarsine oxide results in decreased expression of BRCA2 mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
914,1334703,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31.0,ACACA,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of ACACA mrna|srt1720 inhibits the reaction [[INS protein co-treated with glucose] results in increased expression of ACACA mrna],,,PMID:19724016,https://www.ncbi.nlm.nih.gov/pubmed/19724016,19724016,,
915,1334704,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31.0,ACACA,9606,Homo sapiens (human),SIRT1 protein inhibits the reaction [glucose results in decreased phosphorylation of ACACA protein]|prkaa2 protein promotes the reaction [SIRT1 protein inhibits the reaction [glucose results in decreased phosphorylation of ACACA protein]],,,PMID:18482975,https://www.ncbi.nlm.nih.gov/pubmed/18482975,18482975,,
916,1334705,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31.0,ACACA,9606,Homo sapiens (human),[pyruvic acid co-treated with glucose] results in increased phosphorylation of ACACA protein,,,PMID:19071085,https://www.ncbi.nlm.nih.gov/pubmed/19071085,19071085,,
917,1334706,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31.0,ACACA,10090,Mus musculus (house mouse),Glucose results in increased expression of ACACA mRNA,,,PMID:15066988,https://www.ncbi.nlm.nih.gov/pubmed/15066988,15066988,,
918,1334707,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31.0,ACACA,10116,Rattus norvegicus (Norway rat),Glucose results in increased expression of ACACA mRNA,,,PMID:24349266,https://www.ncbi.nlm.nih.gov/pubmed/24349266,24349266,,
919,1334708,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31.0,ACACA,9823,Sus scrofa (pig),Glucose results in increased expression of ACACA mrna|mlxip protein affects the reaction [glucose results in increased expression of ACACA mrna],,,PMID:25827716,https://www.ncbi.nlm.nih.gov/pubmed/25827716,25827716,,
920,1334709,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,32,ACACB,https://ctdbase.org/detail.go?type=gene&acc=32,,,32.0,ACACB,9606,Homo sapiens (human),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [ACACB protein affects the reaction [glucose results in decreased expression of PPARGC1A protein]]|acacb protein affects the reaction [glucose results in decreased phosphorylation of IRS1 protein]|acacb protein affects the reaction [glucose results in decreased expression of NPHS1 protein]|acacb protein affects the reaction [glucose results in decreased expression of SIRT1 protein]|glucose results in decreased phosphorylation of ACACB protein|acacb protein affects the reaction [glucose results in decreased expression of PPARGC1A protein]|6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [ACACB protein affects the reaction [glucose results in decreased expression of SIRT1 protein]]|acacb protein affects the reaction [glucose results in decreased expression of SLC2A4 protein]|acacb protein affects the reaction [glucose results in decreased phosphorylation of AKT1 protein]",,,PMID:33957017,https://www.ncbi.nlm.nih.gov/pubmed/33957017,33957017,,
921,1334710,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,36,ACADSB,https://ctdbase.org/detail.go?type=gene&acc=36,,,36.0,ACADSB,9606,Homo sapiens (human),"2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with palmitic acid co-treated with glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mrna]|rosiglitazone affects the reaction [[osteum co-treated with palmitic acid co-treated with glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mrna]|[osteum co-treated with palmitic acid co-treated with glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA",,,PMID:32613381,https://www.ncbi.nlm.nih.gov/pubmed/32613381,32613381,,
922,1345151,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,8728,ADAM19,https://ctdbase.org/detail.go?type=gene&acc=8728,,,8728.0,ADAM19,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in increased expression of ADAM19 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
923,1345152,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,203102,ADAM32,https://ctdbase.org/detail.go?type=gene&acc=203102,,,203102.0,ADAM32,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with herbicides] results in increased expression of ADAM32 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
924,1345153,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,8756,ADAM7,https://ctdbase.org/detail.go?type=gene&acc=8756,,,8756.0,ADAM7,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with herbicides] results in decreased expression of ADAM7 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
925,1345154,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,101,ADAM8,https://ctdbase.org/detail.go?type=gene&acc=101,,,101.0,ADAM8,10090,Mus musculus (house mouse),Glucose results in increased expression of ADAM8 mRNA,,,PMID:17178593,https://www.ncbi.nlm.nih.gov/pubmed/17178593,17178593,,
926,1345155,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,101,ADAM8,https://ctdbase.org/detail.go?type=gene&acc=101,,,101.0,ADAM8,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of ADAM8 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
927,1345156,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,9510,ADAMTS1,https://ctdbase.org/detail.go?type=gene&acc=9510,,,9510.0,ADAMTS1,10090,Mus musculus (house mouse),Glucose results in increased expression of ADAMTS1 mRNA,,,PMID:17178593,https://www.ncbi.nlm.nih.gov/pubmed/17178593,17178593,,
928,1345157,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,113,ADCY7,https://ctdbase.org/detail.go?type=gene&acc=113,,,113.0,ADCY7,10090,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in increased expression of ADCY7 mrna]|glucose results in decreased methylation of ADCY7 gene|glucose results in increased expression of ADCY7 mrna|fucoxanthin inhibits the reaction [glucose results in decreased methylation of ADCY7 gene],,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
929,1108759,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,26118,WSB1,https://ctdbase.org/detail.go?type=gene&acc=26118,,,26118.0,WSB1,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of WSB1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
930,1109231,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,23174,ZCCHC14,https://ctdbase.org/detail.go?type=gene&acc=23174,,,23174.0,ZCCHC14,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ZCCHC14 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
931,1109232,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,219654,ZCCHC24,https://ctdbase.org/detail.go?type=gene&acc=219654,,,219654.0,ZCCHC24,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ZCCHC24 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
932,1109233,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,85437,ZCRB1,https://ctdbase.org/detail.go?type=gene&acc=85437,,,85437.0,ZCRB1,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ZCRB1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
933,1109234,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,79844,ZDHHC11,https://ctdbase.org/detail.go?type=gene&acc=79844,,,79844.0,ZDHHC11,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ZDHHC11 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
934,1109235,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,55625,ZDHHC7,https://ctdbase.org/detail.go?type=gene&acc=55625,,,55625.0,ZDHHC7,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ZDHHC7 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
935,1109236,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,90637,ZFAND2A,https://ctdbase.org/detail.go?type=gene&acc=90637,,,90637.0,ZFAND2A,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ZFAND2A mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
936,1109237,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,130617,ZFAND2B,https://ctdbase.org/detail.go?type=gene&acc=130617,,,130617.0,ZFAND2B,10090,Mus musculus (house mouse),Epoxiconazole results in increased expression of ZFAND2B mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
937,1109238,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,79776,ZFHX4,https://ctdbase.org/detail.go?type=gene&acc=79776,,,79776.0,ZFHX4,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ZFHX4 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
938,1109239,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,54678,ZFP108,https://ctdbase.org/detail.go?type=gene&acc=54678,,,54678.0,Zfp108,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ZFP108 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
939,1109240,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,22648,ZFP11,https://ctdbase.org/detail.go?type=gene&acc=22648,,,22648.0,Zfp11,10090,Mus musculus (house mouse),Epoxiconazole results in increased expression of ZFP11 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
940,1164603,123952,Comparative Toxicogenomics Database (CTD),Nicotinic acid adenine dinucleotide phosphate,C024376,NAADP,https://ctdbase.org/detail.go?type=chem&acc=C024376,57192,MCOLN1,https://ctdbase.org/detail.go?type=gene&acc=57192,,,57192.0,MCOLN1,9606,Homo sapiens (human),NAADP results in increased activity of MCOLN1 protein|[naadp results in increased activity of MCOLN1 protein] which affects the localization of calcium,,,PMID:21613607,https://www.ncbi.nlm.nih.gov/pubmed/21613607,21613607,,
941,1164604,123952,Comparative Toxicogenomics Database (CTD),Nicotinic acid adenine dinucleotide phosphate,C024376,NAADP,https://ctdbase.org/detail.go?type=chem&acc=C024376,27035,NOX1,https://ctdbase.org/detail.go?type=gene&acc=27035,,,27035.0,NOX1,10090,Mus musculus (house mouse),NOX1 mutant form inhibits the reaction [EDN1 protein results in increased metabolism of NAADP],,,PMID:23940720,https://www.ncbi.nlm.nih.gov/pubmed/23940720,23940720,,
942,1164605,123959,Comparative Toxicogenomics Database (CTD),"Ac-(5H-Dibenzyl(a,d)cycloheptene-10,11-dihydroglycine-leu-asp-ile-ile-trp)",C082887,PD 145065,https://ctdbase.org/detail.go?type=chem&acc=C082887,1909,EDNRA,https://ctdbase.org/detail.go?type=gene&acc=1909,,,1909.0,EDNRA,9986,Oryctolagus cuniculus (rabbit),PD 145065 binds to and results in decreased activity of EDNRA protein,,,PMID:17578707,https://www.ncbi.nlm.nih.gov/pubmed/17578707,17578707,,
943,1164606,123959,Comparative Toxicogenomics Database (CTD),"Ac-(5H-Dibenzyl(a,d)cycloheptene-10,11-dihydroglycine-leu-asp-ile-ile-trp)",C082887,PD 145065,https://ctdbase.org/detail.go?type=chem&acc=C082887,1910,EDNRB,https://ctdbase.org/detail.go?type=gene&acc=1910,,,1910.0,EDNRB,9986,Oryctolagus cuniculus (rabbit),PD 145065 binds to and results in decreased activity of EDNRB protein,,,PMID:17578707,https://www.ncbi.nlm.nih.gov/pubmed/17578707,17578707,,
944,1164607,123973,IUPHAR/BPS Guide to PHARMACOLOGY,"L-Arginine, N2-(N-(N-(N-(N-(N-(1-(1-(N2-D-arginyl-L-arginyl)-L-prolyl)-trans-4-hydroxy-L-prolyl)glycyl)-3-(2-thienyl)-L-alanyl)-L-seryl)-D-phenylalanyl)-3-(2-thienyl)-L-alanyl)-",675,NPC-349,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=675,42,B2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=42,P32299,B2 bradykinin receptor,12062.0,Bdkrb2,10090,Mus musculus (house mouse),Antagonist,pIC50,8.9,PMID:8302267,https://www.ncbi.nlm.nih.gov/pubmed/8302267,8302267,,
945,1164608,123973,IUPHAR/BPS Guide to PHARMACOLOGY,"L-Arginine, N2-(N-(N-(N-(N-(N-(1-(1-(N2-D-arginyl-L-arginyl)-L-prolyl)-trans-4-hydroxy-L-prolyl)glycyl)-3-(2-thienyl)-L-alanyl)-L-seryl)-D-phenylalanyl)-3-(2-thienyl)-L-alanyl)-",675,NPC-349,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=675,42,B2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=42,P30411,B2 bradykinin receptor,624.0,BDKRB2,9606,Homo sapiens (human),Antagonist,pIC50,7,PMID:8302267,https://www.ncbi.nlm.nih.gov/pubmed/8302267,8302267,,
946,1164609,123984,IUPHAR/BPS Guide to PHARMACOLOGY,"N-ethyl-1,2-dimethyl-6-methylimino-N-phenylpyrimidin-4-amine",2359,ZD7288,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2359,402,HCN3,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=402,Q9P1Z3,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3,57657.0,HCN3,9606,Homo sapiens (human),Antagonist,pIC50,4.5,PMID:16043489,https://www.ncbi.nlm.nih.gov/pubmed/16043489,16043489,,
947,1164610,123984,IUPHAR/BPS Guide to PHARMACOLOGY,"N-ethyl-1,2-dimethyl-6-methylimino-N-phenylpyrimidin-4-amine",2359,ZD7288,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2359,403,HCN4,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=403,Q9Y3Q4,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,10021.0,HCN4,9606,Homo sapiens (human),Antagonist,pIC50,4.7,PMID:16043489,https://www.ncbi.nlm.nih.gov/pubmed/16043489,16043489,,
948,1164611,123984,IUPHAR/BPS Guide to PHARMACOLOGY,"N-ethyl-1,2-dimethyl-6-methylimino-N-phenylpyrimidin-4-amine",2359,ZD7288,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2359,400,HCN1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=400,O60741,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,348980.0,HCN1,9606,Homo sapiens (human),Antagonist,pIC50,4.7,PMID:16043489,https://www.ncbi.nlm.nih.gov/pubmed/16043489,16043489,,
949,1164736,123984,IUPHAR/BPS Guide to PHARMACOLOGY,"N-ethyl-1,2-dimethyl-6-methylimino-N-phenylpyrimidin-4-amine",2359,ZD7288,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2359,401,HCN2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=401,Q9UL51,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,610.0,HCN2,9606,Homo sapiens (human),Antagonist,pIC50,4.4,PMID:16043489,https://www.ncbi.nlm.nih.gov/pubmed/16043489,16043489,,
950,1164737,124087,DrugBank,Desloratadine,DB00967,Desloratadine,https://www.drugbank.ca/drugs/DB00967,BE0000442,Histamine H1 receptor,https://www.drugbank.ca/bio_entities/BE0000442,P35367,Histamine H1 receptor,3269.0,HRH1,9606,Homo sapiens (human),Antagonist,,,PMID:15564772|PMID:7581058|PMID:8174605|PMID:11752352|PMID:18336052|PMID:17902729|PMID:12642846|PMID:18797058,https://www.ncbi.nlm.nih.gov/pubmed/15564772|https://www.ncbi.nlm.nih.gov/pubmed/7581058|https://www.ncbi.nlm.nih.gov/pubmed/8174605|https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/18336052|https://www.ncbi.nlm.nih.gov/pubmed/17902729|https://www.ncbi.nlm.nih.gov/pubmed/12642846|https://www.ncbi.nlm.nih.gov/pubmed/18797058,15564772|7581058|8174605|11752352|18336052|17902729|12642846|18797058,,
951,1163834,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,342538,NACA2,https://ctdbase.org/detail.go?type=gene&acc=342538,,,342538.0,NACA2,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of NACA2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
952,1163835,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,138151,NACC2,https://ctdbase.org/detail.go?type=gene&acc=138151,,,138151.0,NACC2,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of NACC2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
953,1163836,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,65220,NADK,https://ctdbase.org/detail.go?type=gene&acc=65220,,,65220.0,NADK,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of NADK mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
954,1163837,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,133686,NADK2,https://ctdbase.org/detail.go?type=gene&acc=133686,,,133686.0,NADK2,9031,Gallus gallus (chicken),[aflatoxin B1 co-treated with selenium deficiency] results in decreased expression of NADK2 protein|aflatoxin B1 results in decreased expression of NADK2 protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,
955,1163838,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,133686,NADK2,https://ctdbase.org/detail.go?type=gene&acc=133686,,,133686.0,NADK2,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of NADK2 mrna|aflatoxin B1 results in decreased methylation of NADK2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
956,1163839,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4668,NAGA,https://ctdbase.org/detail.go?type=gene&acc=4668,,,4668.0,NAGA,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of NAGA intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
957,1163840,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51172,NAGPA,https://ctdbase.org/detail.go?type=gene&acc=51172,,,51172.0,NAGPA,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of NAGPA mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
958,1163970,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,646309,NAMPTP1,https://ctdbase.org/detail.go?type=gene&acc=646309,,,646309.0,NAMPTP1,9031,Gallus gallus (chicken),[aflatoxin B1 co-treated with selenium deficiency] results in increased expression of NAMPTP1 protein|aflatoxin B1 results in increased expression of NAMPTP1 protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,
959,1163971,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,340719,NANOS1,https://ctdbase.org/detail.go?type=gene&acc=340719,,,340719.0,NANOS1,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of NANOS1 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
960,1163972,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,340719,NANOS1,https://ctdbase.org/detail.go?type=gene&acc=340719,,,340719.0,NANOS1,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of NANOS1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
961,1163973,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,140838,NANP,https://ctdbase.org/detail.go?type=gene&acc=140838,,,140838.0,NANP,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of NANP intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
962,1163974,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54187,NANS,https://ctdbase.org/detail.go?type=gene&acc=54187,,,54187.0,NANS,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of NANS intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
963,1163975,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54187,NANS,https://ctdbase.org/detail.go?type=gene&acc=54187,,,54187.0,NANS,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of NANS mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
964,1344294,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7941,PLA2G7,https://ctdbase.org/detail.go?type=gene&acc=7941,,,7941.0,PLA2G7,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PLA2G7 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
965,1344295,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,22925,PLA2R1,https://ctdbase.org/detail.go?type=gene&acc=22925,,,22925.0,PLA2R1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PLA2R1 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
966,1344296,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,22925,PLA2R1,https://ctdbase.org/detail.go?type=gene&acc=22925,,,22925.0,PLA2R1,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of PLA2R1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
967,1344297,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9373,PLAA,https://ctdbase.org/detail.go?type=gene&acc=9373,,,9373.0,PLAA,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PLAA mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
968,1344298,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9373,PLAA,https://ctdbase.org/detail.go?type=gene&acc=9373,,,9373.0,PLAA,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PLAA protein,,,PMID:29044176,https://www.ncbi.nlm.nih.gov/pubmed/29044176,29044176,,
969,1344299,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,57110,PLAAT1,https://ctdbase.org/detail.go?type=gene&acc=57110,,,57110.0,PLAAT1,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of PLAAT1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
970,1344300,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,54979,PLAAT2,https://ctdbase.org/detail.go?type=gene&acc=54979,,,54979.0,PLAAT2,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PLAAT2 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
971,1344301,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,11145,PLAAT3,https://ctdbase.org/detail.go?type=gene&acc=11145,,,11145.0,PLAAT3,9606,Homo sapiens (human),Sodium arsenite affects the expression of PLAAT3 mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
